<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | A review of type 2 diabetes mellitus and cognitive impairment</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.G8Gc_r9x.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.D28fhFCU.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BlX2Cz3M.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/l0jHfajE.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DYN1s-Xq.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CD4qBbFY.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dts-EAXz.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eXUaRzJx.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bo9_K6z3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHM6nMTY.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B1fFwJGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Di9znkJ7.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CPZN2_Bm.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DtIx_aOo.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B2VEUP4r.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dv5mmZXs.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHe6lDGB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BCjFX_1y.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/wJAsf1xy.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DNDUX-8l.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/I7IeNEc2.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CGD7YFzg.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":4.515481,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpQCAYOBUEKCl9fV1UcGgcQFQ9QDwFDHBIdA1AIBg5IAVNWBR0JBFcBUlVTSVUWCFw=","queueTime":0,"ttGuid":"200381ea7d3baa26"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029"};;/*! For license information please see nr-loader-spa-1.299.0.min.js.LICENSE.txt */
(()=>{var e,t,r={8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{if(null===e[a]){r[a]=null;continue}Array.isArray(e[a])&&Array.isArray(t[a])?r[a]=Array.from(new Set([...e[a],...t[a]])):"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){r[a]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>s,f:()=>a});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function a(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const s=e=>(0,i.a)(e,o)},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>i,No:()=>n,qh:()=>a,uh:()=>o});const n=16e3,i=1e6,o="NR_CONTAINER_AGENT",a="SESSION_ERROR"},9324:(e,t,r)=>{"use strict";r.d(t,{F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.299.0",i="PROD",o="CDN",a="^2.0.0-alpha.18"},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>s,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>a,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),a=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),s="complete"===a?.document?.readyState,c=Boolean("hidden"===a?.document?.visibilityState),u=""+a?.location,d=/iPad|iPhone|iPod/.test(a.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=a.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>a,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(s(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function a(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,a;i>0?(o=r.substring(0,i),a=r.substring(i)):(o=r,a="");let[s]=o.split(":");n.push({hostname:s,pathname:a})}}function s(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),a=r(860),s=r(2646);const c={};function u(e,t){const r={staged:!1,priority:a.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every((([e,t])=>t.staged))&&(t.sort(((e,t)=>e[1].priority-t[1].priority)),t.forEach((([t])=>{c[e].delete(t),p(e,t)})))}function p(e,t,r=!0){const a=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!a.aborted&&a.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=a.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach((([e,t])=>{Object.values(t||{}).forEach((t=>{t[0]?.on&&t[0]?.context()instanceof s.y&&t[0].on(e,t[1])}))}))}}a.isolatedBacklog||delete c[t],a.backlog[t]=null,a.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach((t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}}))}},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>s,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),a=r(5607);const s="nr@context:".concat(a.W),c=function e(t,r){var n={},a={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var s=h(n);g(e).forEach((e=>{e.apply(s,r)}));var u=v()[a[e]];u&&u.push([f,e,r,s]);return s},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach((([e,n])=>{a[n]=t,t in r||(r[t]=[])}))},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach((e=>{delete f.backlog[e]}))},isBuffering:function(e){return!!v()[a[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,s,(()=>new o.y(s))):new o.y(s)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.d,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>s,ZF:()=>c,bz:()=>a,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map((e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const a=[];for(var s=0;s<e;s++)a.push(o(r,i++).toString(16));return a.join("")}function c(){return s(16)}function u(){return s(32)}},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>a,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>s,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,a=18e5,s={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>a});var n=r(3241);const i=new Set,o={};function a(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout((()=>{i=clearTimeout(i)}),t)),n||(clearTimeout(i),i=setTimeout((()=>{e.apply(this,r)}),t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every((e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t}))}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3496:(e,t,r)=>{"use strict";function n(e){return!e||!(!e.licenseKey||!e.applicationID)}function i(e,t){return!e||e.licenseKey===t.info.licenseKey&&e.applicationID===t.info.applicationID}r.d(t,{A:()=>i,I:()=>n})},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>s,sB:()=>a});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function a(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function s(e){if(i())return e();(0,n.sp)("popstate",e)}},384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>a,US:()=>d,Zm:()=>s,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const a={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function s(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=s();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=s();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){s()[e]=t}function l(){return function(){let e=s();const t=e.info||{};e.info={beacon:a.beacon,errorBeacon:a.errorBeacon,...t}}(),function(){let e=s();const t=e.init||{};e.init={...t}}(),c(),function(){let e=s();const t=e.loader_config||{};e.loader_config={...t}}(),s()}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",(function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)}),r,i)}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),a=r(6154);const s={},c=a.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(s[t.debugId]++)return t;s[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(a.RI&&h(document,f),c&&h(c.prototype,f),h(a.gm,f)),t.on(u+"-start",(function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,(function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n}));this.wrapped=e[1]=i}})),t.on(d+"-start",(function(e){e[1]=this.wrapped||e[1]})),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),a=50;var s=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const a="-"===n.charAt(0);for(let s=0;s<t.length;s++){const c=t[s],u=e[c];l(u)||(e[c]=r(u,a?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){d([e],r)}for(var n in e)s.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,s,l,f;let h;try{s=this,o=[...arguments],l="function"==typeof n?n(o,s):n||{}}catch(t){d([t,"",[o,s,c],l],e)}i(r+"start",[o,s,c],l,u);const p=performance.now();let g;try{return f=t.apply(s,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,s,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=a,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,s],l,u),i(r+"end",[o,s,f],l,u)}}}function i(r,n,i,o){if(!c||t){var a=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=a}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>s,nf:()=>a,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],a=4,s=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={MARKS:"experimental.marks",MEASURES:"experimental.measures",RESOURCES:"experimental.resources"}},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>a,TZ:()=>s,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},a="log",s=n.K7.logging},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),a=r(8154),s=r(993);function c(e,t,r={},c=s.p_.INFO,u,d=(0,i.t)()){(0,n.p)(a.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(s.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(s.p_).some((t=>t===e.toUpperCase().trim()))}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>s,TZ:()=>n,rs:()=>i,xV:()=>a});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,G4:()=>o,Qb:()=>l,TZ:()=>i,Ug:()=>a,_s:()=>s,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o={RECORD:"recordReplay",PAUSE:"pauseReplay",ERROR_DURING_REPLAY:"errorDuringReplay"},a=.12,s={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>a,SR:()=>o,rF:()=>s});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function a(e){return!0===e?.session_replay.preload&&o(e)}function s(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>s,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>a,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState",l=1e3,f=3e4},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>a,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>s,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",a="api",s="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>s,wW:()=>T,xq:()=>a});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(){return this.#e(i.dT)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Tb:()=>f,U2:()=>a,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>s,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",a="addToTrace",s="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure"},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>S});var n=r(384),i=r(1741);var o=r(2555),a=r(3333);const s=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{marks:!1,measures:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{allow_registered_children:!0,duplicate_registered_data:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{get capture_marks(){return e.feature_flags.includes(a.$v.MARKS)||e.experimental.marks},set capture_marks(t){e.experimental.marks=t},get capture_measures(){return e.feature_flags.includes(a.$v.MEASURES)||e.experimental.measures},set capture_measures(t){e.experimental.measures=t},capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(a.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){s(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){s(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={appMetadata:{},customTransaction:void 0,denyList:void 0,disabled:!1,entityManager:void 0,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},b=e=>{const t=(0,d.a)(e,v),r=Object.keys(m).reduce(((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e)),{});return Object.defineProperties(t,r)};var y=r(5701);const w=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var R=r(7836),x=r(3241);const T={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},E=e=>(0,d.a)(e,T),A=new Set;function S(e,t={},r,a){let{init:s,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();s=e.init,c=e.info,u=e.loader_config}e.init=f(s||{}),e.loader_config=E(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];A.has(e.agentIdentifier)||(p.proxy.assets&&(w(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach((r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})}))}(e),(0,n.US)("activatedFeatures",y.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=b(d),A.has(e.agentIdentifier)||(e.ee=R.ee.get(e.agentIdentifier),e.exposed=l,(0,x.W)({agentIdentifier:e.agentIdentifier,drained:!!y.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),A.add(e.agentIdentifier)}},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>s,df:()=>o,qY:()=>n,v4:()=>a});const n="events",i="jserrors",o="browser/blobs",a="rum",s="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:a,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:s,[c.genericEvents]:"ins"}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.299.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.299.0.PROD:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){s=l;break}}if(!s){c=!0;var f={478:"sha512-yFJXofnEnG8GVm9Qz5bow499gEH4SUOHqCjdkgsEOCxDOsZoo6GAo0XOXkpDWCr8r/qh/17K3wtEjY+UStuwyw==",249:"sha512-3rG4bEt0s/aK1DXD9BmVuktPkzvPXiB21q2yBNlhxwh6FzcavxvecMtedf3aoJl9CNoyGK6ELRA9yaR0cXbgrQ==",212:"sha512-vjMr4Qq4Ot5S5x5z8QHtNerncpBJSI4ZG0LtBk34EJW4Qtauz9/kg4PFIxMbgq9NSWQyPfCLMnjuTBIHagA1aQ=="};(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r,0!==s.src.indexOf(window.location.origin+"/")&&(s.crossOrigin="anonymous"),f[a]&&(s.integrity=f[a])}e[r]=[n];var h=(t,n)=>{s.onerror=s.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=h.bind(null,s.onerror),s.onload=h.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.299.0.PROD"]=self["webpackChunk:NRBA-1.299.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var a=i(5205);var s=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const a=o||i;!a||a[e]&&a[e]!==r.prototype[e]||(a[e]=function(){(0,s.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,s.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.onAggregateImported=void 0,this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise(((t,r)=>{this.ee.on("manual-start-all",(0,x.J)((()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()})))})):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let o;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));o=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,s.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,o,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void n(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),n(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),n(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)((()=>o()),!0):o()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class O extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,(function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,s.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))}),t),this.ee.on("api-send-rum",((e,t)=>(0,s.p)("send-rum",[e,t],void 0,this.featureName,this.ee))),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,1983))))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)((e=>{t(e,"DOMContentLoaded")})),(0,b.GG)((e=>{t(e,"load")})),(0,b.Qr)((e=>{t(e,"navigate")})),this.ee.on(S.tS.UPDATE,((t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})}))}}var _=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)((()=>(0,s.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee)),!0),(0,I.sp)("pagehide",(()=>(0,s.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee))),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,9917)))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",(e=>{(0,s.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)})),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,6555))))}}var C=i(6774),L=i(3304);class M{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function H(e){return U(e)?e:new M(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function D(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return H(e.reason)}const r=H(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function K(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new M(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:H(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,s.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,s.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(3496),B=i(993),G=i(3785);function V(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,G.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,s.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e){p(u.eY,(function(t){return function(e,t){const r={};let i,o;(0,l.R)(54,"newrelic.register"),e.init.api.allow_registered_children||(i=()=>(0,l.R)(55));t&&(0,W.I)(t)||(i=()=>(0,l.R)(48,t));const a={addPageAction:(n,i={})=>{u(z,[n,{...r,...i},e],t)},log:(n,i={})=>{u(V,[n,{...i,customAttributes:{...r,...i.customAttributes||{}}},e],t)},noticeError:(n,i={})=>{u(F,[n,{...r,...i},e],t)},setApplicationVersion:e=>{r["application.version"]=e},setCustomAttribute:(e,t)=>{r[e]=t},setUserId:e=>{r["enduser.id"]=e},metadata:{customAttributes:r,target:t,get connected(){return o||Promise.reject(new Error("Failed to connect"))}}};i?i():o=new Promise(((n,i)=>{try{const o=e.runtime?.entityManager;let s=!!o?.get().entityGuid,c=o?.getEntityGuidFor(t.licenseKey,t.applicationID),u=!!c;if(s&&u)t.entityGuid=c,n(a);else{const d=setTimeout((()=>i(new Error("Failed to connect - Timeout"))),15e3);function l(r){(0,W.A)(r,e)?s||=!0:t.licenseKey===r.licenseKey&&t.applicationID===r.applicationID&&(u=!0,t.entityGuid=r.entityGuid),s&&u&&(clearTimeout(d),e.ee.removeEventListener("entity-added",l),n(a))}e.ee.emit("api-send-rum",[r,t]),e.ee.on("entity-added",l)}}catch(f){i(f)}}));const u=async(t,r,a)=>{if(i)return i();const u=(0,c.t)();(0,s.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{await o;const n=e.init.api.duplicate_registered_data;(!0===n||Array.isArray(n)&&n.includes(a.entityGuid))&&t(...r,void 0,u),t(...r,a.entityGuid,u)}catch(e){(0,l.R)(50,e)}};return a}(e,t)}),e)}class q extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,((e,r)=>F(e,r,t)),t),function(e){p(u.bt,(function(t){e.runtime.onerror=t}),e)}(e),function(e){let t=0;p(u.k6,(function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))}),e)}(e),Z(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",((t,r)=>{this.abortHandler&&(0,s.p)("ierr",[H(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)})),y.gm.addEventListener("unhandledrejection",(t=>{this.abortHandler&&(0,s.p)("err",[D(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)}),(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",(t=>{this.abortHandler&&(0,s.p)("err",[K(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)}),(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,(()=>i.e(478).then(i.bind(i,2176))))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var X=i(8990);let Y=1;function Q(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,X.I)(e,"nr@id",(function(){return Y++}))}function J(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ee=i(8139),te=i(7836),re=i(3434);const ne={},ie=["open","send"];function oe(e){var t=e||te.ee;const r=function(e){return(e||te.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(ne[r.debugId]++)return r;ne[r.debugId]=1,(0,ee.u)(t);var n=(0,re.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,a=y.gm.Promise,s=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(a=o,function(){var e=this;e.readyState>3&&!a.resolved&&(a.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var a;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ie,"-xhr-",b),r.on("send-xhr-start",(function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):s?s(v):(g=-g,m.data=g))}(t)})),r.on("open-xhr-start",h),o){var p=a&&a.resolve();if(!s&&!a){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===c||v()}));function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ae="fetch-",se=ae+"body-",ce=["arrayBuffer","blob","json","text","formData"],ue=y.gm.Request,de=y.gm.Response,le="prototype";const fe={};function he(e){const t=function(e){return(e||te.ee).get("fetch")}(e);if(!(ue&&de&&y.gm.fetch))return t;if(fe[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[te.P]&&o[te.P].dt&&(e=o[te.P].dt);var a=i.apply(this,r);return t.emit(n+"start",[r,e],a),a.then((function(e){return t.emit(n+"end",[null,e],a),e}),(function(e){throw t.emit(n+"end",[e],a),e}))})}return fe[t.debugId]=1,ce.forEach((e=>{r(ue[le],e,se),r(de[le],e,se)})),r(y.gm,"fetch",ae),t.on(ae+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ae+"done",[null,r],n)}else t.emit(ae+"done",[e],n)})),t}var pe=i(7485);class ge{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,e.ZF)(),s=(0,e.el)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,L.A)(a))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,pe.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var me=i(9300),ve=i(7295);function be(e){return"string"==typeof e?e:e instanceof(0,_.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var ye=["load","error","abort","timeout"],we=ye.length,Re=(0,_.dV)().o.REQ,xe=(0,_.dV)().o.XHR;const Te="X-NewRelic-App-Data";class Ee extends E{static featureName=me.T;constructor(e){super(e,me.T),this.dt=new ge(e),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach((t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Ae(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}}))}catch(e){}he(this.ee),oe(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",(function(r){A(t,e)}),(0,I.jT)(!1)),y.lR||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,I.jT)(!1))}function a(e){this.params={method:e[0]},Ae(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var a=J(i);a&&(n.txSize=a)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var s=0;s<we;s++)r.addEventListener(ye[s],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+Q(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+Q(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof xe&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof xe&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof xe&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,pe.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)s(e[0].headers,n)&&(this.dt=n);else{var o={};for(var a in r)o[a]=r[a];o.headers=new Headers(r.headers||{}),s(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Ae(this,be(n));var i=(""+(n&&n instanceof Re&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=J(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,ve.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<we;t++)e.removeEventListener(ye[t],this.listener,!1);t.aborted||(0,ve.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?J(e.response):"text"===r||""===r||void 0===r?J(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Te)>=0){var o=r.getResponseHeader(Te);o&&((0,s.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",a),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,3845))))}}function Ae(e,t){var r=(0,pe.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Se={},Oe=["pushState","replaceState"];function _e(e){const t=function(e){return(e||te.ee).get("history")}(e);return!y.RI||Se[t.debugId]++||(Se[t.debugId]=1,(0,re.YM)(t).inPlace(window.history,Oe,"-")),t}var Ne=i(3738);function Ie(e){p(u.BL,(function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,s.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,s.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)}),e)}const{He:Pe,bD:je,d3:ke,Kp:Ce,TZ:Le,Lc:Me,uP:He,Rz:De}=Ne;class Ke extends E{static featureName=Le;constructor(e){var t;super(e,Le),t=e,p(u.U2,(function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,s.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)}),t),Ie(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;_e(r),this.eventsEE=(0,ee.u)(r),this.eventsEE.on(He,(function(e,t){this.bstStart=(0,c.t)()})),this.eventsEE.on(Me,(function(e,t){(0,s.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)})),r.on(De+ke,(function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash})),r.on(De+Ce,(function(e){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)}));try{o=new PerformanceObserver((e=>{const t=e.getEntries();(0,s.p)(Pe,[t],void 0,n.K7.sessionTrace,r)})),o.observe({type:je,buffered:!0})}catch(e){}this.importAggregator(e,(()=>i.e(478).then(i.bind(i,6974))),{resourceObserver:o})}}var Ue=i(6344);class Fe extends E{static featureName=Ue.TZ;#n;recorder;constructor(e){var t;let r;super(e,Ue.TZ),t=e,p(u.CH,(function(){(0,s.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)}),t),function(e){p(u.Tb,(function(){(0,s.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)}),e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(Ue.G4.RECORD,(()=>this.#i())),this.#o(r)&&this.importRecorder().then((e=>{e.startRecording(Ue.Qb.PRELOAD,r?.sessionReplayMode)})),this.importAggregator(this.agentRef,(()=>i.e(478).then(i.bind(i,6167))),this),this.ee.on("err",(e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,s.p)(Ue.G4.ERROR_DURING_REPLAY,[e],void 0,this.featureName,this.ee))}))}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,8589)).then((({Recorder:e})=>(this.recorder=new e(this),this.recorder))).catch((e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e})),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Ue.Qb.API):this.importRecorder().then((()=>{this.recorder.startRecording(Ue.Qb.API,S.g.FULL)})))}}var We=i(3962);function Be(e){const t=e.ee.get("tracer");function r(){}p(u.dT,(function(e){return(new r).get("object"==typeof e?e:{})}),e);const i=r.prototype={createTracer:function(r,i){var o={},a=this,d="function"==typeof i;return(0,s.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,s.p)(u.hw+"tracer",[(0,c.t)(),r,o],a,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),a,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((t=>{p.apply(this,[t,function(){return(0,s.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])})),p(u.PA,(function(){e.runSoftNavOverSpa?(0,s.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,s.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)}),e)}class Ge extends E{static featureName=We.TZ;constructor(e){if(super(e,We.TZ),Be(e),!y.RI||!(0,_.dV)().o.MO)return;const t=_e(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}We.tC.forEach((e=>{(0,I.sp)(e,(e=>{a(e)}),!0,this.removeOnAbort?.signal)}));const r=()=>(0,s.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(We.OV,(e=>{a(e),(0,s.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)}),!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,_.dV)().o.MO)(((e,t)=>{n||(n=!0,requestAnimationFrame((()=>{(0,s.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1})))})),a=(0,x.s)((e=>{(0,s.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})}),100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,(()=>i.e(478).then(i.bind(i,4393))),{domObserver:o})}}var Ve=i(7378);const ze={},Ze=["appendChild","insertBefore","replaceChild"];function qe(e){const t=function(e){return(e||te.ee).get("jsonp")}(e);if(!y.RI||ze[t.debugId])return t;ze[t.debugId]=!0;var r=(0,re.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function a(e,t){if(!e)return t;const r=e.match(o),n=r[1];return a(r[3],t[n])}return r.inPlace(Node.prototype,Ze,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(s=e.src,c=s.match(n),c?c[1]:null);var s,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:a(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}const Xe={};function Ye(e){const t=function(e){return(e||te.ee).get("promise")}(e);if(Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=t.context,n=(0,re.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),a=n(r,"executor-",o,null,!1);const s=Reflect.construct(i,[a],e);return t.context(s).getCtx=function(){return o},s}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach((function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,a=r(i);a.promise=i,e[0]=n(e[0],"cb-",a,null,!1),e[1]=n(e[1],"cb-",a,null,!1);const s=o.apply(this,e);return a.nextPromise=s,t.emit("propagate",[i,!0],s,!1,!1),s},i.prototype.then[re.Jt]=o,t.on("executor-start",(function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)})),t.on("executor-err",(function(e,t,r){e[1](r)})),t.on("cb-end",(function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)})),t.on("propagate",(function(e,r,n){this.getCtx&&!r||(this.getCtx=function(){if(e instanceof Promise)var r=t.context(e);return r&&r.getCtx?r.getCtx():this})}))}(),t}const $e={},Qe="setTimeout",Je="setInterval",et="clearTimeout",tt="-start",rt=[Qe,"setImmediate",Je,et,"clearImmediate"];function nt(e){const t=function(e){return(e||te.ee).get("timer")}(e);if($e[t.debugId]++)return t;$e[t.debugId]=1;var r=(0,re.YM)(t);return r.inPlace(y.gm,rt.slice(0,2),Qe+"-"),r.inPlace(y.gm,rt.slice(2,3),Je+"-"),r.inPlace(y.gm,rt.slice(3),et+"-"),t.on(Je+tt,(function(e,t,n){e[0]=r(e[0],"fn-",null,n)})),t.on(Qe+tt,(function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)})),t}const it={};function ot(e){const t=function(e){return(e||te.ee).get("mutation")}(e);if(!y.RI||it[t.debugId])return t;it[t.debugId]=!0;var r=(0,re.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:at,d3:st,Kp:ct,$p:ut,wW:dt,e5:lt,tH:ft,uP:ht,rw:pt,Lc:gt}=Ve;class mt extends E{static featureName=at;constructor(e){if(super(e,at),Be(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=qe(this.ee),a=Ye(this.ee),u=nt(this.ee),d=oe(this.ee),l=this.ee.get("events"),f=he(this.ee),h=_e(this.ee),p=ot(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[ht]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[lt]=~~this[lt]+e-this[ht],this[gt]=e}function b(e,t){e.on(t,(function(){this[t]=(0,c.t)()}))}this.ee.on(ht,m),a.on(pt,m),o.on(pt,m),this.ee.on(gt,v),a.on(dt,v),o.on(dt,v),this.ee.on("fn-err",((...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,s.p)("function-err",[...t],void 0,this.featureName,this.ee)})),this.ee.buffer([ht,gt,"xhr-resolved"],this.featureName),l.buffer([ht],this.featureName),u.buffer(["setTimeout"+ct,"clearTimeout"+st,ht],this.featureName),d.buffer([ht,"new-xhr","send-xhr"+st],this.featureName),f.buffer([ft+st,ft+"-done",ft+ut+st,ft+ut+ct],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([ht],this.featureName),a.buffer(["propagate",pt,dt,"executor-err","resolve"+st],this.featureName),n.buffer([ht,"no-"+ht],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,ft+st),b(f,ft+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){g(0,r>1)}),(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,(()=>i.e(478).then(i.bind(i,5592))))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var vt=i(3333);class bt extends E{static featureName=vt.TZ;constructor(e){super(e,vt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;if(r=e,p(u.hG,((e,t)=>z(e,t,r)),r),function(e){p(u.fF,(function(){(0,s.p)(u.Pl+u.fF,[(0,c.t)(),...arguments],void 0,n.K7.genericEvents,e.ee)}),e)}(e),Ie(e),Z(e),function(e){p(u.V1,(function(t,r){const i=(0,c.t)(),{start:o,end:a,customAttributes:d}=r||{},f={customAttributes:d||{}};if("object"!=typeof f.customAttributes||"string"!=typeof t||0===t.length)return void(0,l.R)(57);const h=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(f.start=h(o,0),f.end=h(a,i),Number.isNaN(f.start)||Number.isNaN(f.end))(0,l.R)(57);else{if(f.duration=f.end-f.start,!(f.duration<0))return(0,s.p)(u.Pl+u.V1,[f,t],void 0,n.K7.genericEvents,e.ee),f;(0,l.R)(58)}}),e)}(e),y.RI){if(e.init.user_actions.enabled&&(vt.Zp.forEach((e=>(0,I.sp)(e,(e=>(0,s.p)("ua",[e],void 0,this.featureName,this.ee)),!0))),vt.qN.forEach((e=>{const t=(0,x.s)((e=>{(0,s.p)("ua",[e],void 0,this.featureName,this.ee)}),500,{leading:!0});(0,I.sp)(e,t)}))),e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver((e=>{e.getEntries().forEach((e=>{(0,s.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)}))})).observe({type:"resource",buffered:!0})}const a=_e(this.ee);function d(){a.emit("navChange")}a.on("pushState-end",d),a.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}try{this.removeOnAbort=new AbortController}catch(f){}function o(t){const r=(0,pe.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},y.gm.addEventListener("error",(()=>{(0,s.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)}),(0,I.jT)(!1,this.removeOnAbort?.signal)),he(this.ee),oe(this.ee),this.ee.on("open-xhr-start",((e,t)=>{o(e[1])||t.addEventListener("readystatechange",(()=>{2===t.readyState&&(0,s.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}))})),this.ee.on("fetch-start",(e=>{e.length>=1&&!o(be(e[0]))&&(0,s.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})),t.some((e=>e))?this.importAggregator(e,(()=>i.e(478).then(i.bind(i,8019)))):this.deregisterDrain()}}var yt=i(2646);const wt=new Map;function Rt(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||te.ee).get("logger")}(e),o=(0,re.YM)(i),a=new yt.y(te.P);a.level=n.level,a.customAttributes=n.customAttributes;const s=t[r]?.[re.Jt]||t[r];return wt.set(s,a),o.inPlace(t,[r],"wrap-logger-",(()=>wt.get(s))),i}var xt=i(1910);class Tt extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,((e,r)=>V(e,r,t)),t),function(e){p(u.Wb,((t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Rt(e.ee,t,r,{customAttributes:n,level:i})}),e)}(e),Z(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach((e=>{(0,xt.i)(y.gm.console[e]),Rt(r,y.gm.console,e,{level:"log"===e?"info":e})})),this.ee.on("wrap-logger-end",(function([e]){const{level:t,customAttributes:n}=this;(0,G.R)(r,e,n,t)})),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,5288))))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,_.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(O),this.runSoftNavOverSpa=[...this.desiredFeatures].some((e=>e.featureName===n.K7.softNav)),(0,a.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,(function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)}),t),function(e){p(u.Dl,(function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)}),e)}(this),function(e){p(u.nb,(function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)}),e)}(this),function(e){p(u.d3,(function(){e.ee.emit("manual-start-all")}),e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach((r=>{t[r]=!!e[r]?.enabled})),t}(this.init),t=[...this.desiredFeatures];t.sort(((e,t)=>n.P3[e.featureName]-n.P3[t.featureName])),t.forEach((t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter((e=>!(e in this.features)));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)}))}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,_.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[Ee,O,j,Ke,Fe,k,q,bt,Tt,Ge,mt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full">
<meta property="description" name="description" content="The association between type 2 diabetes mellitus (T2DM) and cognitive impairment represents a critical public health concern, particularly against the backdr...">
<meta property="og:title" name="title" content="Frontiers | A review of type 2 diabetes mellitus and cognitive impairment">
<meta property="og:description" name="description" content="The association between type 2 diabetes mellitus (T2DM) and cognitive impairment represents a critical public health concern, particularly against the backdr...">
<meta name="keywords" content="type 2 diabetes mellitus,insulin resistance,oxidative stress,cognitive impairment,mitochondrial dysfunction">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="16">
<meta name="citation_journal_title" content="Frontiers in Endocrinology">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Endocrinol.">
<meta name="citation_issn" content="1664-2392">
<meta name="citation_doi" content="10.3389/fendo.2025.1624472">
<meta name="citation_firstpage" content="1624472">
<meta name="citation_language" content="English">
<meta name="citation_title" content="A review of type 2 diabetes mellitus and cognitive impairment">
<meta name="citation_keywords" content="type 2 diabetes mellitus; insulin resistance; oxidative stress; cognitive impairment; mitochondrial dysfunction">
<meta name="citation_abstract" content="The association between type 2 diabetes mellitus (T2DM) and cognitive impairment represents a critical public health concern, particularly against the backdrop of the rising global prevalence of diabetes and aging populations. Accumulating evidence indicates that T2DM is linked to declines in multiple cognitive domains, which may progress to cognitive impairment or even dementia. This cognitive impairment arises from complex interactions among insulin resistance, chronic inflammatory responses, vascular injury and microangiopathy and oxidative stress. Clinical studies suggest that strict glycemic control combined with behavioral and lifestyle interventions may delay cognitive decline, though their long-term efficacy requires further evidence-based validation. Future research should leverage multi-omics technologies to identify early biomarkers for T2DM-related cognitive impairment, elucidate the underlying molecular mechanisms, identify specific therapeutic targets, and develop personalized intervention strategies. This review systematically examines the epidemiological correlations, pathophysiological mechanisms, and advances in clinical management of T2DM-related cognitive disorders, with the aim of providing a theoretical foundation for early prevention and targeted treatment.">
<meta name="citation_article_type" content="Review">
<meta name="citation_pdf_url" content="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/pdf">
<meta name="citation_xml_url" content="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2025/07/16">
<meta name="citation_publication_date" content="2025/08/04">
<meta name="citation_author" content="Kan, Wen ">
<meta name="citation_author_institution" content="Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, China">
<meta name="citation_author" content="Qu, Meijie ">
<meta name="citation_author_institution" content="Department of Neurology, Affiliated Hospital of Qingdao University, China">
<meta name="citation_author" content="Wang, Yunyang ">
<meta name="citation_author_institution" content="Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, China">
<meta name="citation_author" content="Zhang, Xianjun ">
<meta name="citation_author_institution" content="Department of Neurology, Affiliated Hospital of Qingdao University, China">
<meta name="citation_author" content="Xu, Lili ">
<meta name="citation_author_institution" content="Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, China">
<meta name="dc.identifier" content="doi:10.3389/fendo.2025.1624472">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"A review of type 2 diabetes mellitus and cognitive impairment","author":[{"@type":"Person","name":"Wen Kan","affiliation":["Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, China"]},{"@type":"Person","name":"Meijie Qu","affiliation":["Department of Neurology, Affiliated Hospital of Qingdao University, China"]},{"@type":"Person","name":"Yunyang Wang","affiliation":["Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, China"]},{"@type":"Person","name":"Xianjun Zhang","affiliation":["Department of Neurology, Affiliated Hospital of Qingdao University, China"]},{"@type":"Person","name":"Lili Xu","affiliation":["Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, China"]}],"datePublished":"2025-08-04","dateModified":"2025-10-12","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2025","isPartOf":{"@type":"PublicationVolume","volumeNumber":"16","isPartOf":{"@type":"Periodical","name":"Frontiers in Endocrinology"}}},"citation":["https://doi.org/10.3389/fendo.2025.1624472"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/BlX2Cz3M.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="red"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/endocrinology" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Endocrinology</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=23&amp;specialtyid=0&amp;entitytype=2&amp;entityid=106" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/endocrinology" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Endocrinology</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/adrenal-endocrinology" data-event="iBarJournal-sections-a_id_2258">Adrenal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/bone-research" data-event="iBarJournal-sections-a_id_457">Bone Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cancer-endocrinology" data-event="iBarJournal-sections-a_id_116">Cancer Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cardiovascular-endocrinology" data-event="iBarJournal-sections-a_id_2259">Cardiovascular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cellular-endocrinology" data-event="iBarJournal-sections-a_id_120">Cellular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/clinical-diabetes" data-event="iBarJournal-sections-a_id_107">Clinical Diabetes</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/developmental-endocrinology" data-event="iBarJournal-sections-a_id_2261">Developmental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/diabetes-molecular-mechanisms" data-event="iBarJournal-sections-a_id_1548">Diabetes: Molecular Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/endocrinology-of-aging" data-event="iBarJournal-sections-a_id_127">Endocrinology of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/experimental-endocrinology" data-event="iBarJournal-sections-a_id_121">Experimental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/gut-endocrinology" data-event="iBarJournal-sections-a_id_1770">Gut Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/molecular-and-structural-endocrinology" data-event="iBarJournal-sections-a_id_118">Molecular and Structural Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/neuroendocrine-science" data-event="iBarJournal-sections-a_id_113">Neuroendocrine Science</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/obesity" data-event="iBarJournal-sections-a_id_458">Obesity</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pediatric-endocrinology" data-event="iBarJournal-sections-a_id_124">Pediatric Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pituitary-endocrinology" data-event="iBarJournal-sections-a_id_112">Pituitary Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/renal-endocrinology" data-event="iBarJournal-sections-a_id_2257">Renal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/reproduction" data-event="iBarJournal-sections-a_id_126">Reproduction</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/systems-endocrinology" data-event="iBarJournal-sections-a_id_117">Systems Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/thyroid-endocrinology" data-event="iBarJournal-sections-a_id_128">Thyroid Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/translational-and-clinical-endocrinology" data-event="iBarJournal-sections-a_id_122">Translational and Clinical Endocrinology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=23&amp;specialtyid=0&amp;entitytype=2&amp;entityid=106" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/endocrinology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Endocrinology</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/adrenal-endocrinology" data-event="iBarJournal-sections-a_id_2258">Adrenal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/bone-research" data-event="iBarJournal-sections-a_id_457">Bone Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cancer-endocrinology" data-event="iBarJournal-sections-a_id_116">Cancer Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cardiovascular-endocrinology" data-event="iBarJournal-sections-a_id_2259">Cardiovascular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cellular-endocrinology" data-event="iBarJournal-sections-a_id_120">Cellular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/clinical-diabetes" data-event="iBarJournal-sections-a_id_107">Clinical Diabetes</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/developmental-endocrinology" data-event="iBarJournal-sections-a_id_2261">Developmental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/diabetes-molecular-mechanisms" data-event="iBarJournal-sections-a_id_1548">Diabetes: Molecular Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/endocrinology-of-aging" data-event="iBarJournal-sections-a_id_127">Endocrinology of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/experimental-endocrinology" data-event="iBarJournal-sections-a_id_121">Experimental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/gut-endocrinology" data-event="iBarJournal-sections-a_id_1770">Gut Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/molecular-and-structural-endocrinology" data-event="iBarJournal-sections-a_id_118">Molecular and Structural Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/neuroendocrine-science" data-event="iBarJournal-sections-a_id_113">Neuroendocrine Science</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/obesity" data-event="iBarJournal-sections-a_id_458">Obesity</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pediatric-endocrinology" data-event="iBarJournal-sections-a_id_124">Pediatric Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pituitary-endocrinology" data-event="iBarJournal-sections-a_id_112">Pituitary Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/renal-endocrinology" data-event="iBarJournal-sections-a_id_2257">Renal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/reproduction" data-event="iBarJournal-sections-a_id_126">Reproduction</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/systems-endocrinology" data-event="iBarJournal-sections-a_id_117">Systems Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/thyroid-endocrinology" data-event="iBarJournal-sections-a_id_128">Thyroid Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/translational-and-clinical-endocrinology" data-event="iBarJournal-sections-a_id_122">Translational and Clinical Endocrinology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/endocrinology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Endocrinology</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/adrenal-endocrinology" data-event="iBarJournal-sections-a_id_2258">Adrenal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/bone-research" data-event="iBarJournal-sections-a_id_457">Bone Research</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cancer-endocrinology" data-event="iBarJournal-sections-a_id_116">Cancer Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cardiovascular-endocrinology" data-event="iBarJournal-sections-a_id_2259">Cardiovascular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/cellular-endocrinology" data-event="iBarJournal-sections-a_id_120">Cellular Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/clinical-diabetes" data-event="iBarJournal-sections-a_id_107">Clinical Diabetes</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/developmental-endocrinology" data-event="iBarJournal-sections-a_id_2261">Developmental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/diabetes-molecular-mechanisms" data-event="iBarJournal-sections-a_id_1548">Diabetes: Molecular Mechanisms</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/endocrinology-of-aging" data-event="iBarJournal-sections-a_id_127">Endocrinology of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/experimental-endocrinology" data-event="iBarJournal-sections-a_id_121">Experimental Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/gut-endocrinology" data-event="iBarJournal-sections-a_id_1770">Gut Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/molecular-and-structural-endocrinology" data-event="iBarJournal-sections-a_id_118">Molecular and Structural Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/neuroendocrine-science" data-event="iBarJournal-sections-a_id_113">Neuroendocrine Science</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/obesity" data-event="iBarJournal-sections-a_id_458">Obesity</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pediatric-endocrinology" data-event="iBarJournal-sections-a_id_124">Pediatric Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/pituitary-endocrinology" data-event="iBarJournal-sections-a_id_112">Pituitary Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/renal-endocrinology" data-event="iBarJournal-sections-a_id_2257">Renal Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/reproduction" data-event="iBarJournal-sections-a_id_126">Reproduction</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/systems-endocrinology" data-event="iBarJournal-sections-a_id_117">Systems Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/thyroid-endocrinology" data-event="iBarJournal-sections-a_id_128">Thyroid Endocrinology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/endocrinology/sections/translational-and-clinical-endocrinology" data-event="iBarJournal-sections-a_id_122">Translational and Clinical Endocrinology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/endocrinology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/endocrinology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=23&amp;specialtyid=0&amp;entitytype=2&amp;entityid=106" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">REVIEW article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Endocrinol.</span><span>, 04 August 2025</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Neuroendocrine Science</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 16 - 2025 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fendo.2025.1624472">https://doi.org/10.3389/fendo.2025.1624472</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Association of Diabetes Mellitus with Cognitive Impairment and Neurological Disorders Vol. 2</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 7 articles" href="https://www.frontiersin.org/research-topics/68922/association-of-diabetes-mellitus-with-cognitive-impairment-and-neurological-disorders-vol-2/articles" target="_self" data-event="customLink-linkType-a_viewAll7Articles"><span>View all 7 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>A review of type 2 diabetes mellitus and cognitive impairment</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract"><a id="h1" name="h1"></a><div class="authors"><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/3045155/overview" class="user-id-3045155/overview"><img class="pr5" src="https://loop.frontiersin.org/images/profile/3045155/overview/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Wen Kan">Wen Kan</a><sup>1</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1582163/overview" class="user-id-1582163/overview"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1582163/overview/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Meijie Qu">Meijie Qu</a><sup>2</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2360031/overview" class="user-id-2360031/overview"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2360031/overview/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Yunyang Wang">Yunyang Wang</a><sup>1</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Xianjun Zhang" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Xianjun Zhang<sup>2</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2803876/overview" class="user-id-2803876/overview"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2803876/overview/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Lili Xu*">Lili Xu</a><sup>1*</sup></span></div><ul class="notes"><li><span><sup>1</sup></span>Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, Qingdao,&#xa0;China</li><li><span><sup>2</sup></span>Department of Neurology, Affiliated Hospital of Qingdao University, Qingdao,&#xa0;China</li></ul><p>The association between type 2 diabetes mellitus (T2DM) and cognitive impairment represents a critical public health concern, particularly against the backdrop of the rising global prevalence of diabetes and aging populations. Accumulating evidence indicates that T2DM is linked to declines in multiple cognitive domains, which may progress to cognitive impairment or even dementia. This cognitive impairment arises from complex interactions among insulin resistance, chronic inflammatory responses, vascular injury and microangiopathy and oxidative stress. Clinical studies suggest that strict glycemic control combined with behavioral and lifestyle interventions may delay cognitive decline, though their long-term efficacy requires further evidence-based validation. Future research should leverage multi-omics technologies to identify early biomarkers for T2DM-related cognitive impairment, elucidate the underlying molecular mechanisms, identify specific therapeutic targets, and develop personalized intervention strategies. This review systematically examines the epidemiological correlations, pathophysiological mechanisms, and advances in clinical management of T2DM-related cognitive disorders, with the aim of providing a theoretical foundation for early prevention and targeted treatment.</p><div class="clear"></div></div><div class="JournalFullText"><a id="h2" name="h2"></a><h2>1 Introduction</h2><p class="mb0">T2DM has emerged as a global epidemic and a major public health challenge. Global prevalence of T2DM is expected to increase to 7,079 cases per 100,000 population by 2030, reflecting a sustained upward trend across all regions (<a href="#B1">1</a>). T2DM significantly elevates the risk of microvascular complications (e.g., retinopathy, nephropathy, neuropathy) and macrovascular diseases (e.g., coronary artery disease, stroke) (<a href="#B2">2</a>). Cognitive impairment is defined as a decline in one or more cognitive domains, including memory, attention, orientation, judgment, and problem-solving abilities (<a href="#B3">3</a>). Manifestations of impairment may include slowed information processing, memory deficits, and challenges in learning or decision-making (<a href="#B4">4</a>). Cognitive impairment severely impacts overall well-being by compromising social engagement and functional independence, increasing reliance on caregivers while reducing autonomy, and posing safety risks, ultimately elevating morbidity and mortality rates through diminished self-care capacity and delayed medical intervention (<a href="#B3">3</a>, <a href="#B5">5</a>). Given the escalating global prevalence of T2DM and its profound implications for cognitive health, elucidating the underlying pathophysiological pathways and identifying preventive interventions are critical for mitigating dual disease burdens. Research in this domain holds significant clinical and societal relevance. Understanding how metabolic dysregulation accelerates neurodegenerative processes could inform early biomarkers for cognitive risk stratification and targeted therapies. Ultimately, advancing this field may enhance patient outcomes and quality of life.</p><a id="h3" name="h3"></a><h2>2 Pathophysiology of T2DM and its impact on cognitive function</h2><h3>2.1 Basic pathogenesis of T2DM</h3><p class="mb15">T2DM is characterized by two central pathophysiological defects: pancreatic &#x3b2;-cell dysfunction and insulin resistance (IR). &#x3b2;-cell dysfunction manifests as inadequate insulin secretion or decompensation, ultimately resulting in hyperglycemia. IR refers to diminished responsiveness of peripheral tissues (e.g., skeletal muscle, adipose tissue, liver) to insulin signaling, glucose uptake into these cells becomes inefficient, resulting in its accumulation in the bloodstream and consequent hyperglycemia. To compensate, pancreatic &#x3b2;-cells augment insulin secretion, leading to a state of hyperinsulinemia. These defects mutually reinforce each other, establishing a vicious cycle. Chronic inflammation, ectopic lipid deposition, endoplasmic reticulum stress (ERS), and oxidative stress further exacerbate metabolic dysregulation by impairing insulin sensitivity and/or &#x3b2;-cell function, thereby driving the onset and progression of T2DM and its target organ damage (TOD) (<a href="#B6">6</a>).</p><p class="mb15">&#x3b2;-cells integrate signals from glucose, free fatty acids (FFA), hormones (e.g., incretins GLP-1/GIP), and neural inputs to dynamically regulate insulin secretion (<a href="#B7">7</a>). Factors contributing to &#x3b2;-cell failure include: aging and genetic predisposition, incretin resistance/deficiency (e.g., impaired glucagon-like peptide-1 [GLP-1] and glucose-dependent insulinotropic polypeptide [GIP] signaling), lipotoxicity (FFA-induced &#x3b2;-cell apoptosis) and glucotoxicity (chronic hyperglycemia-induced oxidative stress), insulin resistance-induced &#x3b2;-cell stress, islet amyloid deposition (excessive islet amyloid polypeptide [IAPP] aggregation), reactive oxygen species (ROS)-mediated damage and proinflammatory signaling (<a href="#B8">8</a>).</p><p class="mb0">IR is a multifactorial metabolic disorder marked by reduced responsiveness of insulin-target tissues (liver, adipose tissue, skeletal muscle) to physiological insulin levels. It is closely linked to metabolic syndrome (MS), where obesity, dyslipidemia, and hypertension amplify IR through: proinflammatory cytokine release (e.g., TNF-&#x3b1;, IL-6), ectopic lipid accumulation (hepatic and muscular lipotoxicity), oxidative stress-mediated inhibition of insulin receptor signaling (e.g., PI3K/Akt pathway) (<a href="#B9">9</a>).</p><h3>2.2 Impact of diabetes-related complications on cognitive function</h3><h4>2.2.1 Cerebrovascular complications</h4><p class="mb0">Diabetes-induced macrovascular pathologies, such as atherosclerosis (AS), drive structural alterations in cerebral vasculature, including stenosis, occlusion, and intima-media thickening&#x2014;hallmarks of AS (<a href="#B10">10</a>). Chronic vascular occlusion disrupts central hemodynamics, cerebral perfusion, and cerebrovascular function. Key functional impairments include: endothelial-dependent vasodilation deficits and impaired cerebrovascular autoregulation (<a href="#B11">11</a>, <a href="#B12">12</a>). These dysfunctions directly manifest as abnormal cerebral blood flow (CBF) (<a href="#B13">13</a>). Evidence linking carotid AS to cerebral atrophy suggests that sustained CBF reduction contributes to brain volume loss, a recognized precursor to vascular dementia (VD). Moreover, Chronic hypoperfusion exacerbates neuroinflammation by activating microglia, leading to white matter lesions (WMLs) and neurodegeneration. WMLs are strongly associated with progressive cognitive decline and eventual VD onset.</p><h4>2.2.2 Diabetic retinopathy</h4><p class="mb0">Diabetic retinopathy, a microvascular complication of diabetes, may reflect systemic microvascular damage. Wu et&#xa0;al. reported that DR is associated with psychomotor slowing and attentional deficits. Electrophysiological studies in diabetic models demonstrate reduced neuronal activity in the primary visual cortex, impairing visual information processing (<a href="#B14">14</a>). Meta-analytic evidence further links retinal pathology to cognitive decline, any retinopathy was significantly associated with the presence of dementia and cognitive deficits, as well as with reduced processing speed (<a href="#B15">15</a>).These associations persist even in patients without overt retinopathy, suggesting that retinal microvascular changes (e.g., altered vessel caliber, fractal dimension) may serve as biomarkers of cerebral microangiopathy and neurodegeneration. Additionally, diabetes frequently induces visual system dysfunction, including impaired motion detection, reduced contrast sensitivity, and defective color discrimination, which may indirectly exacerbate cognitive load by disrupting sensory input integration (<a href="#B14">14</a>).</p><h4>2.2.3 Diabetic kidney disease</h4><p class="mb0">Diabetic kidney disease (DKD), a diabetes-specific complication characterized by progressive renal damage, exacerbates blood-brain barrier (BBB) disruption and is increasingly recognized as a risk factor for neurocognitive deficits. Clinical studies reveal a bidirectional relationship between renal dysfunction and cognitive impairment, where elevated urinary albumin excretion rate (UAER) predicts poorer cognitive performance, while declining glomerular filtration rate (GFR) is associated with worsening cognitive scores, highlighting a dose-dependent link between renal impairment and neurodegeneration (<a href="#B16">16</a>). DKD contributes to cognitive impairment through interconnected pathophysiological pathways. Impaired renal clearance of uremic toxins, such as indoxyl sulfate, promotes neuroinflammation and oxidative stress, accelerating BBB disruption and neuronal apoptosis (<a href="#B17">17</a>). These mechanisms synergistically disrupt neurovascular homeostasis, creating a self-reinforcing cycle of neurodegeneration and cognitive decline in diabetic patients. Serum creatinine, an indicator of renal dysfunction, inversely correlates with cognitive performance in elderly diabetic populations, suggesting its potential as a prognostic marker for cognitive decline, while early detection of DKD through measures like UAER monitoring can help stratify dementia risk and guide interventions, such as renin-angiotensin system inhibitors, to preserve both renal and cognitive function (<a href="#B18">18</a>).</p><h4>2.2.4 Diabetic peripheral neuropathy</h4><p class="mb0">Diabetic peripheral neuropathy (DPN), a prevalent complication of diabetes, is increasingly linked to cognitive impairment. Evidence demonstrates that individuals with T2DM and DPN exhibit lower global cognitive performance compared to those without DPN, including deficits in memory, attention, and psychomotor speed (<a href="#B19">19</a>). In type 1 diabetes, cognitive impairment is similarly pronounced, with DPN patients showing marked impairments in attention, visuospatial/executive functions, language, and abstract reasoning (<a href="#B20">20</a>). Notably, painful DPN correlates with more severe cognitive deficits than painless DPN (<a href="#B21">21</a>), particularly in domains of attention and memory. These findings suggest that DPN severity and subtype may serve as biomarkers for neurodegeneration risk in diabetic populations, underscoring the need for integrated neurological and cognitive assessments in diabetes care (<a href="#B22">22</a>).</p><h4>2.2.5 Diabetes-related foot complications</h4><p class="mb0">Emerging evidence highlights a significant association between diabetes-related foot complications (DRFC) and cognitive impairment. Studies demonstrate that individuals with DRFC exhibit more pronounced cognitive deficits compared to diabetic patients without foot complications, particularly in domains of verbal memory, executive function, and inhibitory control (<a href="#B23">23</a>). Furthermore, diabetes-associated cognitive impairment encompasses broader deficits, including impairments in attention, memory, executive function, visuospatial abilities, and language. The severity of DRFC-related cognitive decline underscores the need for integrated care models addressing both metabolic and neurological health in diabetic populations (<a href="#B24">24</a>).</p><a id="h4" name="h4"></a><h2>3 Mechanistic insights into T2DM and cognitive impairment</h2><h3>3.1 Insulin resistance and cerebral metabolism</h3><p class="mb15">Insulin acts on insulin receptors in the brain to promote neurotransmitter synthesis, synaptic plasticity, and neuronal differentiation&#x2014;processes critical for learning and memory. Insulin signaling in the brain is essential for normal cognitive function, particularly in key regions such as the hippocampus and prefrontal cortex (<a href="#B25">25</a>), where it regulates glucose utilization, energy homeostasis, synaptogenesis and long-term potentiation (LTP). It also governs appetite regulation and systemic metabolic balance (<a href="#B26">26</a>). Brain insulin resistance (BIR) is recognized as a key factor linking metabolic disorders like obesity and T2DM to cognitive decline. It disrupts normal insulin signaling pathways, leading to mitochondrial structural and functional abnormalities, which in turn result in &#x200b;&#x200b;impaired energy metabolism&#x200b;&#x200b; and &#x200b;&#x200b;increased oxidative stress&#x200b;&#x200b;. This dysfunction triggers &#x200b;&#x200b;neuronal damage&#x200b;&#x200b; and &#x200b;&#x200b;cognitive deterioration&#x200b;&#x200b;, ultimately contributing to &#x200b;&#x200b;cognitive impairment&#x200b;&#x200b; (<a href="#B27">27</a>).</p><p class="mb0">BIR reduces plasma levels of neurotrophic factors such as brain-derived neurotrophic factor (BDNF) (<a href="#B28">28</a>), which plays a critical role in promoting structural and functional plasticity in the central nervous system (CNS) (<a href="#B29">29</a>). Additionally, BIR downregulates the expression of neuronal glucose transporters (e.g., GLUT4), impairing cerebral glucose uptake (<a href="#B30">30</a>). This energy deficit results in decreased brain glucose utilization, triggering neuronal metabolic dysfunction. Such metabolic disturbances not only compromise synaptic plasticity but may also threaten neuronal survival, contributing to memory deficits and executive dysfunction.</p><h3>3.2 Chronic inflammatory response</h3><p class="mb15">Diabetes mellitus, a chronic metabolic disorder, significantly disrupts systemic and localized inflammatory responses, thereby compromising brain health. The systemic inflammation associated with diabetes promotes increased BBB permeability, neuroinflammation, and subsequent neurodegenerative alterations. These inflammatory processes are mechanistically linked to cognitive impairment and an elevated risk of neurodegenerative disorders, including Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease.</p><p class="mb0">Characterized by chronic low-grade inflammation, diabetes alters the expression of key inflammatory mediators such as monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6), and C-C motif chemokine receptor 2 (CCR2), which collectively modulate peripheral and central immune responses (<a href="#B31">31</a>). Activation of inflammatory pathways, particularly those mediated by NF-&#x3ba;B, synergizes with oxidative stress and impaired autophagy to exacerbate neuronal damage and accelerate cognitive decline (<a href="#B32">32</a>). Dysregulated inflammatory signaling in diabetic individuals amplifies ischemic brain injury.</p><h3>3.3 Vascular injury and microangiopathy</h3><p class="mb15">Diabetes exerts profound detrimental effects on cerebrovascular health, precipitating vascular injury and microvascular pathologies closely associated with cognitive impairment. The relationship between diabetes and cerebrovascular pathology is multifaceted, encompassing both macrovascular and microvascular abnormalities that synergistically contribute to cognitive decline (<a href="#B33">33</a>).</p><p class="mb15">Accumulating evidence indicates that diabetes independently increases the incidence of cerebral infarctions and vascular brain injuries, both of which are critical determinants of cognitive deterioration (<a href="#B33">33</a>). Diabetic-induced cerebrovascular damage manifests as endothelial dysfunction, increased arterial stiffness, and thickening of capillary basement membranes (<a href="#B34">34</a>). These pathological alterations compromise cerebrovascular elasticity and integrity, leading to reduced cerebral blood flow and chronic cerebral hypoperfusion, thereby exacerbating cognitive deficits.</p><p class="mb0">As an established risk factor for cerebrovascular diseases, diabetes is characterized by a higher prevalence of cerebral infarctions, white matter hyperintensities (WMH), and cerebral small vessel disease (CSVD) (<a href="#B33">33</a>). These pathologies exhibit greater severity in diabetic populations and correlate with an elevated risk of accelerated cognitive decline. Preclinical studies utilizing diabetic rodent models demonstrate that hyperglycemia exacerbates cerebrovascular dysfunction, which parallels observed cognitive impairments, highlighting diabetes-specific vulnerabilities in neurovascular coupling (<a href="#B35">35</a>).</p><h3>3.4 Oxidative stress and neuronal injury</h3><p class="mb15">Chronic hyperglycemia drives oxidative stress, a pivotal mechanism underlying neuronal injury in diabetes. Sustained elevation of blood glucose promotes excessive generation of ROS and reactive nitrogen species (RNS), overwhelming endogenous antioxidant defenses. This redox imbalance critically contributes multifaceted biochemical cascades and cellular dysfunction. Prolonged hyperglycemia activates four major oxidative stress-inducing pathways: the polyol pathway, advanced glycation end-product (AGE) accumulation, protein kinase C (PKC) activation, and dysregulation of the hexosamine pathway (<a href="#B36">36</a>, <a href="#B37">37</a>). These interconnected pathways work synergistically to amplify ROS production, which directly damages neuronal membranes, proteins, and DNA.</p><p class="mb0">Moreover, oxidative stress activates redox-sensitive transcription factors, such as NF-&#x3ba;B, leading to the upregulation of pro-inflammatory cytokines (e.g., TNF-&#x3b1;, IL-1&#x3b2;, IL-6) (<a href="#B37">37</a>, <a href="#B38">38</a>). These cytokines exacerbate neuroinflammation, creating a vicious cycle in which oxidative stress and inflammation synergistically drive neurodegeneration. Diabetic rodents exhibit elevated oxidative markers (8-OHdG, nitrotyrosine) and increased apoptosis in dorsal root ganglion (DRG) neurons, confirming oxidative damage as a driver of peripheral neuropathy (<a href="#B39">39</a>).</p><h3>3.5 The interplay between T2DM and Alzheimer&#x2019;s disease</h3><p class="mb0">Emerging evidence reveals significant pathophysiological intersections between diabetes mellitus, particularly T2DM, and neurodegenerative disorders, with Alzheimer&#x2019;s disease (AD) demonstrating particularly strong associations (<a href="#B40">40</a>). T2DM has been established as an independent risk factor for accelerated cognitive decline and neurodegeneration, potentially increasing AD susceptibility through shared biological mechanisms. The disease continuum appears driven by overlapping pathways including chronic insulin resistance, systemic inflammation, and mitochondrial dysfunction, which collectively create a neurodegenerative milieu (<a href="#B41">41</a>, <a href="#B42">42</a>). Notably, hallmark AD pathologies &#x2013; &#x3b2;-amyloid (A&#x3b2;) plaque deposition and tau protein hyperphosphorylation &#x2013; are exacerbated by diabetic metabolic disturbances. Sustained hyperglycemia and impaired insulin signaling in T2DM patients potentiate amyloidogenic processing while compromising tau protein homeostasis, thereby accelerating the neuropathological cascade characteristic of AD progression (<a href="#B43">43</a>).</p><h3>3.6 T2DM-related cognitive impairment and gut-brain axis disruption</h3><p class="mb15">The gut-brain axis is a bidirectional communication system between the gastrointestinal tract and the central nervous system that influences cognitive function through various mechanisms (<a href="#B44">44</a>). In T2DM, significant alterations occur in the composition of the gut microbiota, which affect cognitive abilities. Specific genera (e.g., <i>Parabacteroides</i> and <i>Lactobacillus</i>) have been shown to modulate metabolites, thereby improving cognitive behavior in diabetic models (<a href="#B45">45</a>). Changes in the gut microbiome directly or indirectly impact brain function through vagal, endocrine, and immune pathways. Metabolites directly activate vagal afferent nerves, transmitting signals to the brain via vagal pathways. In the endocrine pathway, enteroendocrine L cells release gut hormones such as GLP1, peptide YY (PYY), and cholecystokinin (CCK), which subsequently influence learning, memory, and mood. Within the immune pathway, immune cells including helper T cell 1 (Th1), helper T cell 17 (Th17), regulatory T cells (Treg), neutrophils, and macrophages are stimulated (<a href="#B46">46</a>). Fecal microbiota transplantation has demonstrated potential in alleviating diabetes-related cognitive decline by altering gut microbiota composition and enhancing brain insulin signaling pathways (<a href="#B45">45</a>).</p><p class="mb0">Although the gut-brain axis plays a significant role in T2DM-related cognitive impairment, it is essential to consider other contributing factors, such as genetic predisposition and lifestyle. The interactions between these factors and the gut-brain axis are complex and require further research to fully elucidate the underlying mechanisms.</p><a id="h5" name="h5"></a><h2>4 Sociodemographic moderators in T2DM-related cognitive impairment</h2><p class="mb15">In recent years, an increasing number of studies have explored the potential roles of gender, age, educational level, and social determinants in the link between T2DM and cognitive function from demographic and sociological perspectives, offering new pathways for identifying vulnerable populations and developing intervention strategies.</p><p class="mb15">Age is a key factor for cognitive impairment in T2DM patients. Older age has consistently been associated with a higher risk of cognitive impairment. Studies show that individuals aged 60 and above with T2DM are particularly susceptible to cognitive decline, with the risk increasing with advancing age (<a href="#B47">47</a>, <a href="#B48">48</a>).</p><p class="mb15">Research shows that, independent of diabetes status, women generally perform better in certain cognitive domains (e.g., global cognition and verbal abilities) (<a href="#B49">49</a>). However, other studies suggest that middle-aged men with T2D have a higher risk of mild cognitive impairment (MCI) compared to women (<a href="#B50">50</a>).</p><p class="mb15">Education is widely recognized as a core component of cognitive reserve and also plays a significant moderating role in the association between T2DM and cognitive function. Research by Reinke published in <i>BMC Public Health</i> indicates that higher education is not only associated with better glycemic control but can also slow diabetes-related cognitive decline (<a href="#B51">51</a>). Pe&#xf1;a-Gonz&#xe1;lez further points out that education can mitigate the negative effects of the disease by building cognitive reserve, enhancing an individual&#x2019;s neuroplasticity and cognitive resilience in the face of hyperglycemia or metabolic dysregulation (<a href="#B52">52</a>).</p><p class="mb15">Social determinants such as socioeconomic status, race/ethnicity, and healthcare access also play crucial roles in T2DM-related cognitive impairment (<a href="#B53">53</a>). Studies comparing elderly populations in the US and Mexico found that low socioeconomic status is significantly associated with cognitive decline, and the level of social support significantly influences the cognitive trajectory of diabetes (<a href="#B54">54</a>).</p><p class="mb0">In summary, gender, age, education, and social determinants all play complex and interacting roles in the link between T2DM and cognitive function. Research indicates that individuals with early-onset diabetes, those with lower educational attainment, and those of low socioeconomic status face a higher risk of cognitive impairment. Theories such as cognitive reserve, the accumulated stress model, and research on health inequalities provide multidimensional perspectives for understanding diabetes-induced cognitive impairment. Future research should deepen efforts in the following areas: First, strengthen stratified studies on different population subgroups to precisely identify high-risk groups. Second, integrate metabolic, physiological, psychological, and social dimensions to construct multi-level assessment models. Third, enhance educational interventions and social support within community health promotion to mitigate the cognitive risks stemming from structural health inequalities.</p><a id="h6" name="h6"></a><h2>5 T2DM management and cognitive impairment</h2><h3>5.1 Glycemic control and cognitive function in T2DM</h3><p class="mb0">The relationship between glycemic control and cognitive performance represents a critical focus in diabetes research, particularly in the context of neurodegeneration. Accumulating evidence indicates that suboptimal glycemic management is strongly associated with accelerated cognitive impairment, whereas rigorous blood glucose regulation may attenuate neurodegenerative progression. In patients with T2DM, chronic hyperglycemia and elevated glycated hemoglobin (HbA1c) levels correlate with measurable declines in global cognitive function. Multiple studies have shown that improving blood sugar control can enhance cognitive function. For example, a systematic review found that antidiabetic treatment can significantly alleviate the decline in cognitive ability in diabetic patients (<a href="#B55">55</a>).</p><h3>5.2 Potential effects of common glucose-lowering drugs on cognitive function</h3><p class="mb0">The potential impact of glucose-lowering drugs on cognitive function is multifaceted, encompassing both adverse effects resulting from drug-induced hypoglycemia and possible cognitive benefits associated with specific drugs. These effects are systematically summarized in <a href="#T1">Table 1</a>.</p><div class="DottedLine"></div><div class="Imageheaders">Table&#xa0;1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg" name="table&#xa0;1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy">
  </picture>
</a><p><b>Table&#xa0;1</b>. Potential effects of common glucose-lowering drugs on cognitive function.</p></div><div class="DottedLine"></div><p class="mb0">As a first-line oral hypoglycemic agent for T2DM, metformin demonstrates bidirectional regulatory effects on cognition. Accumulating evidence suggests its neuroprotective properties through mechanisms including AMPK signaling pathway activation and oxidative stress inhibition, with demonstrated improvements in specific cognitive domains such as verbal learning, working memory, and executive function in diabetic patients (<a href="#B56">56</a>). Notably, prolonged metformin therapy may induce vitamin B12 deficiency, which has been established as a risk factor for cognitive decline (<a href="#B57">57</a>, <a href="#B58">58</a>). This dual mechanism indicates that while metformin may mitigate diabetes-related neurodegenerative processes, it could paradoxically impair cognitive health in susceptible individuals through nutritional metabolic disturbances. Clinical protocols should therefore incorporate regular serum vitamin B12 monitoring and timely nutritional supplementation to prevent associated complications (<a href="#B59">59</a>).</p><h4>5.2.1 GLP-1 receptor agonists</h4><p class="mb0">The neuroprotective effects of GLP-1RA are believed to be mediated through multiple mechanisms, including the reduction of neuroinflammation, enhancement of mitochondrial function, antioxidant stress, prevention of &#x3b2;-amyloid and tau protein aggregation, and improvement of synaptic function (<a href="#B60">60</a>). A systematic review and meta-analysis found that GLP-1RA did not significantly affect overall cognitive function in patients with type 2 diabetes. However, subgroup analysis indicated potential benefits for patients under 65 years of age or those without a history of cardiovascular or cerebrovascular disease, suggesting that age and comorbidities may influence cognitive outcomes with GLP-1 therapy (<a href="#B61">61</a>). Another study reported that the GLP-1RA liraglutide improved short-term memory and memory composite scores in obese patients with prediabetes or early-stage type 2 diabetes, independent of weight loss effects. This suggests that GLP-1RA provide direct cognitive benefits in early-stage diabetes (<a href="#B62">62</a>). In animal models, GLP-1RA have shown promising results in improving cognitive function. For example, liraglutide improved memory retention and increased hippocampal neuron count in an Alzheimer&#x2019;s disease mouse model, indicating its potential neuroprotective effects (<a href="#B63">63</a>).</p><h4>5.2.2 Sodium-glucose cotransporter 2 inhibitors</h4><p class="mb15">(SGLT2is) exerts beneficial effects on cognitive impairment through multifaceted mechanisms involving metabolic regulation, anti-inflammatory actions, antioxidant properties, and modulation of neurotrophic factors (<a href="#B64">64</a>). Preclinical studies demonstrate that dapagliflozin ameliorates cognitive deficits in diabetic murine models by restoring hippocampal mitochondrial dynamics - a critical process for synaptic plasticity and memory formation (<a href="#B65">65</a>). Particularly in dual pathology models combining T2DM and AD, SGLT2is not only enhance insulin sensitivity but also significantly reduce &#x3b2;-amyloid deposition, addressing two fundamental pathological hallmarks of AD.</p><p class="mb15">Clinical investigations reveal substantial cognitive improvements associated with SGLT2i therapy, especially in populations with mild cognitive impairment or established dementia. A meta-analysis quantifying cognitive outcomes showed a standardized mean difference of 0.88 (95% CI: 0.32-1.44) in cognitive assessment scores, indicating clinically meaningful enhancement (<a href="#B66">66</a>).</p><p class="mb0">Notably, large-scale clinical data analysis demonstrates significant dementia risk reduction with SGLT2i use. In a population-based study of 331,908 T2DM patients, SGLT2i treatment was associated with 23% lower dementia incidence (HR: 0.77; 95% CI: 0.71-0.84) (<a href="#B67">67</a>). The observed cerebroprotection may derive from synergistic effects including blood pressure optimization, sodium homeostasis regulation, and metabolic reprogramming, collectively preserving neuronal integrity in chronic metabolic disorders (<a href="#B68">68</a>).</p><h4>5.2.3 DPP-4 inhibitors</h4><p class="mb15">DPP-4is improve glucose tolerance and insulin sensitivity, which are critical for maintaining cognitive function in diabetic patients. Improvements in metabolic parameters such as reduced fasting blood glucose and HbA1c levels are consistently associated with better cognitive outcomes (<a href="#B69">69</a>, <a href="#B70">70</a>). Sitagliptin has been shown to reduce oxidative stress and promote hippocampal neurogenesis, both essential for cognitive health. These effects are further supported by the upregulation of genes involved in neuroprotection and synaptic plasticity (<a href="#B69">69</a>).</p><p class="mb15">At the molecular level, DPP-4is likely exert their benefits via the AMPK/mTOR pathway, enhancing neuronal autophagy and reducing tau protein phosphorylation&#x2014;mechanisms that are neuroprotective (<a href="#B71">71</a>). A meta-analysis involving 5,583 participants demonstrated that DPP-4is significantly reduce the incidence of cognitive impairment in T2DM patients, with a standardized mean difference (SMD) of 0.99. Additionally, clinical studies revealed that these agents improve scores on the Mini-Mental State Examination (MMSE) and Instrumental Activities of Daily Living (IADL), indicating measurable cognitive benefits (<a href="#B70">70</a>, <a href="#B72">72</a>). Notably, in elderly patients with mild cognitive impairment, DPP-4is stabilize cognitive function by reducing glycemic variability (<a href="#B73">73</a>).</p><p class="mb0">Preclinical evidence further supports these findings: in insulin-resistant rat models, DPP-4is such as sitagliptin and vildagliptin improve cognitive behaviors and restore cerebral mitochondrial function, demonstrating protective effects against diet-induced cognitive decline (<a href="#B74">74</a>).</p><h4>5.2.4 Sulfonylureas</h4><p class="mb15">Sulfonylureas may exert dual effects on cognitive function in diabetic populations. Preclinical studies indicate potential neuroprotective properties: glimepiride ameliorated learning and memory deficits in diabetic rodent models, potentially through antioxidant mechanisms and upregulation of BDNF levels (<a href="#B75">75</a>). Similarly, glyburide prevented chronic stress-induced cognitive impairment in murine models, possibly via modulation of the hypothalamic-pituitary-adrenal (HPA) axis and glucocorticoid receptor stabilization (<a href="#B76">76</a>).</p><p class="mb0">However, these potential benefits must be weighed against well-documented adverse effects. Sulfonylureas are associated with hypoglycemia episodes and progressive &#x3b2;-cell exhaustion, factors that may exacerbate cognitive decline, particularly in elderly patients with compromised cerebral autoregulation. Population-based studies reveal concerning epidemiological patterns. A retrospective cohort analysis (n = 45,632 T2DM patients) comparing sulfonylureas with DPP-4is demonstrated increased dementia risk with sulfonylurea use over 4.82 mean follow-up years (<a href="#B77">77</a>). Network meta-analyses further position sulfonylureas as second-highest among antidiabetic agents for dementia risk escalation (surface under cumulative ranking [SUCRA] score: 73.4), surpassed only by insulin analogs (<a href="#B78">78</a>).</p><h3>5.3 Behavioral and lifestyle interventions: synergistic effects of diet, exercise, and cognitive training</h3><p class="mb0">Accumulating evidence supports behavioral and lifestyle interventions&#x2014;including dietary modification, physical exercise, and cognitive training&#x2014;as promising non-pharmacological strategies to mitigate diabetes-related cognitive decline. T2DM is a well-established independent risk factor for mild cognitive impairment and dementia progression. While current pharmacological interventions remain suboptimal, multimodal lifestyle approaches demonstrate clinically meaningful potential for preserving neurocognitive function in T2DM populations.</p><h4>5.3.1 Exercise and cognitive function</h4><p class="mb0">Controlled trials reveal differential cognitive benefits of structured exercise regimens in T2DM patients. Both resistance training and aerobic exercise protocols show efficacy (<a href="#B79">79</a>), with meta-analytic data indicating significant attenuation of cognitive decline through multicomponent programs (sessions &gt;40 minutes, &#x2265;4 times weekly over 6 months; pooled effect size: 0.61, 95% CI: 0.40&#x2013;0.82) (<a href="#B80">80</a>). Notably, intervention heterogeneity exists, with some studies reporting only moderate effects or null findings in single-modality approaches, underscoring the need for optimized intensity-duration parameters (<a href="#B81">81</a>, <a href="#B82">82</a>).</p><h4>5.3.2 Cognitive training interventions</h4><p class="mb0">Domain-specific cognitive interventions yield measurable neuropsychological improvements. Dual-task training and targeted cognitive remediation significantly enhance memory performance and executive function in T2DM cohorts. Although mechanistic links to glycemic control remain inconclusive, these interventions demonstrate synergistic benefits when combined with lifestyle education, enhancing both cognitive capacity and diabetes self-management skills (<a href="#B83">83</a>).</p><h4>5.3.3 Combined interventions</h4><p class="mb15">Integrating diet, exercise, and cognitive training&#x2014;seem to offer the most comprehensive benefits. Research indicates that multimodal interventions can improve cognitive function and overall health outcomes in patients with T2DM (<a href="#B80">80</a>). The LIFE study, which included physical activity interventions, reported beneficial effects on global cognitive function and memory slowing in elderly individuals with T2DM, highlighting the potential of a combined approach (<a href="#B84">84</a>).</p><p class="mb0">Current evidence positions multimodal lifestyle interventions as clinically actionable strategies for addressing diabetes-associated cognitive impairment. The triad of dietary optimization, structured exercise, and cognitive engagement demonstrates synergistic neuroprotection, potentially delaying dementia onset while improving metabolic health. Future research should prioritize protocol standardization.</p><a id="h7" name="h7"></a><h2>6 Biomarkers of cognitive impairment in T2DM</h2><p class="mb15">Given the significantly increased risk of dementia and cognitive decline in patients with T2DM, research on predictive biomarkers and early detection technologies for cognitive impairment in this population has gained increasing attention in recent years, which is of great significance for achieving early diagnosis and timely intervention. Recent research advances have revealed several categories of biomarkers with potential clinical applications, including but not limited to Neuron-Derived Exosomes (NDEs) and metabolic signatures.</p><p class="mb15">NDEs are small extracellular vesicles that can cross the blood-brain barrier and are enriched with neuron-specific proteins, RNAs, and other biomolecules. These vesicles have emerged as promising tools for early diagnosis of neurodegenerative diseases (<a href="#B85">85</a>). Chi et&#xa0;al. discovered that plasma NDEs from T2DM patients showed significantly reduced levels of mitochondrial complex I protein NDUFS3 and complex II protein SDHB. Lower SDHB levels were positively correlated with progression from MCI to AD (<a href="#B86">86</a>). Specific miRNAs and proteins in NDEs, including but not limited to miR-185-5p, miR-132-3p, and miR-34a-5p (<a href="#B87">87</a>&#x2013;<a href="#B89">89</a>), have been linked to AD and cognitive impairment, highlighting their biomarker potential.</p><p class="mb15">Elevated myo-inositol (MI) concentrations coupled with reduced glutamate (Glu), Glx (glutamate + glutamine), and NAA/Cr (N-acetylaspartate/creatine) ratios within the hippocampus represent sensitive metabolic biomarkers for monitoring diabetic cognitive impairment progression (<a href="#B90">90</a>). Additional metabolic biomarkers under consideration include C-reactive protein, tau protein, BDNF and AGEs (<a href="#B91">91</a>).</p><p class="mb15">The hippocampus, a brain region critically involved in learning and memory processes, may serve as an early &#x201c;warning indicator&#x201d; for diabetes-associated cognitive impairment through its volumetric changes (<a href="#B92">92</a>). High-resolution MRI segmentation analyses have demonstrated significant volumetric reductions in memory-critical hippocampal subfields (CA1, dentate gyrus [DG], and subiculum) among middle-aged T2DM patients. These specific subregions are known to be fundamentally involved in memory encoding and consolidation processes. These structurally measured hippocampal subfield atrophies not only directly correlated with cognitive performance but may also reflect persistent neural damage caused by glucose metabolic dysregulation. Importantly, these findings provide neuroimaging evidence for early identification of high-risk populations (<a href="#B93">93</a>).</p><p class="mb15">In newly diagnosed T2DM patients, elevated venular tortuosity shows significant association with cognitive impairment. This correlation remained significant after adjustment for multiple demographic and health factors, suggesting retinal vascular tortuosity may serve as an early indicator of cognitive decline (<a href="#B94">94</a>). Retinal vascular metrics (RVMs) can function as imaging biomarkers to predict cognitive impairment in T2DM, thereby enhancing risk stratification (<a href="#B95">95</a>). Furthermore, patients with T2DM and mild cognitive impairment (MCI) exhibit significant thinning of the macular retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) (<a href="#B96">96</a>). These structural changes can be effectively quantified through <i>in vivo</i> optical coherence tomography (OCT) imaging, highlighting the potential of retinal assessment for predicting diabetes-related cognitive dysfunction (<a href="#B97">97</a>).</p><p class="mb0">The complexity of T2DM-related cognitive dysfunction involves multiple pathways and contributing factors, necessitating a multi-faceted approach to biomarker discovery. Future research should prioritize validation of these biomarkers in larger longitudinal cohorts and explore their potential for guiding personalized therapeutic strategies.</p><a id="h8" name="h8"></a><h2>7 Conclusion</h2><p class="mb15">In summary, a complex pathophysiological relationship exists between T2DM and cognitive impairment. Mechanisms including insulin resistance, chronic inflammation, vascular injury, and oxidative stress collectively drive disease progression. Effective glycemic control not only mitigates metabolic dysregulation but also exerts protective effects on cognitive function. Concurrently, factors such as age, educational attainment, and socioeconomic determinants play pivotal roles in disease development, thereby providing new perspectives for multidimensional intervention strategies. Furthermore, the discovery of novel biomarkers and early detection technologies offers promising avenues for early screening and disease monitoring.</p><p class="mb15">These findings hold significant implications for both clinical practice and public health: On the one hand, they underscore the necessity for early cognitive assessment and integrated management in T2DM patients; On the other hand, they emphasize the importance of establishing social support systems to reduce cognitive risk in high-risk populations. However, current research still has limitations, such as small sample sizes in longitudinal cohort studies, incomplete understanding of mechanistic differences across diverse ethnic groups, and the need for further validation of newly identified biomarkers in clinical translation.</p><p class="mb15">Future research could focus on leveraging multi-omics technologies to explore novel pathogenic mechanisms, conducting long-term, multicenter, cross-cultural cohort studies to clarify the universality of risk factors, and developing early warning models based on emerging biomarkers. There is also an urgent need to explore personalized comprehensive treatment strategies that integrate metabolic regulation and social interventions, thereby providing a more robust theoretical and practical foundation for improving cognitive health in patients with T2DM.</p><a id="h9" name="h9"></a><h2>Author contributions</h2><p class="mb0">WK: Writing &#x2013; original draft. MQ: Writing &#x2013; review &amp; editing. YW: Writing &#x2013; review &amp; editing. XZ: Writing &#x2013; review &amp; editing. LX: Writing &#x2013; review &amp; editing, Supervision.</p><a id="h10" name="h10"></a><h2>Funding</h2><p class="mb0">The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p><a id="h11" name="h11"></a><h2>Conflict of interest</h2><p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p><a id="h12" name="h12"></a><h2>Generative AI statement</h2><p class="mb0">The author(s) declare that Generative AI was used in the creation of this manuscript. We acknowledge the use of ChatGPT for language polishing and proofreading in the preparation of this manuscript. The authors take full responsibility for the content and interpretation of the study.</p><a id="h13" name="h13"></a><h2>Publisher&#x2019;s note</h2><p class="mb15">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p><a id="h14" name="h14"></a><h2>References</h2><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B1" id="B1"></a> 1. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, AlKaabi J, et al. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. <i>J Epidemiol Global Health</i>. (2020) 10:107&#x2013;11. doi:&#xa0;10.2991/jegh.k.191028.001</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/32175717/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2991/jegh.k.191028.001" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MAB+Khan&amp;author=MJ+Hashim&amp;author=JK+King&amp;author=RD+Govender&amp;author=H+Mustafa&amp;author=J+AlKaabi&amp;publication_year=2020&amp;title=Epidemiology%20of%20type%202%20diabetes%20-%20global%20burden%20of%20disease%20and%20forecasted%20trends&amp;journal=J+Epidemiol+Global+Health&amp;volume=10&amp;pages=107-11" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B2" id="B2"></a> 2. M&#x142;ynarska E, Czarnik W, Dzie&#x17c;a N, J&#x119;draszak W, Majchrowicz G, Prusinowski F, et al. Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications. <i>Int J Mol Sci</i>. (2025) 26(3):1094. doi:&#xa0;10.3390/ijms26031094</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39940862/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms26031094" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=E+M%C5%82ynarska&amp;author=W+Czarnik&amp;author=N+Dzie%C5%BCa&amp;author=W+J%C4%99draszak&amp;author=G+Majchrowicz&amp;author=F+Prusinowski&amp;publication_year=2025&amp;title=Type%202%20diabetes%20mellitus%3A%20new%20pathogenetic%20mechanisms%2C%20treatment%20and%20the%20most%20important%20complications&amp;journal=Int+J+Mol+Sci&amp;volume=26&amp;pages=1094" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B3" id="B3"></a> 3. Chang HJ, Burke AE, and Glass RM. Older drivers and cognitive impairment. <i>JAMA</i>. (2010) 303:1660&#x2013;. doi:&#xa0;10.1001/jama.281.16.1560</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://doi.org/10.1001/jama.281.16.1560" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=HJ+Chang&amp;author=AE+Burke&amp;author=RM+Glass&amp;publication_year=2010&amp;title=Older%20drivers%20and%20cognitive%20impairment&amp;journal=JAMA&amp;volume=303&amp;pages=1660-" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B4" id="B4"></a> 4. Shang H, Xu C, Lu H, and Zhang J. The early stage of abnormal aging: cognitive impairment. <i>Adv Exp Med Biol</i>. (2023) 1419:149&#x2013;55. doi:&#xa0;10.1007/978-981-99-1627-6_11</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37418212/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/978-981-99-1627-6_11" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H+Shang&amp;author=C+Xu&amp;author=H+Lu&amp;author=J+Zhang&amp;publication_year=2023&amp;title=The%20early%20stage%20of%20abnormal%20aging%3A%20cognitive%20impairment&amp;journal=Adv+Exp+Med+Biol&amp;volume=1419&amp;pages=149-55" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B5" id="B5"></a> 5. Foreman MD and Grabowski R. Diagnostic dilemma: cognitive impairment in the elderly. <i>J gerontological Nurs</i>. (1992) 18:5&#x2013;12. doi:&#xa0;10.3928/0098-9134-19920901-04</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/1430903/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3928/0098-9134-19920901-04" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MD+Foreman&amp;author=R+Grabowski&amp;publication_year=1992&amp;title=Diagnostic%20dilemma%3A%20cognitive%20impairment%20in%20the%20elderly&amp;journal=J+gerontological+Nurs&amp;volume=18&amp;pages=5" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B6" id="B6"></a> 6. Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. <i>Signal transduction targeted Ther</i>. (2024) 9:262. doi:&#xa0;10.1038/s41392-024-01951-9</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39353925/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41392-024-01951-9" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X+Lu&amp;author=Q+Xie&amp;author=X+Pan&amp;author=R+Zhang&amp;author=X+Zhang&amp;author=G+Peng&amp;publication_year=2024&amp;title=Type%202%20diabetes%20mellitus%20in%20adults%3A%20pathogenesis%2C%20prevention%20and%20therapy&amp;journal=Signal+transduction+targeted+Ther&amp;volume=9&amp;pages=262" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B7" id="B7"></a> 7. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. <i>Nat Rev Dis Primers</i>. (2015) 1:15019. doi:&#xa0;10.1038/nrdp.2015.19</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27189025/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrdp.2015.19" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=RA+DeFronzo&amp;author=E+Ferrannini&amp;author=L+Groop&amp;author=RR+Henry&amp;author=WH+Herman&amp;author=JJ+Holst&amp;publication_year=2015&amp;title=Type%202%20diabetes%20mellitus&amp;journal=Nat+Rev+Dis+Primers&amp;volume=1&amp;pages=15019" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B8" id="B8"></a> 8. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. <i>Int J Mol Sci</i>. (2020) 21(17):6275. doi:&#xa0;10.3390/ijms21176275</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/32872570/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms21176275" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=U+Galicia-Garcia&amp;author=A+Benito-Vicente&amp;author=S+Jebari&amp;author=A+Larrea-Sebal&amp;author=H+Siddiqi&amp;author=KB+Uribe&amp;publication_year=2020&amp;title=Pathophysiology%20of%20type%202%20diabetes%20mellitus&amp;journal=Int+J+Mol+Sci&amp;volume=21&amp;pages=6275" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B9" id="B9"></a> 9. Lee SH, Park SY, and Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. <i>Diabetes Metab J</i>. (2022) 46:15&#x2013;37. doi:&#xa0;10.4093/dmj.2021.0280</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/34965646/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4093/dmj.2021.0280" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SH+Lee&amp;author=SY+Park&amp;author=CS+Choi&amp;publication_year=2022&amp;title=Insulin%20resistance%3A%20from%20mechanisms%20to%20therapeutic%20strategies&amp;journal=Diabetes+Metab+J&amp;volume=46&amp;pages=15" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B10" id="B10"></a> 10. Alhusaini S, Karama S, Nguyen TV, Thiel A, Bernhardt BC, Cox SR, et al. Association between carotid atheroma and cerebral cortex structure at age 73 years. <i>Ann Neurol</i>. (2018) 84:576&#x2013;87. doi:&#xa0;10.1002/ana.25324</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/30179274/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/ana.25324" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Alhusaini&amp;author=S+Karama&amp;author=TV+Nguyen&amp;author=A+Thiel&amp;author=BC+Bernhardt&amp;author=SR+Cox&amp;publication_year=2018&amp;title=Association%20between%20carotid%20atheroma%20and%20cerebral%20cortex%20structure%20at%20age%2073%20years&amp;journal=Ann+Neurol&amp;volume=84&amp;pages=576-87" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B11" id="B11"></a> 11. Aparicio HJ, Petrea RE, Massaro JM, Manning WJ, Oyama-Manabe N, Beiser AS, et al. Association of descending thoracic aortic plaque with brain atrophy and white matter hyperintensities: The Framingham Heart Study. <i>Atherosclerosis</i>. (2017) 265:305&#x2013;11. doi:&#xa0;10.1016/j.atherosclerosis.2017.06.919</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/28673480/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.atherosclerosis.2017.06.919" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=HJ+Aparicio&amp;author=RE+Petrea&amp;author=JM+Massaro&amp;author=WJ+Manning&amp;author=N+Oyama-Manabe&amp;author=AS+Beiser&amp;publication_year=2017&amp;title=Association%20of%20descending%20thoracic%20aortic%20plaque%20with%20brain%20atrophy%20and%20white%20matter%20hyperintensities%3A%20The%20Framingham%20Heart%20Study&amp;journal=Atherosclerosis&amp;volume=265&amp;pages=305-11" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B12" id="B12"></a> 12. Ogoh S. Relationship between cognitive function and regulation of cerebral blood flow. <i>J Physiol sciences: JPS</i>. (2017) 67:345&#x2013;51. doi:&#xa0;10.1007/s12576-017-0525-0</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/28155036/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s12576-017-0525-0" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Ogoh&amp;publication_year=2017&amp;title=Relationship%20between%20cognitive%20function%20and%20regulation%20of%20cerebral%20blood%20flow&amp;journal=J+Physiol+sciences:+JPS&amp;volume=67&amp;pages=345-51" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B13" id="B13"></a> 13. Moroni F, Ammirati E, Magnoni M, D'Ascenzo F, Anselmino M, Anzalone N, et al. Carotid atherosclerosis, silent ischemic brain damage and brain atrophy: A systematic review and meta-analysis. <i>Int J Cardiol</i>. (2016) 223:681&#x2013;7. doi:&#xa0;10.1016/j.ijcard.2016.08.234</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27568989/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ijcard.2016.08.234" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=F+Moroni&amp;author=E+Ammirati&amp;author=M+Magnoni&amp;author=F+D%27Ascenzo&amp;author=M+Anselmino&amp;author=N+Anzalone&amp;publication_year=2016&amp;title=Carotid%20atherosclerosis%2C%20silent%20ischemic%20brain%20damage%20and%20brain%20atrophy%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Int+J+Cardiol&amp;volume=223&amp;pages=681-7" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B14" id="B14"></a> 14. Chen H, Wang M, Xia L, Dong J, Xu G, Wang Z, et al. New evidence of central nervous system damage in diabetes: impairment of fine visual discrimination. <i>Diabetes</i>. (2022) 71:1772&#x2013;84. doi:&#xa0;10.2337/db21-0715</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35612428/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2337/db21-0715" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H+Chen&amp;author=M+Wang&amp;author=L+Xia&amp;author=J+Dong&amp;author=G+Xu&amp;author=Z+Wang&amp;publication_year=2022&amp;title=New%20evidence%20of%20central%20nervous%20system%20damage%20in%20diabetes%3A%20impairment%20of%20fine%20visual%20discrimination&amp;journal=Diabetes&amp;volume=71&amp;pages=1772-84" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B15" id="B15"></a> 15. Heringa SM, Bouvy WH, VanDenBerg E, Moll AC, Kappelle LJ, Biessels GJ, et al. Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review. <i>J Cereb Blood Flow Metab</i>. (2013) 33:983&#x2013;95. doi:&#xa0;10.1038/jcbfm.2013.58</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/23591648/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/jcbfm.2013.58" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SM+Heringa&amp;author=WH+Bouvy&amp;author=E+VanDenBerg&amp;author=AC+Moll&amp;author=LJ+Kappelle&amp;author=GJ+Biessels&amp;publication_year=2013&amp;title=Associations%20between%20retinal%20microvascular%20changes%20and%20dementia%2C%20cognitive%20functioning%2C%20and%20brain%20imaging%20abnormalities%3A%20a%20systematic%20review&amp;journal=J+Cereb+Blood+Flow+Metab&amp;volume=33&amp;pages=983-95" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B16" id="B16"></a> 16. Shi X, Zhang Y, Niu H, Wang R, Shen J, Zhou S, et al. Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus. <i>Zhong nan da xue xue bao Yi xue ban = J Cent South Univ Med Sci</i>. (2016) 41:143&#x2013;50. doi:&#xa0;10.11817/j.issn.1672-7347.2016.02.005</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/26932211/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.11817/j.issn.1672-7347.2016.02.005" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X+Shi&amp;author=Y+Zhang&amp;author=H+Niu&amp;author=R+Wang&amp;author=J+Shen&amp;author=S+Zhou&amp;publication_year=2016&amp;title=Correlation%20between%20cognitive%20impairment%20and%20diabetic%20nephropathy%20in%20patients%20with%20Type%202%20diabetes%20mellitus&amp;journal=Zhong+nan+da+xue+xue+bao+Yi+xue+ban+=+J+Cent+South+Univ+Med+Sci&amp;volume=41&amp;pages=143-50" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B17" id="B17"></a> 17. Bossola M and Picconi B. Uremic toxins and the brain in chronic kidney disease. <i>J Nephrol</i>. (2024) 37:1391&#x2013;5. doi:&#xa0;10.1007/s40620-024-01929-4</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/38625502/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s40620-024-01929-4" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Bossola&amp;author=B+Picconi&amp;publication_year=2024&amp;title=Uremic%20toxins%20and%20the%20brain%20in%20chronic%20kidney%20disease&amp;journal=J+Nephrol&amp;volume=37&amp;pages=1391-5" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B18" id="B18"></a> 18. Xiao Y, Devakumar V, Xu L, Liu L, Mo H, Hong X, et al. Elevated serum creatinine levels and risk of cognitive impairment in older adults with diabetes: a NHANES study from 2011&#x2013;2014. <i>Front Endocrinol</i>. (2023) 14:1149084. doi:&#xa0;10.3389/fendo.2023.1149084</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37900140/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fendo.2023.1149084" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Xiao&amp;author=V+Devakumar&amp;author=L+Xu&amp;author=L+Liu&amp;author=H+Mo&amp;author=X+Hong&amp;publication_year=2023&amp;title=Elevated%20serum%20creatinine%20levels%20and%20risk%20of%20cognitive%20impairment%20in%20older%20adults%20with%20diabetes%3A%20a%20NHANES%20study%20from%202011%E2%80%932014&amp;journal=Front+Endocrinol&amp;volume=14&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B19" id="B19"></a> 19. Palomo-Osuna J, DeSola H, Due&#xf1;as M, Moral-Munoz JA, and Failde I. Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis. <i>Expert Rev Neurother</i>. (2022) 22:269&#x2013;81. doi:&#xa0;10.1080/14737175.2022.2048649</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35232335/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1080/14737175.2022.2048649" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Palomo-Osuna&amp;author=H+DeSola&amp;author=M+Due%C3%B1as&amp;author=JA+Moral-Munoz&amp;author=I+Failde&amp;publication_year=2022&amp;title=Cognitive%20function%20in%20diabetic%20persons%20with%20peripheral%20neuropathy%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Expert+Rev+Neurother&amp;volume=22&amp;pages=269-81" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B20" id="B20"></a> 20. Ding X, Fang C, Li X, Cao YJ, Zhang QL, Huang Y, et al. Type 1 diabetes-associated cognitive impairment and diabetic peripheral neuropathy in Chinese adults: results from a prospective cross-sectional study. <i>BMC endocrine Disord</i>. (2019) 19:34. doi:&#xa0;10.1186/s12902-019-0359-2</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/30917808/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/s12902-019-0359-2" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X+Ding&amp;author=C+Fang&amp;author=X+Li&amp;author=YJ+Cao&amp;author=QL+Zhang&amp;author=Y+Huang&amp;publication_year=2019&amp;title=Type%201%20diabetes-associated%20cognitive%20impairment%20and%20diabetic%20peripheral%20neuropathy%20in%20Chinese%20adults%3A%20results%20from%20a%20prospective%20cross-sectional%20study&amp;journal=BMC+endocrine+Disord&amp;volume=19&amp;pages=34" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B21" id="B21"></a> 21. Abo-Elfetoh NM, Farag AI, and Gabra RH. Impact of pain severity on functioning domains, sleep, and cognition in painful diabetic peripheral polyneuropathy patients. <i>Middle East Curr Psychiatry</i>. (2022) 29:83. doi:&#xa0;10.1186/s43045-022-00243-8</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://doi.org/10.1186/s43045-022-00243-8" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=NM+Abo-Elfetoh&amp;author=AI+Farag&amp;author=RH+Gabra&amp;publication_year=2022&amp;title=Impact%20of%20pain%20severity%20on%20functioning%20domains%2C%20sleep%2C%20and%20cognition%20in%20painful%20diabetic%20peripheral%20polyneuropathy%20patients&amp;journal=Middle+East+Curr+Psychiatry&amp;volume=29&amp;pages=83" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B22" id="B22"></a> 22. Croosu SS, Gjela M, R&#xf8;ikjer J, Hansen TM, M&#xf8;rch CD, Fr&#xf8;kj&#xe6;r JB, et al. Cognitive function in individuals with and without painful and painless diabetic polyneuropathy-A cross-sectional study in type 1 diabetes. <i>Endocrinology Diabetes Metab</i>. (2023) 6:e420. doi:&#xa0;10.1002/edm2.420</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37073434/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/edm2.420" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SS+Croosu&amp;author=M+Gjela&amp;author=J+R%C3%B8ikjer&amp;author=TM+Hansen&amp;author=CD+M%C3%B8rch&amp;author=JB+Fr%C3%B8kj%C3%A6r&amp;publication_year=2023&amp;title=Cognitive%20function%20in%20individuals%20with%20and%20without%20painful%20and%20painless%20diabetic%20polyneuropathy-A%20cross-sectional%20study%20in%20type%201%20diabetes&amp;journal=Endocrinology+Diabetes+Metab&amp;volume=6&amp;pages=e420" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B23" id="B23"></a> 23. Nguyen ML, Wong D, Barson E, Staunton E, and Fisher CA. Cognitive dysfunction in diabetes-related foot complications: A cohort study. <i>J Diabetes Metab Disord</i>. (2024) 23:1017&#x2013;38. doi:&#xa0;10.1007/s40200-023-01381-4</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/38932904/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s40200-023-01381-4" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=ML+Nguyen&amp;author=D+Wong&amp;author=E+Barson&amp;author=E+Staunton&amp;author=CA+Fisher&amp;publication_year=2024&amp;title=Cognitive%20dysfunction%20in%20diabetes-related%20foot%20complications%3A%20A%20cohort%20study&amp;journal=J+Diabetes+Metab+Disord&amp;volume=23&amp;pages=1017-38" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B24" id="B24"></a> 24. Yu X, He H, Wen J, Xu X, Ruan Z, Hu R, et al. Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments. <i>Open Med (Warsaw Poland)</i>. (2025) 20:20241091. doi:&#xa0;10.1515/med-2024-1091</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39822993/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1515/med-2024-1091" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X+Yu&amp;author=H+He&amp;author=J+Wen&amp;author=X+Xu&amp;author=Z+Ruan&amp;author=R+Hu&amp;publication_year=2025&amp;title=Diabetes-related%20cognitive%20impairment%3A%20Mechanisms%2C%20symptoms%2C%20and%20treatments&amp;journal=Open+Med+(Warsaw+Poland)&amp;volume=20&amp;pages=20241091" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B25" id="B25"></a> 25. Milstein JL and Ferris HA. The brain as an insulin-sensitive metabolic organ. <i>Mol Metab</i>. (2021) 52:101234. doi:&#xa0;10.1016/j.molmet.2021.101234</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/33845179/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.molmet.2021.101234" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JL+Milstein&amp;author=HA+Ferris&amp;publication_year=2021&amp;title=The%20brain%20as%20an%20insulin-sensitive%20metabolic%20organ&amp;journal=Mol+Metab&amp;volume=52&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B26" id="B26"></a> 26. Cetinkalp S, Simsir IY, and Ertek S. Insulin resistance in brain and possible therapeutic approaches. <i>Curr Vasc Pharmacol</i>. (2014) 12:553&#x2013;64. doi:&#xa0;10.2174/1570161112999140206130426</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/23627981/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2174/1570161112999140206130426" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Cetinkalp&amp;author=IY+Simsir&amp;author=S+Ertek&amp;publication_year=2014&amp;title=Insulin%20resistance%20in%20brain%20and%20possible%20therapeutic%20approaches&amp;journal=Curr+Vasc+Pharmacol&amp;volume=12&amp;pages=553-64" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B27" id="B27"></a> 27. Luo JS, Ning JQ, Chen ZY, Li WJ, Zhou RL, Yan RY, et al. The role of mitochondrial quality control in cognitive dysfunction in diabetes. <i>Neurochemical Res</i>. (2022) 47:2158&#x2013;72. doi:&#xa0;10.1007/s11064-022-03631-y</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35661963/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s11064-022-03631-y" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JS+Luo&amp;author=JQ+Ning&amp;author=ZY+Chen&amp;author=WJ+Li&amp;author=RL+Zhou&amp;author=RY+Yan&amp;publication_year=2022&amp;title=The%20role%20of%20mitochondrial%20quality%20control%20in%20cognitive%20dysfunction%20in%20diabetes&amp;journal=Neurochemical+Res&amp;volume=47&amp;pages=2158-72" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B28" id="B28"></a> 28. Grillo CA, Woodruff JL, Macht VA, and Reagan LP. Insulin resistance and hippocampal dysfunction: Disentangling peripheral and brain causes from consequences. <i>Exp Neurol</i>. (2019) 318:71&#x2013;7. doi:&#xa0;10.1016/j.expneurol.2019.04.012</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/31028829/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.expneurol.2019.04.012" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=CA+Grillo&amp;author=JL+Woodruff&amp;author=VA+Macht&amp;author=LP+Reagan&amp;publication_year=2019&amp;title=Insulin%20resistance%20and%20hippocampal%20dysfunction%3A%20Disentangling%20peripheral%20and%20brain%20causes%20from%20consequences&amp;journal=Exp+Neurol&amp;volume=318&amp;pages=71-7" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B29" id="B29"></a> 29. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. <i>Proc Natl Acad Sci U S A</i>. (2004) 101:10827&#x2013;32. doi:&#xa0;10.1073/pnas.0402141101</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/15249684/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.0402141101" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=LM+Monteggia&amp;author=M+Barrot&amp;author=CM+Powell&amp;author=O+Berton&amp;author=V+Galanis&amp;author=T+Gemelli&amp;publication_year=2004&amp;title=Essential%20role%20of%20brain-derived%20neurotrophic%20factor%20in%20adult%20hippocampal%20function&amp;journal=Proc+Natl+Acad+Sci+U+S+A&amp;volume=101&amp;pages=10827-32" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B30" id="B30"></a> 30. Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT, et al. Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease. <i>JAMA Neurol</i>. (2015) 72:1013&#x2013;20. doi:&#xa0;10.1001/jamaneurol.2015.0613</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/26214150/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1001/jamaneurol.2015.0613" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=AA+Willette&amp;author=BB+Bendlin&amp;author=EJ+Starks&amp;author=AC+Birdsill&amp;author=SC+Johnson&amp;author=BT+Christian&amp;publication_year=2015&amp;title=Association%20of%20insulin%20resistance%20with%20cerebral%20glucose%20uptake%20in%20late%20middle-aged%20adults%20at%20risk%20for%20Alzheimer%20disease&amp;journal=JAMA+Neurol&amp;volume=72&amp;pages=1013-20" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B31" id="B31"></a> 31. Kim E, Tolhurst AT, and Cho S. Deregulation of inflammatory response in the diabetic condition is associated with increased ischemic brain injury. <i>J Neuroinflamm</i>. (2014) 11:83. doi:&#xa0;10.1186/1742-2094-11-83</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/24886035/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/1742-2094-11-83" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=E+Kim&amp;author=AT+Tolhurst&amp;author=S+Cho&amp;publication_year=2014&amp;title=Deregulation%20of%20inflammatory%20response%20in%20the%20diabetic%20condition%20is%20associated%20with%20increased%20ischemic%20brain%20injury&amp;journal=J+Neuroinflamm&amp;volume=11&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B32" id="B32"></a> 32. Muriach M, Flores-Bellver M, Romero FJ, and Barcia JM. Diabetes and the brain: oxidative stress, inflammation, and autophagy. <i>Oxid Med Cell Longevity</i>. (2014) 2014:102158. doi:&#xa0;10.1155/2014/102158</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/25215171/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1155/2014/102158" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Muriach&amp;author=M+Flores-Bellver&amp;author=FJ+Romero&amp;author=JM+Barcia&amp;publication_year=2014&amp;title=Diabetes%20and%20the%20brain%3A%20oxidative%20stress%2C%20inflammation%2C%20and%20autophagy&amp;journal=Oxid+Med+Cell+Longevity&amp;volume=2014&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B33" id="B33"></a> 33. Gerstein HC, Smith EE, Ramasundarahettige C, Desai D, Awadalla P, Broet P, et al. Diabetes, brain infarcts, cognition, and small vessels in the Canadian alliance for healthy hearts and minds study. <i>J Clin Endocrinol Metab</i>. (2021) 106:e891&#x2013;e8. doi:&#xa0;10.1210/clinem/dgaa815</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/33165530/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1210/clinem/dgaa815" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=HC+Gerstein&amp;author=EE+Smith&amp;author=C+Ramasundarahettige&amp;author=D+Desai&amp;author=P+Awadalla&amp;author=P+Broet&amp;publication_year=2021&amp;title=Diabetes%2C%20brain%20infarcts%2C%20cognition%2C%20and%20small%20vessels%20in%20the%20Canadian%20alliance%20for%20healthy%20hearts%20and%20minds%20study&amp;journal=J+Clin+Endocrinol+Metab&amp;volume=106&amp;pages=e891-e8" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B34" id="B34"></a> 34. Mechanisms of cognitive decline in newly diagnosed diabetics: A review of pathophysiological contributions and intervention strategies. <i>MEDS Basic Med</i>. (2024) 2(2). doi:&#xa0;10.23977/medbm.2024.020203</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://doi.org/10.23977/medbm.2024.020203" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?publication_year=2024&amp;title=Mechanisms%20of%20cognitive%20decline%20in%20newly%20diagnosed%20diabetics%3A%20A%20review%20of%20pathophysiological%20contributions%20and%20intervention%20strategies&amp;journal=MEDS+Basic+Med&amp;volume=2&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B35" id="B35"></a> 35. Chandran R, He L, Nie X, Voltin J, Jamil S, Doueiry C, et al. Magnetic resonance imaging reveals microemboli-mediated pathological changes in brain microstructure in diabetic rats: relevance to vascular cognitive impairment/dementia. <i>Clin Sci (London England: 1979)</i>. (2022) 136:1555&#x2013;70. doi:&#xa0;10.1042/cs20220465</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/36314470/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1042/cs20220465" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Chandran&amp;author=L+He&amp;author=X+Nie&amp;author=J+Voltin&amp;author=S+Jamil&amp;author=C+Doueiry&amp;publication_year=2022&amp;title=Magnetic%20resonance%20imaging%20reveals%20microemboli-mediated%20pathological%20changes%20in%20brain%20microstructure%20in%20diabetic%20rats%3A%20relevance%20to%20vascular%20cognitive%20impairment%2Fdementia&amp;journal=Clin+Sci+(London+England:+1979)&amp;volume=136&amp;pages=1555-70" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B36" id="B36"></a> 36. Umegaki H. Neurodegeneration in diabetes mellitus. <i>Adv Exp Med Biol</i>. (2012) 724:258&#x2013;65. doi:&#xa0;10.1007/978-1-4614-0653-2_19</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/22411248/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/978-1-4614-0653-2_19" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H+Umegaki&amp;publication_year=2012&amp;title=Neurodegeneration%20in%20diabetes%20mellitus&amp;journal=Adv+Exp+Med+Biol&amp;volume=724&amp;pages=258-65" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B37" id="B37"></a> 37. Sandireddy R, Yerra VG, Areti A, Komirishetty P, and Kumar A. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. <i>Int J Endocrinol</i>. (2014) 2014:674987. doi:&#xa0;10.1155/2014/674987</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/24883061/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1155/2014/674987" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Sandireddy&amp;author=VG+Yerra&amp;author=A+Areti&amp;author=P+Komirishetty&amp;author=A+Kumar&amp;publication_year=2014&amp;title=Neuroinflammation%20and%20oxidative%20stress%20in%20diabetic%20neuropathy%3A%20futuristic%20strategies%20based%20on%20these%20targets&amp;journal=Int+J+Endocrinol&amp;volume=2014&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B38" id="B38"></a> 38. Kumar P, Raman T, Swain MM, Mishra R, and Pal A. Hyperglycemia-induced oxidative-nitrosative stress induces inflammation and neurodegeneration via augmented tuberous sclerosis complex-2 (TSC-2) activation in neuronal cells. <i>Mol Neurobiol</i>. (2017) 54:238&#x2013;54. doi:&#xa0;10.1007/s12035-015-9667-3</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/26738854/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s12035-015-9667-3" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P+Kumar&amp;author=T+Raman&amp;author=MM+Swain&amp;author=R+Mishra&amp;author=A+Pal&amp;publication_year=2017&amp;title=Hyperglycemia-induced%20oxidative-nitrosative%20stress%20induces%20inflammation%20and%20neurodegeneration%20via%20augmented%20tuberous%20sclerosis%20complex-2%20%28TSC-2%29%20activation%20in%20neuronal%20cells&amp;journal=Mol+Neurobiol&amp;volume=54&amp;pages=238-54" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B39" id="B39"></a> 39. Schmeichel AM, Schmelzer JD, and Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. <i>Diabetes</i>. (2003) 52:165&#x2013;71. doi:&#xa0;10.2337/diabetes.52.1.165</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/12502508/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2337/diabetes.52.1.165" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=AM+Schmeichel&amp;author=JD+Schmelzer&amp;author=PA+Low&amp;publication_year=2003&amp;title=Oxidative%20injury%20and%20apoptosis%20of%20dorsal%20root%20ganglion%20neurons%20in%20chronic%20experimental%20diabetic%20neuropathy&amp;journal=Diabetes&amp;volume=52&amp;pages=165-71" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B40" id="B40"></a> 40. Kale MB, Bhondge HM, Wankhede NL, Shende PV, Thanekaer RP, Aglawe MM, et al. Navigating the intersection: Diabetes and Alzheimer's intertwined relationship. <i>Ageing Res Rev</i>. (2024) 100:102415. doi:&#xa0;10.1016/j.arr.2024.102415</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39002642/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.arr.2024.102415" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MB+Kale&amp;author=HM+Bhondge&amp;author=NL+Wankhede&amp;author=PV+Shende&amp;author=RP+Thanekaer&amp;author=MM+Aglawe&amp;publication_year=2024&amp;title=Navigating%20the%20intersection%3A%20Diabetes%20and%20Alzheimer%27s%20intertwined%20relationship&amp;journal=Ageing+Res+Rev&amp;volume=100&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B41" id="B41"></a> 41. Nasrolahi A, Mahmoudi J, Noori-Zadeh A, Haghani K, Bakhtiyari S, Darabi S, et al. Shared pathological mechanisms between diabetes mellitus and neurodegenerative diseases. <i>Curr Pharmacol Rep</i>. (2019) 5:219&#x2013;31. doi:&#xa0;10.1007/s40495-019-00191-8</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://doi.org/10.1007/s40495-019-00191-8" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Nasrolahi&amp;author=J+Mahmoudi&amp;author=A+Noori-Zadeh&amp;author=K+Haghani&amp;author=S+Bakhtiyari&amp;author=S+Darabi&amp;publication_year=2019&amp;title=Shared%20pathological%20mechanisms%20between%20diabetes%20mellitus%20and%20neurodegenerative%20diseases&amp;journal=Curr+Pharmacol+Rep&amp;volume=5&amp;pages=219-31" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B42" id="B42"></a> 42. Szablewski L. Associations between diabetes mellitus and neurodegenerative diseases. <i>Int J Mol Sci</i>. (2025) 26(2):542. doi:&#xa0;10.3390/ijms26020542</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39859258/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms26020542" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=L+Szablewski&amp;publication_year=2025&amp;title=Associations%20between%20diabetes%20mellitus%20and%20neurodegenerative%20diseases&amp;journal=Int+J+Mol+Sci&amp;volume=26&amp;pages=542" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B43" id="B43"></a> 43. Ahmad R, Chowdhury K, Kumar S, Irfan M, Reddy GS, Akter F, et al. Diabetes mellitus: A path to amnesia, personality, and behavior change. <i>Biology</i>. (2022) 11(3):382. doi:&#xa0;10.3390/biology11030382</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35336756/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/biology11030382" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Ahmad&amp;author=K+Chowdhury&amp;author=S+Kumar&amp;author=M+Irfan&amp;author=GS+Reddy&amp;author=F+Akter&amp;publication_year=2022&amp;title=Diabetes%20mellitus%3A%20A%20path%20to%20amnesia%2C%20personality%2C%20and%20behavior%20change&amp;journal=Biology&amp;volume=11&amp;pages=382" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B44" id="B44"></a> 44. H S, T T, and Vellapandian C. Gut-brain axis: unveiling the interplay between diabetes mellitus and Alzheimer's disease. <i>Cureus</i>. (2024) 16:e68083. doi:&#xa0;10.7759/cureus.68083</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39347125/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.7759/cureus.68083" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+H&amp;author=T+T&amp;author=C+Vellapandian&amp;publication_year=2024&amp;title=Gut-brain%20axis%3A%20unveiling%20the%20interplay%20between%20diabetes%20mellitus%20and%20Alzheimer%27s%20disease&amp;journal=Cureus&amp;volume=16&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B45" id="B45"></a> 45. Bi T, Zhang L, Zhan L, Feng R, Zhao T, Ren W, et al. Integrated analyses of microbiomics and metabolomics explore the effect of gut microbiota transplantation on diabetes-associated cognitive decline in Zucker diabetic fatty rats. <i>Front Aging Neurosci</i>. (2022) 14:913002. doi:&#xa0;10.3389/fnagi.2022.913002</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35721013/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnagi.2022.913002" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=T+Bi&amp;author=L+Zhang&amp;author=L+Zhan&amp;author=R+Feng&amp;author=T+Zhao&amp;author=W+Ren&amp;publication_year=2022&amp;title=Integrated%20analyses%20of%20microbiomics%20and%20metabolomics%20explore%20the%20effect%20of%20gut%20microbiota%20transplantation%20on%20diabetes-associated%20cognitive%20decline%20in%20Zucker%20diabetic%20fatty%20rats&amp;journal=Front+Aging+Neurosci&amp;volume=14&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B46" id="B46"></a> 46. Zhang Q, Jin K, Chen B, Liu R, Cheng S, Zhang Y, et al. Overnutrition induced cognitive impairment: insulin resistance, gut-brain axis, and neuroinflammation. <i>Front Neurosci</i>. (2022) 16:884579. doi:&#xa0;10.3389/fnins.2022.884579</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35873818/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnins.2022.884579" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Q+Zhang&amp;author=K+Jin&amp;author=B+Chen&amp;author=R+Liu&amp;author=S+Cheng&amp;author=Y+Zhang&amp;publication_year=2022&amp;title=Overnutrition%20induced%20cognitive%20impairment%3A%20insulin%20resistance%2C%20gut-brain%20axis%2C%20and%20neuroinflammation&amp;journal=Front+Neurosci&amp;volume=16&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B47" id="B47"></a> 47. Bozanic A, Toro P, Bello-Lepe S, Hurtado-Oliva J, Beyle C, Vald&#xe9;s C, et al. Cognitive impairment with Type 2 Diabetes Mellitus among community-dwelling older adults in Chile: Prevalence, risk factors and cognitive characteristics. <i>Front Hum Neurosci</i>. (2022) 16:1070611. doi:&#xa0;10.3389/fnhum.2022.1070611</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/36741779/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnhum.2022.1070611" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Bozanic&amp;author=P+Toro&amp;author=S+Bello-Lepe&amp;author=J+Hurtado-Oliva&amp;author=C+Beyle&amp;author=C+Vald%C3%A9s&amp;publication_year=2022&amp;title=Cognitive%20impairment%20with%20Type%202%20Diabetes%20Mellitus%20among%20community-dwelling%20older%20adults%20in%20Chile%3A%20Prevalence%2C%20risk%20factors%20and%20cognitive%20characteristics&amp;journal=Front+Hum+Neurosci&amp;volume=16&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B48" id="B48"></a> 48. Wu X, Tang Y, He Y, Wang Q, Wang Y, Qin X, et al. Prevalence of cognitive impairment and its related factors among Chinese older adults: an analysis based on the 2018 CHARLS data. <i>Front Public Health</i>. (2024) 12:1500172. doi:&#xa0;10.3389/fpubh.2024.1500172</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39776486/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fpubh.2024.1500172" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X+Wu&amp;author=Y+Tang&amp;author=Y+He&amp;author=Q+Wang&amp;author=Y+Wang&amp;author=X+Qin&amp;publication_year=2024&amp;title=Prevalence%20of%20cognitive%20impairment%20and%20its%20related%20factors%20among%20Chinese%20older%20adults%3A%20an%20analysis%20based%20on%20the%202018%20CHARLS%20data&amp;journal=Front+Public+Health&amp;volume=12&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B49" id="B49"></a> 49. Moran C, Gilsanz P, Beeri MS, Whitmer RA, and Lacy ME. Sex, diabetes status and cognition: findings from the study of longevity in diabetes. <i>BMJ Open Diabetes Res Care</i>. (2021) 9:e001646. doi:&#xa0;10.1136/bmjdrc-2020-001646</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/33509934/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1136/bmjdrc-2020-001646" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C+Moran&amp;author=P+Gilsanz&amp;author=MS+Beeri&amp;author=RA+Whitmer&amp;author=ME+Lacy&amp;publication_year=2021&amp;title=Sex%2C%20diabetes%20status%20and%20cognition%3A%20findings%20from%20the%20study%20of%20longevity%20in%20diabetes&amp;journal=BMJ+Open+Diabetes+Res+Care&amp;volume=9&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B50" id="B50"></a> 50. Jokisch M, Platzbecker AL, Gronewold J, J&#xf6;ckel KH, Moebus S, Erbel R, et al. Gender- and age-specific association of known type 2 diabetes mellitus on incident mild cognitive impairment five years later: Results from the population-based Heinz Nixdorf Recall Study. <i>Alzheimer's Dementia</i>. (2024) 20:e084652. doi:&#xa0;10.1002/alz.084652</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/40502925/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/alz.084652" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Jokisch&amp;author=AL+Platzbecker&amp;author=J+Gronewold&amp;author=KH+J%C3%B6ckel&amp;author=S+Moebus&amp;author=R+Erbel&amp;publication_year=2024&amp;title=Gender-%20and%20age-specific%20association%20of%20known%20type%202%20diabetes%20mellitus%20on%20incident%20mild%20cognitive%20impairment%20five%20years%20later%3A%20Results%20from%20the%20population-based%20Heinz%20Nixdorf%20Recall%20Study&amp;journal=Alzheimer's+Dementia&amp;volume=20&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B51" id="B51"></a> 51. Reinke C. The effect of diabetes in the multifaceted relationship between education and cognitive function. <i>BMC Public Health</i>. (2024) 24:2584. doi:&#xa0;10.1186/s12889-024-20156-x</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39334040/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/s12889-024-20156-x" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C+Reinke&amp;publication_year=2024&amp;title=The%20effect%20of%20diabetes%20in%20the%20multifaceted%20relationship%20between%20education%20and%20cognitive%20function&amp;journal=BMC+Public+Health&amp;volume=24&amp;pages=2584" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B52" id="B52"></a> 52. Pe&#xf1;a-Gonz&#xe1;lez P, Mondrag&#xf3;n-Maya A, Silva-Pereyra J, and Roa-Rojas P. Cognitive reserve and executive functions in adults with type 2 diabetes. <i>J Diabetes Res</i>. (2020) 2020:7941543. doi:&#xa0;10.1155/2020/7941543</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/33083496/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1155/2020/7941543" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P+Pe%C3%B1a-Gonz%C3%A1lez&amp;author=A+Mondrag%C3%B3n-Maya&amp;author=J+Silva-Pereyra&amp;author=P+Roa-Rojas&amp;publication_year=2020&amp;title=Cognitive%20reserve%20and%20executive%20functions%20in%20adults%20with%20type%202%20diabetes&amp;journal=J+Diabetes+Res&amp;volume=2020&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B53" id="B53"></a> 53. Connors MH, Seeher K, Teixeira-Pinto A, Woodward M, Ames D, Brodaty H, et al. Dementia and caregiver burden: A three-year longitudinal study. <i>Int J geriatric Psychiatry</i>. (2020) 35:250&#x2013;8. doi:&#xa0;10.1002/gps.5244</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/31821606/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/gps.5244" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MH+Connors&amp;author=K+Seeher&amp;author=A+Teixeira-Pinto&amp;author=M+Woodward&amp;author=D+Ames&amp;author=H+Brodaty&amp;publication_year=2020&amp;title=Dementia%20and%20caregiver%20burden%3A%20A%20three-year%20longitudinal%20study&amp;journal=Int+J+geriatric+Psychiatry&amp;volume=35&amp;pages=250-8" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B54" id="B54"></a> 54. Saldana SL and Guarnaccia CA. Comparing cognitive function in white Mexican &amp; non-Hispanic white Americans with/without diabetes. <i>J Diabetes Metab Disord</i>. (2022) 21:599&#x2013;605. doi:&#xa0;10.1007/s40200-022-01022-2</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35673415/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s40200-022-01022-2" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SL+Saldana&amp;author=CA+Guarnaccia&amp;publication_year=2022&amp;title=Comparing%20cognitive%20function%20in%20white%20Mexican%20%26%20non-Hispanic%20white%20Americans%20with%2Fwithout%20diabetes&amp;journal=J+Diabetes+Metab+Disord&amp;volume=21&amp;pages=599" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B55" id="B55"></a> 55. Lin Y, Gong Z, Ma C, Wang Z, and Wang K. Relationship between glycemic control and cognitive impairment: A systematic review and meta-analysis. <i>Front Aging Neurosci</i>. (2023) 15:1126183. doi:&#xa0;10.3389/fnagi.2023.1126183</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/36776436/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnagi.2023.1126183" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Lin&amp;author=Z+Gong&amp;author=C+Ma&amp;author=Z+Wang&amp;author=K+Wang&amp;publication_year=2023&amp;title=Relationship%20between%20glycemic%20control%20and%20cognitive%20impairment%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Front+Aging+Neurosci&amp;volume=15&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B56" id="B56"></a> 56. Herath PM, Cherbuin N, Eramudugolla R, and Anstey KJ. The effect of diabetes medication on cognitive function: evidence from the PATH through life study. <i>BioMed Res Int</i>. (2016) 2016:7208429. doi:&#xa0;10.1155/2016/7208429</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27195294/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1155/2016/7208429" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=PM+Herath&amp;author=N+Cherbuin&amp;author=R+Eramudugolla&amp;author=KJ+Anstey&amp;publication_year=2016&amp;title=The%20effect%20of%20diabetes%20medication%20on%20cognitive%20function%3A%20evidence%20from%20the%20PATH%20through%20life%20study&amp;journal=BioMed+Res+Int&amp;volume=2016&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B57" id="B57"></a> 57. Chapman LE, Darling AL, and Brown JE. Association between metformin and vitamin B(12) deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. <i>Diabetes Metab</i>. (2016) 42:316&#x2013;27. doi:&#xa0;10.1016/j.diabet.2016.03.008</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27130885/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.diabet.2016.03.008" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=LE+Chapman&amp;author=AL+Darling&amp;author=JE+Brown&amp;publication_year=2016&amp;title=Association%20between%20metformin%20and%20vitamin%20B%2812%29%20deficiency%20in%20patients%20with%20type%202%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Diabetes+Metab&amp;volume=42&amp;pages=316-27" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B58" id="B58"></a> 58. Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D, et al. Cognitive impairment and vitamin B12: a review. <i>Int psychogeriatrics</i>. (2012) 24:541&#x2013;56. doi:&#xa0;10.1017/s1041610211002511</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/22221769/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1017/s1041610211002511" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=E+Moore&amp;author=A+Mander&amp;author=D+Ames&amp;author=R+Carne&amp;author=K+Sanders&amp;author=D+Watters&amp;publication_year=2012&amp;title=Cognitive%20impairment%20and%20vitamin%20B12%3A%20a%20review&amp;journal=Int+psychogeriatrics&amp;volume=24&amp;pages=541-56" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B59" id="B59"></a> 59. Campbell JM, Stephenson MD, De Courten B, Chapman I, Bellman SM, Aromataris E, et al. Metformin use associated with reduced risk of dementia in patients with diabetes: A systematic review and meta-analysis. <i>J Alzheimer's disease: JAD</i>. (2018) 65:1225&#x2013;36. doi:&#xa0;10.3233/jad-180263</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/30149446/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3233/jad-180263" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JM+Campbell&amp;author=MD+Stephenson&amp;author=B+De%20Courten&amp;author=I+Chapman&amp;author=SM+Bellman&amp;author=E+Aromataris&amp;publication_year=2018&amp;title=Metformin%20use%20associated%20with%20reduced%20risk%20of%20dementia%20in%20patients%20with%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=J+Alzheimer's+disease:+JAD&amp;volume=65&amp;pages=1225-36" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B60" id="B60"></a> 60. Siddeeque N, Hussein MH, Abdelmaksoud A, Bishop J, Attia AS, Elshazli RM, et al. Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study. <i>Int Immunopharmacol</i>. (2024) 143:113537. doi:&#xa0;10.1016/j.intimp.2024.113537</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39486172/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.intimp.2024.113537" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=N+Siddeeque&amp;author=MH+Hussein&amp;author=A+Abdelmaksoud&amp;author=J+Bishop&amp;author=AS+Attia&amp;author=RM+Elshazli&amp;publication_year=2024&amp;title=Neuroprotective%20effects%20of%20GLP-1%20receptor%20agonists%20in%20neurodegenerative%20Disorders%3A%20A%20Large-Scale%20Propensity-Matched%20cohort%20study&amp;journal=Int+Immunopharmacol&amp;volume=143&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B61" id="B61"></a> 61. Luan S, Cheng W, Wang C, Gong J, and Zhou J. Impact of glucagon-like peptide 1 analogs on cognitive function among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. <i>Front Endocrinol</i>. (2022) 13:1047883. doi:&#xa0;10.3389/fendo.2022.1047883</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/36387915/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fendo.2022.1047883" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Luan&amp;author=W+Cheng&amp;author=C+Wang&amp;author=J+Gong&amp;author=J+Zhou&amp;publication_year=2022&amp;title=Impact%20of%20glucagon-like%20peptide%201%20analogs%20on%20cognitive%20function%20among%20patients%20with%20type%202%20diabetes%20mellitus%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Front+Endocrinol&amp;volume=13&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B62" id="B62"></a> 62. Vadini F, Simeone PG, Boccatonda A, Guagnano MT, Liani R, Tripaldi R, et al. Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study. <i>Int J Obes (2005)</i>. (2020) 44:1254&#x2013;63. doi:&#xa0;10.1038/s41366-020-0535-5</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/31965072/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41366-020-0535-5" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=F+Vadini&amp;author=PG+Simeone&amp;author=A+Boccatonda&amp;author=MT+Guagnano&amp;author=R+Liani&amp;author=R+Tripaldi&amp;publication_year=2020&amp;title=Liraglutide%20improves%20memory%20in%20obese%20patients%20with%20prediabetes%20or%20early%20type%202%20diabetes%3A%20a%20randomized%2C%20controlled%20study&amp;journal=Int+J+Obes+(2005)&amp;volume=44&amp;pages=1254-63" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B63" id="B63"></a> 63. Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, et al. The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer's disease. <i>J Alzheimer's disease: JAD</i>. (2015) 46:877&#x2013;88. doi:&#xa0;10.3233/jad-143090</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/25869785/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3233/jad-143090" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=HH+Hansen&amp;author=K+Fabricius&amp;author=P+Barkholt&amp;author=ML+Niehoff&amp;author=JE+Morley&amp;author=J+Jelsing&amp;publication_year=2015&amp;title=The%20GLP-1%20receptor%20agonist%20liraglutide%20improves%20memory%20function%20and%20increases%20hippocampal%20CA1%20neuronal%20numbers%20in%20a%20senescence-accelerated%20mouse%20model%20of%20Alzheimer%27s%20disease&amp;journal=J+Alzheimer's+disease:+JAD&amp;volume=46&amp;pages=877-88" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B64" id="B64"></a> 64. Zhang Y, Liao X, Xu J, Yin J, Li S, Li M, et al. The promising potency of sodium-glucose cotransporter 2 inhibitors in the prevention of and as treatment for cognitive impairment among type 2 diabetes patients. <i>Biomedicines</i>. (2024) 12(12):2783. doi:&#xa0;10.3390/biomedicines12122783</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39767690/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/biomedicines12122783" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Zhang&amp;author=X+Liao&amp;author=J+Xu&amp;author=J+Yin&amp;author=S+Li&amp;author=M+Li&amp;publication_year=2024&amp;title=The%20promising%20potency%20of%20sodium-glucose%20cotransporter%202%20inhibitors%20in%20the%20prevention%20of%20and%20as%20treatment%20for%20cognitive%20impairment%20among%20type%202%20diabetes%20patients&amp;journal=Biomedicines&amp;volume=12&amp;pages=2783" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B65" id="B65"></a> 65. Gui Z, Wang J, Zhang Y, et al. Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice. <i>BioFactors (Oxford England)</i>. (2024) 50:145&#x2013;60. doi:&#xa0;10.1002/biof.1998</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37596888/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/biof.1998" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Z+Gui&amp;author=J+Wang&amp;author=Y+Zhang&amp;publication_year=2024&amp;title=Dapagliflozin%20improves%20diabetic%20cognitive%20impairment%20via%20indirectly%20modulating%20the%20mitochondria%20homeostasis%20of%20hippocampus%20in%20diabetic%20mice&amp;journal=BioFactors+(Oxford+England)&amp;volume=50&amp;pages=145-60" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B66" id="B66"></a> 66. Youn YJ, Kim S, Jeong HJ, Ah YM, and Yu YM. Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis. <i>Front Neuroendocrinol</i>. (2024) 73:101131. doi:&#xa0;10.1016/j.yfrne.2024.101131</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/38367940/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.yfrne.2024.101131" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=YJ+Youn&amp;author=S+Kim&amp;author=HJ+Jeong&amp;author=YM+Ah&amp;author=YM+Yu&amp;publication_year=2024&amp;title=Sodium-glucose%20cotransporter-2%20inhibitors%20and%20their%20potential%20role%20in%20dementia%20onset%20and%20cognitive%20function%20in%20patients%20with%20diabetes%20mellitus%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Front+Neuroendocrinol&amp;volume=73&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B67" id="B67"></a> 67. Pan J, Yang H, Lu J, Chen L, Wen T, Zhao S, et al. The impact of SGLT2 inhibitors on dementia onset in patients with type 2 diabetes: A meta-analysis of cohort studies. <i>Neuroendocrinology</i>. (2025) 115(3-4):351&#x2013;9. doi:&#xa0;10.1159/000543533</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39799939/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1159/000543533" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Pan&amp;author=H+Yang&amp;author=J+Lu&amp;author=L+Chen&amp;author=T+Wen&amp;author=S+Zhao&amp;publication_year=2025&amp;title=The%20impact%20of%20SGLT2%20inhibitors%20on%20dementia%20onset%20in%20patients%20with%20type%202%20diabetes%3A%20A%20meta-analysis%20of%20cohort%20studies&amp;journal=Neuroendocrinology&amp;volume=115&amp;pages=351-9" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B68" id="B68"></a> 68. Lardaro A, Quarta L, Pagnotta S, Sodero G, Mariani S, Del Ben M, et al. Impact of sodium glucose cotransporter 2 inhibitors (SGLT2i) therapy on dementia and cognitive decline. <i>Biomedicines</i>. (2024) 12(8):1750. doi:&#xa0;10.3390/biomedicines12081750</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39200215/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/biomedicines12081750" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Lardaro&amp;author=L+Quarta&amp;author=S+Pagnotta&amp;author=G+Sodero&amp;author=S+Mariani&amp;author=M+Del%20Ben&amp;publication_year=2024&amp;title=Impact%20of%20sodium%20glucose%20cotransporter%202%20inhibitors%20%28SGLT2i%29%20therapy%20on%20dementia%20and%20cognitive%20decline&amp;journal=Biomedicines&amp;volume=12&amp;pages=1750" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B69" id="B69"></a> 69. Gault VA, Lennox R, and Flatt PR. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline. <i>Diabetes Obes Metab</i>. (2015) 17:403&#x2013;13. doi:&#xa0;10.1111/dom.12432</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/25580570/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/dom.12432" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=VA+Gault&amp;author=R+Lennox&amp;author=PR+Flatt&amp;publication_year=2015&amp;title=Sitagliptin%2C%20a%20dipeptidyl%20peptidase-4%20inhibitor%2C%20improves%20recognition%20memory%2C%20oxidative%20stress%20and%20hippocampal%20neurogenesis%20and%20upregulates%20key%20genes%20involved%20in%20cognitive%20decline&amp;journal=Diabetes+Obes+Metab&amp;volume=17&amp;pages=403-13" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B70" id="B70"></a> 70. Yuan Y, Zhang Y, Lei M, Guo X, Yang X, Ouyang C, et al. Effects of DPP4 inhibitors as neuroprotective drug on cognitive impairment in patients with type 2 diabetes mellitus: A meta-analysis and systematic review. <i>Int J Endocrinol</i>. (2024) 2024:9294113. doi:&#xa0;10.1155/2024/9294113</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/38379936/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1155/2024/9294113" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Yuan&amp;author=Y+Zhang&amp;author=M+Lei&amp;author=X+Guo&amp;author=X+Yang&amp;author=C+Ouyang&amp;publication_year=2024&amp;title=Effects%20of%20DPP4%20inhibitors%20as%20neuroprotective%20drug%20on%20cognitive%20impairment%20in%20patients%20with%20type%202%20diabetes%20mellitus%3A%20A%20meta-analysis%20and%20systematic%20review&amp;journal=Int+J+Endocrinol&amp;volume=2024&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B71" id="B71"></a> 71. Hu Y, Xu J, Wang J, Zhu L, Wang J, Zhang Q, et al. DPP-4 inhibitors suppress tau phosphorylation and promote neuron autophagy through the AMPK/mTOR pathway to ameliorate cognitive dysfunction in diabetic mellitus. <i>ACS Chem Neurosci</i>. (2023) 14:3335&#x2013;46. doi:&#xa0;10.1021/acschemneuro.2c00733</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37655714/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1021/acschemneuro.2c00733" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Hu&amp;author=J+Xu&amp;author=J+Wang&amp;author=L+Zhu&amp;author=J+Wang&amp;author=Q+Zhang&amp;publication_year=2023&amp;title=DPP-4%20inhibitors%20suppress%20tau%20phosphorylation%20and%20promote%20neuron%20autophagy%20through%20the%20AMPK%2FmTOR%20pathway%20to%20ameliorate%20cognitive%20dysfunction%20in%20diabetic%20mellitus&amp;journal=ACS+Chem+Neurosci&amp;volume=14&amp;pages=3335-46" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B72" id="B72"></a> 72. Meng J, Yan R, Zhang C, Bai X, Yang X, Yang Y, et al. Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus. <i>Lipids Health Dis</i>. (2023) 22:219. doi:&#xa0;10.1186/s12944-023-01985-y</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/38082288/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/s12944-023-01985-y" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Meng&amp;author=R+Yan&amp;author=C+Zhang&amp;author=X+Bai&amp;author=X+Yang&amp;author=Y+Yang&amp;publication_year=2023&amp;title=Dipeptidyl%20peptidase-4%20inhibitors%20alleviate%20cognitive%20dysfunction%20in%20type%202%20diabetes%20mellitus&amp;journal=Lipids+Health+Dis&amp;volume=22&amp;pages=219" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B73" id="B73"></a> 73. Rizzo MR, Barbieri M, Boccardi V, Angellotti E, Marfella R, Paolisso G, et al. Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment. <i>journals gerontology Ser A Biol Sci Med Sci</i>. (2014) 69:1122&#x2013;31. doi:&#xa0;10.1093/gerona/glu032</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/24671867/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/gerona/glu032" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MR+Rizzo&amp;author=M+Barbieri&amp;author=V+Boccardi&amp;author=E+Angellotti&amp;author=R+Marfella&amp;author=G+Paolisso&amp;publication_year=2014&amp;title=Dipeptidyl%20peptidase-4%20inhibitors%20have%20protective%20effect%20on%20cognitive%20impairment%20in%20aged%20diabetic%20patients%20with%20mild%20cognitive%20impairment&amp;journal=journals+gerontology+Ser+A+Biol+Sci+Med+Sci&amp;volume=69&amp;pages=1122-31" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B74" id="B74"></a> 74. Pintana H, Apaijai N, Chattipakorn N, and Chattipakorn SC. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. <i>J Endocrinol</i>. (2013) 218:1&#x2013;11. doi:&#xa0;10.1530/joe-12-0521</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/23591914/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1530/joe-12-0521" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H+Pintana&amp;author=N+Apaijai&amp;author=N+Chattipakorn&amp;author=SC+Chattipakorn&amp;publication_year=2013&amp;title=DPP-4%20inhibitors%20improve%20cognition%20and%20brain%20mitochondrial%20function%20of%20insulin-resistant%20rats&amp;journal=J+Endocrinol&amp;volume=218&amp;pages=1" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B75" id="B75"></a> 75. Anirudhan A, Ahmad SF, Emran TB, Angulo-Bejarano PI, Sharma A, Ahmed S, et al. Comparative efficacy of metformin and glimepiride in modulating pharmacological network to increase BDNF levels and benefit type 2 diabetes-related cognitive impairment. <i>Biomedicines</i>. (2023) 11(11):2939. doi:&#xa0;10.3390/biomedicines11112939</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/38001940/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/biomedicines11112939" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Anirudhan&amp;author=SF+Ahmad&amp;author=TB+Emran&amp;author=PI+Angulo-Bejarano&amp;author=A+Sharma&amp;author=S+Ahmed&amp;publication_year=2023&amp;title=Comparative%20efficacy%20of%20metformin%20and%20glimepiride%20in%20modulating%20pharmacological%20network%20to%20increase%20BDNF%20levels%20and%20benefit%20type%202%20diabetes-related%20cognitive%20impairment&amp;journal=Biomedicines&amp;volume=11&amp;pages=2939" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B76" id="B76"></a> 76. Rosado AF, Rosa PB, Platt N, Pierone BC, Neis VB, Severo Rodrigues AL, et al. Glibenclamide treatment prevents depressive-like behavior and memory impairment induced by chronic unpredictable stress in female mice. <i>Behav Pharmacol</i>. (2021) 32:170&#x2013;81. doi:&#xa0;10.1097/fbp.0000000000000599</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/33079735/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1097/fbp.0000000000000599" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=AF+Rosado&amp;author=PB+Rosa&amp;author=N+Platt&amp;author=BC+Pierone&amp;author=VB+Neis&amp;author=AL+Severo%20Rodrigues&amp;publication_year=2021&amp;title=Glibenclamide%20treatment%20prevents%20depressive-like%20behavior%20and%20memory%20impairment%20induced%20by%20chronic%20unpredictable%20stress%20in%20female%20mice&amp;journal=Behav+Pharmacol&amp;volume=32&amp;pages=170-81" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B77" id="B77"></a> 77. Wu CY, Iskander C, Wang C, Xiong LY, Shah BR, Edwards JD, et al. Association of sulfonylureas with the risk of dementia: A population-based cohort study. <i>J Am Geriatrics Soc</i>. (2023) 71:3059&#x2013;70. doi:&#xa0;10.1111/jgs.18397</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37218376/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/jgs.18397" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=CY+Wu&amp;author=C+Iskander&amp;author=C+Wang&amp;author=LY+Xiong&amp;author=BR+Shah&amp;author=JD+Edwards&amp;publication_year=2023&amp;title=Association%20of%20sulfonylureas%20with%20the%20risk%20of%20dementia%3A%20A%20population-based%20cohort%20study&amp;journal=J+Am+Geriatrics+Soc&amp;volume=71&amp;pages=3059-70" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B78" id="B78"></a> 78. Tian S, Jiang J, Wang J, Zhang Z, Miao Y, Ji X, et al. Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis. <i>Diabetes/metabolism Res Rev</i>. (2023) 39:e3673. doi:&#xa0;10.1002/dmrr.3673</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37302139/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/dmrr.3673" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Tian&amp;author=J+Jiang&amp;author=J+Wang&amp;author=Z+Zhang&amp;author=Y+Miao&amp;author=X+Ji&amp;publication_year=2023&amp;title=Comparison%20on%20cognitive%20outcomes%20of%20antidiabetic%20agents%20for%20type%202%20diabetes%3A%20A%20systematic%20review%20and%20network%20meta-analysis&amp;journal=Diabetes/metabolism+Res+Rev&amp;volume=39&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B79" id="B79"></a> 79. Vandersmissen J, Dewachter I, Cuypers K, and Hansen D. The impact of exercise training on the brain and cognition in T2DM, and its physiological mediators: a systematic review. <i>medRxiv</i>. (2024) 11:42. doi:&#xa0;10.1101/2024.09.19.24313875</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/40274715/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/2024.09.19.24313875" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Vandersmissen&amp;author=I+Dewachter&amp;author=K+Cuypers&amp;author=D+Hansen&amp;publication_year=2024&amp;title=The%20impact%20of%20exercise%20training%20on%20the%20brain%20and%20cognition%20in%20T2DM%2C%20and%20its%20physiological%20mediators%3A%20a%20systematic%20review&amp;journal=medRxiv&amp;volume=11&amp;pages=42" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B80" id="B80"></a> 80. Sun Z, Liu H, Yan M, Zeng H, Hu Y, Tian X, et al. The effect of multi-component exercise on cognition function in patients with diabetes: A systematic review and meta-analysis. <i>PLoS One</i>. (2024) 19:e0304795. doi:&#xa0;10.1371/journal.pone.0304795</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/38900771/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0304795" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Z+Sun&amp;author=H+Liu&amp;author=M+Yan&amp;author=H+Zeng&amp;author=Y+Hu&amp;author=X+Tian&amp;publication_year=2024&amp;title=The%20effect%20of%20multi-component%20exercise%20on%20cognition%20function%20in%20patients%20with%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=PLoS+One&amp;volume=19&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B81" id="B81"></a> 81. Cooke S, Pennington K, Jones A, Bridle C, Smith MF, Curtis F, et al. Effects of exercise, cognitive, and dual-task interventions on cognition in type 2 diabetes mellitus: A systematic review and meta-analysis. <i>PLoS One</i>. (2020) 15:e0232958. doi:&#xa0;10.1371/journal.pone.0232958</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/32407347/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0232958" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Cooke&amp;author=K+Pennington&amp;author=A+Jones&amp;author=C+Bridle&amp;author=MF+Smith&amp;author=F+Curtis&amp;publication_year=2020&amp;title=Effects%20of%20exercise%2C%20cognitive%2C%20and%20dual-task%20interventions%20on%20cognition%20in%20type%202%20diabetes%20mellitus%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=PLoS+One&amp;volume=15&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B82" id="B82"></a> 82. Wang R, Yan W, Du M, Tao L, and Liu J. The effect of physical activity interventions on cognition function in patients with diabetes: A systematic review and meta-analysis. <i>Diabetes/metabolism Res Rev</i>. (2021) 37:e3443. doi:&#xa0;10.1002/dmrr.3443</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/33616310/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/dmrr.3443" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Wang&amp;author=W+Yan&amp;author=M+Du&amp;author=L+Tao&amp;author=J+Liu&amp;publication_year=2021&amp;title=The%20effect%20of%20physical%20activity%20interventions%20on%20cognition%20function%20in%20patients%20with%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Diabetes/metabolism+Res+Rev&amp;volume=37&amp;pages=e3443" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B83" id="B83"></a> 83. Cuevas HE, Stuifbergen AK, Brown SA, and Ward C. A. A nurse-led cognitive training intervention for individuals with type 2 diabetes. <i>Res gerontological Nurs</i>. (2019) 12:203&#x2013;12. doi:&#xa0;10.3928/19404921-20190612-01</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/31335962/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3928/19404921-20190612-01" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=HE+Cuevas&amp;author=AK+Stuifbergen&amp;author=SA+Brown&amp;author=C.%20A+Ward&amp;publication_year=2019&amp;title=A%20nurse-led%20cognitive%20training%20intervention%20for%20individuals%20with%20type%202%20diabetes&amp;journal=Res+gerontological+Nurs&amp;volume=12&amp;pages=203-12" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B84" id="B84"></a> 84. Dyer AH, Briggs R, Mockler D, Gibney J, and Kennelly SP. Non-pharmacological interventions for cognition in patients with Type 2 diabetes mellitus: a systematic review. <i>QJM: monthly J Assoc Physicians</i>. (2020) 113:155&#x2013;61. doi:&#xa0;10.1093/qjmed/hcz053</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/30825309/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/qjmed/hcz053" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=AH+Dyer&amp;author=R+Briggs&amp;author=D+Mockler&amp;author=J+Gibney&amp;author=SP+Kennelly&amp;publication_year=2020&amp;title=Non-pharmacological%20interventions%20for%20cognition%20in%20patients%20with%20Type%202%20diabetes%20mellitus%3A%20a%20systematic%20review&amp;journal=QJM:+monthly+J+Assoc+Physicians&amp;volume=113&amp;pages=155-61" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B85" id="B85"></a> 85. Goetzl EJ, Mustapic M, Kapogiannis D, Eitan E, Lobach IV, Goetzl L, et al. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease. <i>FASEB J</i>. (2016) 30:3853&#x2013;9. doi:&#xa0;10.1096/fj.201600756R</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/27511944/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1096/fj.201600756R" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=EJ+Goetzl&amp;author=M+Mustapic&amp;author=D+Kapogiannis&amp;author=E+Eitan&amp;author=IV+Lobach&amp;author=L+Goetzl&amp;publication_year=2016&amp;title=Cargo%20proteins%20of%20plasma%20astrocyte-derived%20exosomes%20in%20Alzheimer%27s%20disease&amp;journal=FASEB+J&amp;volume=30&amp;pages=3853-9" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B86" id="B86"></a> 86. Chi H, Yao R, Sun C, Leng B, Shen T, Wang T, et al. Blood neuroexosomal mitochondrial proteins predict Alzheimer disease in diabetes. <i>Diabetes</i>. (2022) 71:1313&#x2013;23. doi:&#xa0;10.2337/db21-0969</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35287177/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2337/db21-0969" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H+Chi&amp;author=R+Yao&amp;author=C+Sun&amp;author=B+Leng&amp;author=T+Shen&amp;author=T+Wang&amp;publication_year=2022&amp;title=Blood%20neuroexosomal%20mitochondrial%20proteins%20predict%20Alzheimer%20disease%20in%20diabetes&amp;journal=Diabetes&amp;volume=71&amp;pages=1313-23" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B87" id="B87"></a> 87. Kumar A, Cleary JA, Su Y, Singh S, Howard M, Hayden KM, et al. Multi-omics analysis of neuron-derived small extracellular vesicles to identify novel peripheral biomarker of cognitive impairment in individuals with type 2 diabetes. <i>Alzheimer's Dementia</i>. (2024) 20:e091878. doi:&#xa0;10.1002/alz.091878</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://doi.org/10.1002/alz.091878" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Kumar&amp;author=JA+Cleary&amp;author=Y+Su&amp;author=S+Singh&amp;author=M+Howard&amp;author=KM+Hayden&amp;publication_year=2024&amp;title=Multi-omics%20analysis%20of%20neuron-derived%20small%20extracellular%20vesicles%20to%20identify%20novel%20peripheral%20biomarker%20of%20cognitive%20impairment%20in%20individuals%20with%20type%202%20diabetes&amp;journal=Alzheimer's+Dementia&amp;volume=20&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B88" id="B88"></a> 88. Van Den Berg MMJ, Krauskopf J, Ramaekers JG, Kleinjans JCS, Prickaerts J, Briede JJ, et al. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. <i>Prog Neurobiol</i>. (2020) 185:101732. doi:&#xa0;10.1016/j.pneurobio.2019.101732</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/31816349/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.pneurobio.2019.101732" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MMJ+Van%20Den%20Berg&amp;author=J+Krauskopf&amp;author=JG+Ramaekers&amp;author=JCS+Kleinjans&amp;author=J+Prickaerts&amp;author=JJ+Briede&amp;publication_year=2020&amp;title=Circulating%20microRNAs%20as%20potential%20biomarkers%20for%20psychiatric%20and%20neurodegenerative%20disorders&amp;journal=Prog+Neurobiol&amp;volume=185&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B89" id="B89"></a> 89. Liu X, Zhao Z, Chen D, Zhang Z, Lin X, Shen Z, et al. SIRT1 and miR-34a-5p expression in PBMCs as potential biomarkers for patients with type 2 diabetes with cognitive impairments. <i>J Clin Endocrinol Metab</i>. (2024) 109:815&#x2013;26. doi:&#xa0;10.1210/clinem/dgad562</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37758217/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1210/clinem/dgad562" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X+Liu&amp;author=Z+Zhao&amp;author=D+Chen&amp;author=Z+Zhang&amp;author=X+Lin&amp;author=Z+Shen&amp;publication_year=2024&amp;title=SIRT1%20and%20miR-34a-5p%20expression%20in%20PBMCs%20as%20potential%20biomarkers%20for%20patients%20with%20type%202%20diabetes%20with%20cognitive%20impairments&amp;journal=J+Clin+Endocrinol+Metab&amp;volume=109&amp;pages=815-26" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B90" id="B90"></a> 90. Chen MD, Deng CF, Chen PF, Li A, Wu HZ, Ouyang F, et al. Non-invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta-analysis. <i>Diabetes Obes Metab</i>. (2024) 26:5519&#x2013;36. doi:&#xa0;10.1111/dom.15916</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/39233493/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/dom.15916" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MD+Chen&amp;author=CF+Deng&amp;author=PF+Chen&amp;author=A+Li&amp;author=HZ+Wu&amp;author=F+Ouyang&amp;publication_year=2024&amp;title=Non-invasive%20metabolic%20biomarkers%20in%20initial%20cognitive%20impairment%20in%20patients%20with%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Diabetes+Obes+Metab&amp;volume=26&amp;pages=5519-36" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B91" id="B91"></a> 91. Ehtewish H, Arredouani A, and El-Agnaf O. Diagnostic, prognostic, and mechanistic biomarkers of diabetes mellitus-associated cognitive decline. <i>Int J Mol Sci</i>. (2022) 23(11):6144. doi:&#xa0;10.3390/ijms23116144</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35682821/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms23116144" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H+Ehtewish&amp;author=A+Arredouani&amp;author=O+El-Agnaf&amp;publication_year=2022&amp;title=Diagnostic%2C%20prognostic%2C%20and%20mechanistic%20biomarkers%20of%20diabetes%20mellitus-associated%20cognitive%20decline&amp;journal=Int+J+Mol+Sci&amp;volume=23&amp;pages=6144" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B92" id="B92"></a> 92. Zhang T, Shaw M, and Cherbuin N. Association between type 2 diabetes mellitus and brain atrophy: A meta-analysis. <i>Diabetes Metab J</i>. (2022) 46:781&#x2013;802. doi:&#xa0;10.4093/dmj.2021.0189</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/35255549/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.4093/dmj.2021.0189" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=T+Zhang&amp;author=M+Shaw&amp;author=N+Cherbuin&amp;publication_year=2022&amp;title=Association%20between%20type%202%20diabetes%20mellitus%20and%20brain%20atrophy%3A%20A%20meta-analysis&amp;journal=Diabetes+Metab+J&amp;volume=46&amp;pages=781" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B93" id="B93"></a> 93. Zhang W, Gao C, Qing Z, Zhang Z, Bi Y, Zeng W, et al. Hippocampal subfields atrophy contribute more to cognitive impairment in middle-aged patients with type 2 diabetes rather than microvascular lesions. <i>Acta Diabetologica</i>. (2021) 58:1023&#x2013;33. doi:&#xa0;10.1007/s00592-020-01670-x</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/33751221/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00592-020-01670-x" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W+Zhang&amp;author=C+Gao&amp;author=Z+Qing&amp;author=Z+Zhang&amp;author=Y+Bi&amp;author=W+Zeng&amp;publication_year=2021&amp;title=Hippocampal%20subfields%20atrophy%20contribute%20more%20to%20cognitive%20impairment%20in%20middle-aged%20patients%20with%20type%202%20diabetes%20rather%20than%20microvascular%20lesions&amp;journal=Acta+Diabetologica&amp;volume=58&amp;pages=1023-33" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B94" id="B94"></a> 94. Naidu VV, Ismail K, Amiel S, Kohli R, Crosby-Nwaobi R, Sivaprasad S, et al. Associations between retinal markers of microvascular disease and cognitive impairment in newly diagnosed type 2 diabetes mellitus: A case control study. <i>PLoS One</i>. (2016) 11:e0147160. doi:&#xa0;10.1371/journal.pone.0147160</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/26771382/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0147160" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=VV+Naidu&amp;author=K+Ismail&amp;author=S+Amiel&amp;author=R+Kohli&amp;author=R+Crosby-Nwaobi&amp;author=S+Sivaprasad&amp;publication_year=2016&amp;title=Associations%20between%20retinal%20markers%20of%20microvascular%20disease%20and%20cognitive%20impairment%20in%20newly%20diagnosed%20type%202%20diabetes%20mellitus%3A%20A%20case%20control%20study&amp;journal=PLoS+One&amp;volume=11&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B95" id="B95"></a> 95. Doney ASF, Nar A, Huang Y, Trucco E, MacGillivray T, Connelly P, et al. Retinal vascular measures from diabetes retinal screening photographs and risk of incident dementia in type 2 diabetes: A GoDARTS study. <i>Front digital Health</i>. (2022) 4:945276. doi:&#xa0;10.3389/fdgth.2022.945276</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/36120710/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fdgth.2022.945276" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=ASF+Doney&amp;author=A+Nar&amp;author=Y+Huang&amp;author=E+Trucco&amp;author=T+MacGillivray&amp;author=P+Connelly&amp;publication_year=2022&amp;title=Retinal%20vascular%20measures%20from%20diabetes%20retinal%20screening%20photographs%20and%20risk%20of%20incident%20dementia%20in%20type%202%20diabetes%3A%20A%20GoDARTS%20study&amp;journal=Front+digital+Health&amp;volume=4&amp;" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B96" id="B96"></a> 96. Pedersen FN, Stokholm L, Lois N, Yang D, Cheung CY, Biessels GJ, et al. Structural and metabolic retinal changes associated with mild cognitive impairment in type 2 diabetes. <i>Diabetes</i>. (2023) 72:1853&#x2013;63. doi:&#xa0;10.2337/db23-0025</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37725903/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2337/db23-0025" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=FN+Pedersen&amp;author=L+Stokholm&amp;author=N+Lois&amp;author=D+Yang&amp;author=CY+Cheung&amp;author=GJ+Biessels&amp;publication_year=2023&amp;title=Structural%20and%20metabolic%20retinal%20changes%20associated%20with%20mild%20cognitive%20impairment%20in%20type%202%20diabetes&amp;journal=Diabetes&amp;volume=72&amp;pages=1853-63" target="_blank">Google Scholar</a></p></div><div class="References" style="margin-bottom:0.5em; margin-left:0em;"><p class="ReferencesCopy1" style="margin-left:0em; text-indent:0em;"><a name="B97" id="B97"></a> 97. Majimbi M, McLenachan S, Nesbit M, Chen FK, Lam V, Mamo J, et al. <i>In vivo</i> retinal imaging is associated with cognitive decline, blood-brain barrier disruption and neuroinflammation in type 2 diabetic mice. <i>Front Endocrinol</i>. (2023) 14:2023.1224418. doi:&#xa0;10.3389/fendo.2023.1224418</p><p class="ReferencesCopy2" style="margin-left:0em;"><a href="https://pubmed.ncbi.nlm.nih.gov/37850093/" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fendo.2023.1224418" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Majimbi&amp;author=S+McLenachan&amp;author=M+Nesbit&amp;author=FK+Chen&amp;author=V+Lam&amp;author=J+Mamo&amp;publication_year=2023&amp;title=In%20vivo%20retinal%20imaging%20is%20associated%20with%20cognitive%20decline%2C%20blood-brain%20barrier%20disruption%20and%20neuroinflammation%20in%20type%202%20diabetic%20mice&amp;journal=Front+Endocrinol&amp;volume=14&amp;" target="_blank">Google Scholar</a></p></div></div><div class="thinLineM20"></div><div class="AbstractSummary"><p><span>Keywords:</span> type 2 diabetes mellitus, cognitive impairment, insulin resistance, oxidative stress, mitochondrial dysfunction</p><p><span>Citation:</span> Kan W, Qu M, Wang Y, Zhang X and Xu L (2025) A review of type 2 diabetes mellitus and cognitive impairment. <i>Front. Endocrinol.</i> 16:1624472. doi: 10.3389/fendo.2025.1624472</p><p id="timestamps"><span>Received:</span> 07 May 2025; <span>Accepted:</span> 16 July 2025;<br><span>Published:</span> 04 August 2025.</p><div><p>Edited by:</p><a href="https://loop.frontiersin.org/people/651910">Xiaodong Sun</a>, Affiliated Hospital Of Shandong Second Medical University, China</div><div><p>Reviewed by:</p><a href="https://loop.frontiersin.org/people/2225980">Xiao-Jing Shi</a>, Massachusetts Institute of Technology, United States<br><a href="https://loop.frontiersin.org/people/2251029">Maarja Randv&#xe4;li</a>, Tallinn University, Estonia</div><p><span>Copyright</span> &#xa9; 2025 Kan, Qu, Wang, Zhang and Xu. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p><p><span>*Correspondence:</span> Lili Xu, <a id="encmail">eHVsaWxpMjAxMzE0QDEyNi5jb20=</a></p><div class="clear"></div></div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fendo.2025.1624472" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">epub</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">2,510</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">756</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><!----><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/1624472#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fendo.2025.1624472" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fendo.2025.1624472" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/651910/overview" data-event="editorInfo-a-xiaodongSun" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">X</span><span class="notranslate">S</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Xiaodong  Sun</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"></div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/2225980/overview" data-event="editorInfo-a-xiaoJingShi" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">X</span><span class="notranslate">S</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Xiao-Jing  Shi</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"></div></div></a><a href="https://loop.frontiersin.org/people/2251029/overview" data-event="editorInfo-a-maarjaRandvli" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">M</span><span class="notranslate">R</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Maarja  Randvli</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"></div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal"><li><a href="#h1">Abstract</a></li><li><a href="#h2">1 Introduction</a></li><li><a href="#h3">2 Pathophysiology of T2DM and its impact on cognitive function</a></li><li><a href="#h4">3 Mechanistic insights into T2DM and cognitive impairment</a></li><li><a href="#h5">4 Sociodemographic moderators in T2DM-related cognitive impairment</a></li><li><a href="#h6">5 T2DM management and cognitive impairment</a></li><li><a href="#h7">6 Biomarkers of cognitive impairment in T2DM</a></li><li><a href="#h8">7 Conclusion</a></li><li><a href="#h9">Author contributions</a></li><li><a href="#h10">Funding</a></li><li><a href="#h11">Conflict of interest</a></li><li><a href="#h12">Generative AI statement</a></li><li><a href="#h13">Publisher&#x2019;s note</a></li><li><a href="#h14">References</a></li></ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fendo.2025.1624472" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">epub</a></li><li><a href="/journals/endocrinology/articles/10.3389/fendo.2025.1624472/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media S.A. All rights reserved</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full",["Reactive",16],{"main":17,"user":524,"article":525,"articleHub":776,"mainHeader":780},{"ibar":18,"footer":272,"newsletterComponent":-1,"snackbarItem":354,"toggleShowSnackbar":355,"contentfulJournal":356,"graphJournal":425,"settingsFeaturesSwitchers":429,"templateToggleBanner":430,"tenantConfig":489},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":203,"aboutJournal":204,"mainLinks":253,"journalLinks":260,"helpCenterLink":269},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=2&fieldid=23&specialtyid=0&entitytype=2&entityid=106",{"id":115,"name":116,"slug":117,"sections":118},106,"Frontiers in Endocrinology","endocrinology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199],{"id":120,"name":121,"slug":122},2258,"Adrenal Endocrinology","adrenal-endocrinology",{"id":124,"name":125,"slug":126},457,"Bone Research","bone-research",{"id":128,"name":129,"slug":130},116,"Cancer Endocrinology","cancer-endocrinology",{"id":132,"name":133,"slug":134},2259,"Cardiovascular Endocrinology","cardiovascular-endocrinology",{"id":136,"name":137,"slug":138},120,"Cellular Endocrinology","cellular-endocrinology",{"id":140,"name":141,"slug":142},107,"Clinical Diabetes","clinical-diabetes",{"id":144,"name":145,"slug":146},2261,"Developmental Endocrinology","developmental-endocrinology",{"id":148,"name":149,"slug":150},1548,"Diabetes: Molecular Mechanisms","diabetes-molecular-mechanisms",{"id":152,"name":153,"slug":154},127,"Endocrinology of Aging","endocrinology-of-aging",{"id":156,"name":157,"slug":158},121,"Experimental Endocrinology","experimental-endocrinology",{"id":160,"name":161,"slug":162},1770,"Gut Endocrinology","gut-endocrinology",{"id":164,"name":165,"slug":166},118,"Molecular and Structural Endocrinology","molecular-and-structural-endocrinology",{"id":168,"name":169,"slug":170},113,"Neuroendocrine Science","neuroendocrine-science",{"id":172,"name":173,"slug":174},458,"Obesity","obesity",{"id":176,"name":177,"slug":178},124,"Pediatric Endocrinology","pediatric-endocrinology",{"id":180,"name":181,"slug":182},112,"Pituitary Endocrinology","pituitary-endocrinology",{"id":184,"name":185,"slug":186},2257,"Renal Endocrinology","renal-endocrinology",{"id":188,"name":189,"slug":190},126,"Reproduction","reproduction",{"id":192,"name":193,"slug":194},117,"Systems Endocrinology","systems-endocrinology",{"id":196,"name":197,"slug":198},128,"Thyroid Endocrinology","thyroid-endocrinology",{"id":200,"name":201,"slug":202},122,"Translational and Clinical Endocrinology","translational-and-clinical-endocrinology","Sections",[205,229],{"title":206,"links":207},"Scope",[208,211,214,217,220,223,226],{"text":209,"url":210,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/endocrinology/about#about-editors",{"text":212,"url":213,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/endocrinology/about#about-scope",{"text":215,"url":216,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/endocrinology/about#about-facts",{"text":218,"url":219,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/endocrinology/about#about-submission",{"text":221,"url":222,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/endocrinology/about#about-open",{"text":224,"url":225,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/endocrinology/about#copyright-statement",{"text":227,"url":228,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/endocrinology/about#about-quality",{"title":230,"links":231},"For authors",[232,235,238,241,244,247,250],{"text":233,"url":234,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/endocrinology/for-authors/why-submit",{"text":236,"url":237,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/endocrinology/for-authors/article-types",{"text":239,"url":240,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/endocrinology/for-authors/author-guidelines",{"text":242,"url":243,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/endocrinology/for-authors/editor-guidelines",{"text":245,"url":246,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/endocrinology/for-authors/publishing-fees",{"text":248,"url":249,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/endocrinology/for-authors/submission-checklist",{"text":251,"url":252,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/endocrinology/for-authors/contact-editorial-office",[254,257],{"text":255,"url":256,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":258,"url":259,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[261,264,266],{"text":262,"url":263,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":265,"target":27,"ariaLabel":28},"research-topics",{"text":267,"url":268,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":270,"url":271,"target":77,"ariaLabel":270},"Help center","https://helpcenter.frontiersin.org",{"blocks":273,"socialLinks":327,"copyright":351,"termsAndConditionsUrl":352,"privacyPolicyUrl":353},[274,288,298,312],{"title":275,"links":276},"Guidelines",[277,279,282,285,287],{"text":239,"url":278,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":280,"url":281,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":283,"url":284,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":242,"url":286,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":289,"links":290},"Explore",[291,292,295,297],{"text":262,"url":259,"target":27,"ariaLabel":28},{"text":293,"url":294,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":296,"url":256,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":299,"links":300},"Outreach",[301,304,307,311],{"text":302,"url":92,"target":77,"ariaLabel":303},"Frontiers Forum ","Frontiers Forum website",{"text":305,"url":306,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":308,"url":309,"target":77,"ariaLabel":310},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":313,"links":314},"Connect",[315,316,320,323,326],{"text":270,"url":271,"target":77,"ariaLabel":270},{"text":317,"url":318,"target":77,"ariaLabel":319},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":321,"url":111,"target":27,"ariaLabel":322},"Contact us ","Subscribe to newsletter",{"text":324,"url":325,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[328,336,341,346],{"link":329,"type":332,"color":333,"icon":334,"size":335,"hiddenText":13},{"text":330,"url":331,"target":77,"ariaLabel":330},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":337,"type":332,"color":333,"icon":340,"size":335,"hiddenText":13},{"text":338,"url":339,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":342,"type":332,"color":333,"icon":345,"size":335,"hiddenText":13},{"text":343,"url":344,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":347,"type":332,"color":333,"icon":350,"size":335,"hiddenText":13},{"text":348,"url":349,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media S.A. All rights reserved","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":357,"identifier":115,"name":116,"slug":117,"banner":358,"description":418,"mission":419,"palette":420,"impactFactor":421,"citeScore":422,"citations":423,"showTagline":28,"twitter":424},"Journal",[359],{"id":360,"src":361,"name":362,"tags":363,"type":377,"width":378,"height":379,"idHash":380,"archive":381,"brandId":382,"limited":381,"fileSize":383,"isPublic":384,"original":385,"copyright":19,"extension":386,"thumbnails":388,"dateCreated":396,"description":397,"orientation":398,"userCreated":399,"watermarked":381,"dateModified":396,"datePublished":400,"ecsArchiveFiles":401,"propertyOptions":402,"property_Channel":407,"property_Sub-Type":409,"property_Asset_Type":411,"activeOriginalFocusPoint":413,"property_Office_Department":416},"1AAA1237-EA54-405E-B5292056FC2FC63E","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/1AAA1237-EA54-405E-B5292056FC2FC63E/webimage-52CDCF24-D906-45A5-AFA5AA6D3AD70D22.png","FENDO_Main Visual_Red_Website",[364,365,366,367,117,368,369,370,371,372,373,374,375,376],"medical","endocrine","microscope","tissue","parathyroid","metabolism","thyroid","thyroxine","microscopic","metabolic","histology","medicine","histological","image",3264,2448,"68bd53008f8c9c81",0,"22C10171-81B3-4DA6-99342F272A32E8BB",1779340,1,"https://brand.frontiersin.org/m/68bd53008f8c9c81/original/FENDO_Main-Visual_Red_Website.jpg",[387],"jpg",{"mini":389,"thul":390,"webimage":361,"Guidelines":391,"WebsiteJpg_XL":392,"WebsiteWebP_L":393,"WebsiteWebP_M":394,"WebsiteWebP_XL":395},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/1AAA1237-EA54-405E-B5292056FC2FC63E/mini-F06B3107-6E85-422B-BB0176C677702BA6.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/1AAA1237-EA54-405E-B5292056FC2FC63E/thul-3D3A758F-7CD2-4F27-82D7E7E46E0E8893.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/1AAA1237-EA54-405E-B5292056FC2FC63E/DEA0356A-2D97-438F-99CB1B022967DFB5/Guidelines-FENDO_Main Visual_Red_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/1AAA1237-EA54-405E-B5292056FC2FC63E/DEA0356A-2D97-438F-99CB1B022967DFB5/WebsiteJpg_XL-FENDO_Main Visual_Red_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/1AAA1237-EA54-405E-B5292056FC2FC63E/DEA0356A-2D97-438F-99CB1B022967DFB5/WebsiteWebP_L-FENDO_Main Visual_Red_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/1AAA1237-EA54-405E-B5292056FC2FC63E/DEA0356A-2D97-438F-99CB1B022967DFB5/WebsiteWebP_M-FENDO_Main Visual_Red_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/1AAA1237-EA54-405E-B5292056FC2FC63E/DEA0356A-2D97-438F-99CB1B022967DFB5/WebsiteWebP_XL-FENDO_Main Visual_Red_Website.webp","2022-06-27T09:59:30Z","Thyroid tissue  100X; Shutterstock ID 21695071; purchase_order: Main Visual; job: ; client: ; other:","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[403,404,405,406],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[408],"frontiersin_org",[410],"Main_Visual",[412],"Photography",{"x":414,"y":415},1632,1224,[417],"Publishing","The world's most cited endocrinology and metabolism journal, advancing understanding and treatment of hormonal disorders impacting health worldwide.","\u003Cp>Frontiers in Endocrinology is a journal that advances our understanding of the endocrine system and publishes research in novel therapies for prevalent health issues such as obesity, diabetes, disorders affecting the reproductive system, and the endocrinology of aging.\u003C/p>\n\u003Cp>Led by Field Chief Editor Jeff M. P. Holly (University of Bristol, UK), Frontiers in Endocrinology is indexed in MEDLINE, PubMed Central (PMC), Scopus and Web of Science (SCIE), among others, and welcomes research contributions in the various domains of endocrinology, bridging the gap between basic molecular structure and cellular communication, to clinical care. Topics include:\u003C/p>\n\n\u003Cdiv> &bull; adrenal endocrinology\u003C/div>\n\u003Cdiv> &bull; bone research\u003C/div>\n\u003Cdiv> &bull; cancer endocrinology\u003C/div>\n\u003Cdiv> &bull; cardiovascular endocrinology\u003C/div>\n\u003Cdiv> &bull; cellular endocrinology\u003C/div>\n\u003Cdiv> &bull; clinical diabetes\u003C/div>\n\u003Cdiv> &bull; developmental endocrinology\u003C/div>\n\u003Cdiv> &bull; diabetes: molecular mechanisms\u003C/div>\n\u003Cdiv> &bull; endocrinology of aging\u003C/div>\n\u003Cdiv> &bull; experimental endocrinology\u003C/div>\n\u003Cdiv> &bull; gut endocrinology\u003C/div>\n\u003Cdiv> &bull; molecular and structural endocrinology\u003C/div>\n\u003Cdiv> &bull; neuroendocrine science\u003C/div>\n\u003Cdiv> &bull; obesity\u003C/div>\n\u003Cdiv> &bull; pediatric endocrinology\u003C/div>\n\u003Cdiv> &bull; pituitary endocrinology\u003C/div>\n\u003Cdiv> &bull; renal endocrinology\u003C/div>\n\u003Cdiv> &bull; reproduction\u003C/div>\n\u003Cdiv> &bull; systems endocrinology\u003C/div>\n\u003Cdiv> &bull; thyroid endocrinology\u003C/div>\n\u003Cdiv> &bull; translational and clinical endocrinology\u003C/div>\n\u003Cbr>\n \n\u003Cp>In particular, the journal welcomes submissions which support and advance the UNs Sustainable Development Goal (SDG), notably SDG 3: good health and well-being, in the effort to further our understanding as well as the prevention and treatment of hormonal disorders.\u003Cp>\n\n\u003Cp>Manuscripts relating to diseases or disorders that do not relate to hormones are not suitable for publication in this journal. Manuscripts reporting solely bibliometric analyses will not be considered. Authors are still welcome to submit Systematic Reviews using publicly available data, but these must adhere to the PRISMA guidelines and include a completed \u003Ca href=\"http://prisma-statement.org/documents/PRISMA_2020_checklist.pdf/\">checklist\u003C/a> with submission and have a conclusion related to endocrinology. Similarly meta-analyses must adhere to the PRISMA extension guidelines and include a completed \u003Ca href=\"http://www.prisma-statement.org/documents/PRISMA%20NMA%20checklist.pdf/\">checklist\u003C/a> with submission.\u003Cp>\n\n\u003Cp>Frontiers journals require that manuscripts primarily comprising computational studies of public data, such as NHANES or Mendelian Randomization studies, must include appropriate validation. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information. Manuscripts not adhering to these standards will not be considered.\u003Cp>\n\n\u003Cp>Frontiers in Endocrinology is committed to advancing developments in the field of endocrinology by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public. This multidisciplinary open-access journal is at the forefront of disseminating impactful discoveries to researchers, academics, clinicians, and the public worldwide.\u003Cp>","red","5.2","5.6","297492","@FrontEndocrinol",{"id":115,"name":116,"slug":117,"abbreviation":426,"isOnline":13,"isOpenForSubmissions":13,"citeScore":427,"impactFactor":428},"fendo",7.4,4.6,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":355,"useXmlImages":13},{"isPublic":13,"allowCompanyUsers":355,"whiteListEmails":431,"enableAllJournals":13,"whiteListJournals":453},[432,433,434,435,436,437,438,439,440,437,441,442,443,444,445,446,447,448,449,450,451,452],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[454,455,456,457,458,459,384,460,461,115,462,463,464,465,466,467,468,469,470,471,472,473,474,475,476,477,478,479,480,481,482,483,484,485,486,487,488],2232,1729,2357,2456,2176,2333,1843,602,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":384,"name":384,"availableJournalPages":490,"announcement":494},[263,268,265,491,492,493],"volumes","about","community-reviewers",{"__typename":495,"sys":496,"preHeader":42,"title":498,"description":499,"image":500,"link":522},"Announcement",{"id":497},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[501],{"archive":381,"brandId":382,"copyright":28,"dateCreated":502,"dateModified":503,"datePublished":504,"description":28,"extension":505,"fileSize":507,"height":508,"id":509,"isPublic":381,"limited":381,"name":510,"orientation":398,"original":28,"thumbnails":511,"type":377,"watermarked":381,"width":518,"videoPreviewURLs":519,"tags":520,"textMetaproperties":521,"src":512},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[506],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":512,"thul":513,"mini":514,"WebsiteWebP_L":515,"WebsiteWebP_M":516,"Guidelines":517},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":523,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":526,"isPreviewPage":355,"hasSupplementalData":355,"showCrossmarkWidget":13,"articleTemplate":653,"currentArticlePageMetaInfo":654,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":527,"doi":528,"title":529,"acceptanceDate":530,"receptionDate":531,"publicationDate":532,"lastModifiedDate":533,"isPublished":13,"abstract":534,"researchTopic":535,"articleType":541,"stage":544,"keywords":546,"authors":552,"editors":591,"reviewers":599,"journal":614,"section":622,"impactMetrics":624,"volume":627,"articleVolume":628,"relatedArticles":629,"isPublishedV2":13,"contents":630,"files":633,"htmlZipFileName":652},1624472,"10.3389/fendo.2025.1624472","A review of type 2 diabetes mellitus and cognitive impairment","2025-07-16T15:01:37.000Z","2025-05-07T11:40:16.000Z","2025-08-04T00:00:00.000Z","2025-10-12T02:08:37.985Z","The association between type 2 diabetes mellitus (T2DM) and cognitive impairment represents a critical public health concern, particularly against the backdrop of the rising global prevalence of diabetes and aging populations. Accumulating evidence indicates that T2DM is linked to declines in multiple cognitive domains, which may progress to cognitive impairment or even dementia. This cognitive impairment arises from complex interactions among insulin resistance, chronic inflammatory responses, vascular injury and microangiopathy and oxidative stress. Clinical studies suggest that strict glycemic control combined with behavioral and lifestyle interventions may delay cognitive decline, though their long-term efficacy requires further evidence-based validation. Future research should leverage multi-omics technologies to identify early biomarkers for T2DM-related cognitive impairment, elucidate the underlying molecular mechanisms, identify specific therapeutic targets, and develop personalized intervention strategies. This review systematically examines the epidemiological correlations, pathophysiological mechanisms, and advances in clinical management of T2DM-related cognitive disorders, with the aim of providing a theoretical foundation for early prevention and targeted treatment.",{"id":536,"title":537,"articlesCount":538,"isMagazinePage":355,"slug":539,"isOpenForSubmission":355,"views":540},68922,"Association of Diabetes Mellitus with Cognitive Impairment and Neurological Disorders Vol. 2",7,"association-of-diabetes-mellitus-with-cognitive-impairment-and-neurological-disorders-vol-2",13490,{"id":542,"name":543},27,"Review",{"id":545,"name":19},18,[547,548,549,550,551],"type 2 diabetes mellitus","insulin resistance","oxidative stress","cognitive impairment","mitochondrial dysfunction",[553,562,570,577,583],{"id":554,"firstName":555,"middleName":19,"lastName":556,"givenNames":557,"isCorresponding":355,"isProfilePublic":13,"userId":554,"email":-1,"affiliations":558},3045155,"Wen","Kan","Wen ",[559],{"organizationName":560,"countryName":561,"cityName":19,"stateName":19,"zipCode":19},"Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University","China",{"id":563,"firstName":564,"middleName":19,"lastName":565,"givenNames":566,"isCorresponding":355,"isProfilePublic":13,"userId":563,"email":-1,"affiliations":567},1582163,"Meijie","Qu","Meijie ",[568],{"organizationName":569,"countryName":561,"cityName":19,"stateName":19,"zipCode":19},"Department of Neurology, Affiliated Hospital of Qingdao University",{"id":571,"firstName":572,"middleName":19,"lastName":573,"givenNames":574,"isCorresponding":355,"isProfilePublic":13,"userId":571,"email":-1,"affiliations":575},2360031,"Yunyang","Wang","Yunyang ",[576],{"organizationName":560,"countryName":561,"cityName":19,"stateName":19,"zipCode":19},{"id":381,"firstName":578,"middleName":19,"lastName":579,"givenNames":580,"isCorresponding":355,"isProfilePublic":355,"userId":381,"email":-1,"affiliations":581},"Xianjun","Zhang","Xianjun ",[582],{"organizationName":569,"countryName":561,"cityName":19,"stateName":19,"zipCode":19},{"id":584,"firstName":585,"middleName":19,"lastName":586,"givenNames":587,"isCorresponding":13,"isProfilePublic":13,"userId":584,"email":588,"affiliations":589},2803876,"Lili","Xu","Lili ","xulili201314@126.com",[590],{"organizationName":560,"countryName":561,"cityName":19,"stateName":19,"zipCode":19},[592],{"id":593,"firstName":594,"middleName":19,"lastName":595,"givenNames":596,"isCorresponding":355,"isProfilePublic":13,"userId":593,"email":-1,"affiliations":597},651910,"Xiaodong","Sun","Xiaodong ",[598],{"organizationName":19,"countryName":19,"cityName":19,"stateName":19,"zipCode":19},[600,607],{"id":601,"firstName":602,"middleName":19,"lastName":603,"givenNames":604,"isCorresponding":355,"isProfilePublic":13,"userId":601,"email":-1,"affiliations":605},2225980,"Xiao-Jing","Shi","Xiao-Jing ",[606],{"organizationName":19,"countryName":19,"cityName":19,"stateName":19,"zipCode":19},{"id":608,"firstName":609,"middleName":19,"lastName":610,"givenNames":611,"isCorresponding":355,"isProfilePublic":13,"userId":608,"email":-1,"affiliations":612},2251029,"Maarja","Randvli","Maarja ",[613],{"organizationName":19,"countryName":19,"cityName":19,"stateName":19,"zipCode":19},{"id":115,"slug":117,"name":116,"shortName":615,"electronicISSN":616,"field":617,"specialtyId":28,"journalSectionPaths":620},"Front. Endocrinol.","1664-2392",{"id":618,"domainId":619},23,2,[621],{"section":622},{"id":168,"name":169,"slug":170,"specialtyId":623},744,{"views":625,"downloads":626,"citations":381},2510,756,16,"Volume 16 - 2025",[],{"titleHtml":529,"fullTextHtml":631,"menuHtml":632},"\u003Cdiv class=\"JournalAbstract\">\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/3045155/overview\" class=\"user-id-3045155/overview\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3045155/overview/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Wen Kan\">Wen Kan\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/1582163/overview\" class=\"user-id-1582163/overview\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/1582163/overview/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Meijie Qu\">Meijie Qu\u003C/a>\u003Csup>2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2360031/overview\" class=\"user-id-2360031/overview\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2360031/overview/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Yunyang Wang\">Yunyang Wang\u003C/a>\u003Csup>1\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Xianjun Zhang\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Xianjun Zhang\u003Csup>2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2803876/overview\" class=\"user-id-2803876/overview\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2803876/overview/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Lili Xu*\">Lili Xu\u003C/a>\u003Csup>1*\u003C/sup>\u003C/span>\u003C/div>\u003Cul class=\"notes\">\u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, Qingdao,&#xa0;China\u003C/li>\u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>Department of Neurology, Affiliated Hospital of Qingdao University, Qingdao,&#xa0;China\u003C/li>\u003C/ul>\u003Cp>The association between type 2 diabetes mellitus (T2DM) and cognitive impairment represents a critical public health concern, particularly against the backdrop of the rising global prevalence of diabetes and aging populations. Accumulating evidence indicates that T2DM is linked to declines in multiple cognitive domains, which may progress to cognitive impairment or even dementia. This cognitive impairment arises from complex interactions among insulin resistance, chronic inflammatory responses, vascular injury and microangiopathy and oxidative stress. Clinical studies suggest that strict glycemic control combined with behavioral and lifestyle interventions may delay cognitive decline, though their long-term efficacy requires further evidence-based validation. Future research should leverage multi-omics technologies to identify early biomarkers for T2DM-related cognitive impairment, elucidate the underlying molecular mechanisms, identify specific therapeutic targets, and develop personalized intervention strategies. This review systematically examines the epidemiological correlations, pathophysiological mechanisms, and advances in clinical management of T2DM-related cognitive disorders, with the aim of providing a theoretical foundation for early prevention and targeted treatment.\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\u003Cdiv class=\"JournalFullText\">\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>1 Introduction\u003C/h2>\u003Cp class=\"mb0\">T2DM has emerged as a global epidemic and a major public health challenge. Global prevalence of T2DM is expected to increase to 7,079 cases per 100,000 population by 2030, reflecting a sustained upward trend across all regions (\u003Ca href=\"#B1\">1\u003C/a>). T2DM significantly elevates the risk of microvascular complications (e.g., retinopathy, nephropathy, neuropathy) and macrovascular diseases (e.g., coronary artery disease, stroke) (\u003Ca href=\"#B2\">2\u003C/a>). Cognitive impairment is defined as a decline in one or more cognitive domains, including memory, attention, orientation, judgment, and problem-solving abilities (\u003Ca href=\"#B3\">3\u003C/a>). Manifestations of impairment may include slowed information processing, memory deficits, and challenges in learning or decision-making (\u003Ca href=\"#B4\">4\u003C/a>). Cognitive impairment severely impacts overall well-being by compromising social engagement and functional independence, increasing reliance on caregivers while reducing autonomy, and posing safety risks, ultimately elevating morbidity and mortality rates through diminished self-care capacity and delayed medical intervention (\u003Ca href=\"#B3\">3\u003C/a>, \u003Ca href=\"#B5\">5\u003C/a>). Given the escalating global prevalence of T2DM and its profound implications for cognitive health, elucidating the underlying pathophysiological pathways and identifying preventive interventions are critical for mitigating dual disease burdens. Research in this domain holds significant clinical and societal relevance. Understanding how metabolic dysregulation accelerates neurodegenerative processes could inform early biomarkers for cognitive risk stratification and targeted therapies. Ultimately, advancing this field may enhance patient outcomes and quality of life.\u003C/p>\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>2 Pathophysiology of T2DM and its impact on cognitive function\u003C/h2>\u003Ch3>2.1 Basic pathogenesis of T2DM\u003C/h3>\u003Cp class=\"mb15\">T2DM is characterized by two central pathophysiological defects: pancreatic &#x3b2;-cell dysfunction and insulin resistance (IR). &#x3b2;-cell dysfunction manifests as inadequate insulin secretion or decompensation, ultimately resulting in hyperglycemia. IR refers to diminished responsiveness of peripheral tissues (e.g., skeletal muscle, adipose tissue, liver) to insulin signaling, glucose uptake into these cells becomes inefficient, resulting in its accumulation in the bloodstream and consequent hyperglycemia. To compensate, pancreatic &#x3b2;-cells augment insulin secretion, leading to a state of hyperinsulinemia. These defects mutually reinforce each other, establishing a vicious cycle. Chronic inflammation, ectopic lipid deposition, endoplasmic reticulum stress (ERS), and oxidative stress further exacerbate metabolic dysregulation by impairing insulin sensitivity and/or &#x3b2;-cell function, thereby driving the onset and progression of T2DM and its target organ damage (TOD) (\u003Ca href=\"#B6\">6\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">&#x3b2;-cells integrate signals from glucose, free fatty acids (FFA), hormones (e.g., incretins GLP-1/GIP), and neural inputs to dynamically regulate insulin secretion (\u003Ca href=\"#B7\">7\u003C/a>). Factors contributing to &#x3b2;-cell failure include: aging and genetic predisposition, incretin resistance/deficiency (e.g., impaired glucagon-like peptide-1 [GLP-1] and glucose-dependent insulinotropic polypeptide [GIP] signaling), lipotoxicity (FFA-induced &#x3b2;-cell apoptosis) and glucotoxicity (chronic hyperglycemia-induced oxidative stress), insulin resistance-induced &#x3b2;-cell stress, islet amyloid deposition (excessive islet amyloid polypeptide [IAPP] aggregation), reactive oxygen species (ROS)-mediated damage and proinflammatory signaling (\u003Ca href=\"#B8\">8\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">IR is a multifactorial metabolic disorder marked by reduced responsiveness of insulin-target tissues (liver, adipose tissue, skeletal muscle) to physiological insulin levels. It is closely linked to metabolic syndrome (MS), where obesity, dyslipidemia, and hypertension amplify IR through: proinflammatory cytokine release (e.g., TNF-&#x3b1;, IL-6), ectopic lipid accumulation (hepatic and muscular lipotoxicity), oxidative stress-mediated inhibition of insulin receptor signaling (e.g., PI3K/Akt pathway) (\u003Ca href=\"#B9\">9\u003C/a>).\u003C/p>\u003Ch3>2.2 Impact of diabetes-related complications on cognitive function\u003C/h3>\u003Ch4>2.2.1 Cerebrovascular complications\u003C/h4>\u003Cp class=\"mb0\">Diabetes-induced macrovascular pathologies, such as atherosclerosis (AS), drive structural alterations in cerebral vasculature, including stenosis, occlusion, and intima-media thickening&#x2014;hallmarks of AS (\u003Ca href=\"#B10\">10\u003C/a>). Chronic vascular occlusion disrupts central hemodynamics, cerebral perfusion, and cerebrovascular function. Key functional impairments include: endothelial-dependent vasodilation deficits and impaired cerebrovascular autoregulation (\u003Ca href=\"#B11\">11\u003C/a>, \u003Ca href=\"#B12\">12\u003C/a>). These dysfunctions directly manifest as abnormal cerebral blood flow (CBF) (\u003Ca href=\"#B13\">13\u003C/a>). Evidence linking carotid AS to cerebral atrophy suggests that sustained CBF reduction contributes to brain volume loss, a recognized precursor to vascular dementia (VD). Moreover, Chronic hypoperfusion exacerbates neuroinflammation by activating microglia, leading to white matter lesions (WMLs) and neurodegeneration. WMLs are strongly associated with progressive cognitive decline and eventual VD onset.\u003C/p>\u003Ch4>2.2.2 Diabetic retinopathy\u003C/h4>\u003Cp class=\"mb0\">Diabetic retinopathy, a microvascular complication of diabetes, may reflect systemic microvascular damage. Wu et&#xa0;al. reported that DR is associated with psychomotor slowing and attentional deficits. Electrophysiological studies in diabetic models demonstrate reduced neuronal activity in the primary visual cortex, impairing visual information processing (\u003Ca href=\"#B14\">14\u003C/a>). Meta-analytic evidence further links retinal pathology to cognitive decline, any retinopathy was significantly associated with the presence of dementia and cognitive deficits, as well as with reduced processing speed (\u003Ca href=\"#B15\">15\u003C/a>).These associations persist even in patients without overt retinopathy, suggesting that retinal microvascular changes (e.g., altered vessel caliber, fractal dimension) may serve as biomarkers of cerebral microangiopathy and neurodegeneration. Additionally, diabetes frequently induces visual system dysfunction, including impaired motion detection, reduced contrast sensitivity, and defective color discrimination, which may indirectly exacerbate cognitive load by disrupting sensory input integration (\u003Ca href=\"#B14\">14\u003C/a>).\u003C/p>\u003Ch4>2.2.3 Diabetic kidney disease\u003C/h4>\u003Cp class=\"mb0\">Diabetic kidney disease (DKD), a diabetes-specific complication characterized by progressive renal damage, exacerbates blood-brain barrier (BBB) disruption and is increasingly recognized as a risk factor for neurocognitive deficits. Clinical studies reveal a bidirectional relationship between renal dysfunction and cognitive impairment, where elevated urinary albumin excretion rate (UAER) predicts poorer cognitive performance, while declining glomerular filtration rate (GFR) is associated with worsening cognitive scores, highlighting a dose-dependent link between renal impairment and neurodegeneration (\u003Ca href=\"#B16\">16\u003C/a>). DKD contributes to cognitive impairment through interconnected pathophysiological pathways. Impaired renal clearance of uremic toxins, such as indoxyl sulfate, promotes neuroinflammation and oxidative stress, accelerating BBB disruption and neuronal apoptosis (\u003Ca href=\"#B17\">17\u003C/a>). These mechanisms synergistically disrupt neurovascular homeostasis, creating a self-reinforcing cycle of neurodegeneration and cognitive decline in diabetic patients. Serum creatinine, an indicator of renal dysfunction, inversely correlates with cognitive performance in elderly diabetic populations, suggesting its potential as a prognostic marker for cognitive decline, while early detection of DKD through measures like UAER monitoring can help stratify dementia risk and guide interventions, such as renin-angiotensin system inhibitors, to preserve both renal and cognitive function (\u003Ca href=\"#B18\">18\u003C/a>).\u003C/p>\u003Ch4>2.2.4 Diabetic peripheral neuropathy\u003C/h4>\u003Cp class=\"mb0\">Diabetic peripheral neuropathy (DPN), a prevalent complication of diabetes, is increasingly linked to cognitive impairment. Evidence demonstrates that individuals with T2DM and DPN exhibit lower global cognitive performance compared to those without DPN, including deficits in memory, attention, and psychomotor speed (\u003Ca href=\"#B19\">19\u003C/a>). In type 1 diabetes, cognitive impairment is similarly pronounced, with DPN patients showing marked impairments in attention, visuospatial/executive functions, language, and abstract reasoning (\u003Ca href=\"#B20\">20\u003C/a>). Notably, painful DPN correlates with more severe cognitive deficits than painless DPN (\u003Ca href=\"#B21\">21\u003C/a>), particularly in domains of attention and memory. These findings suggest that DPN severity and subtype may serve as biomarkers for neurodegeneration risk in diabetic populations, underscoring the need for integrated neurological and cognitive assessments in diabetes care (\u003Ca href=\"#B22\">22\u003C/a>).\u003C/p>\u003Ch4>2.2.5 Diabetes-related foot complications\u003C/h4>\u003Cp class=\"mb0\">Emerging evidence highlights a significant association between diabetes-related foot complications (DRFC) and cognitive impairment. Studies demonstrate that individuals with DRFC exhibit more pronounced cognitive deficits compared to diabetic patients without foot complications, particularly in domains of verbal memory, executive function, and inhibitory control (\u003Ca href=\"#B23\">23\u003C/a>). Furthermore, diabetes-associated cognitive impairment encompasses broader deficits, including impairments in attention, memory, executive function, visuospatial abilities, and language. The severity of DRFC-related cognitive decline underscores the need for integrated care models addressing both metabolic and neurological health in diabetic populations (\u003Ca href=\"#B24\">24\u003C/a>).\u003C/p>\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>3 Mechanistic insights into T2DM and cognitive impairment\u003C/h2>\u003Ch3>3.1 Insulin resistance and cerebral metabolism\u003C/h3>\u003Cp class=\"mb15\">Insulin acts on insulin receptors in the brain to promote neurotransmitter synthesis, synaptic plasticity, and neuronal differentiation&#x2014;processes critical for learning and memory. Insulin signaling in the brain is essential for normal cognitive function, particularly in key regions such as the hippocampus and prefrontal cortex (\u003Ca href=\"#B25\">25\u003C/a>), where it regulates glucose utilization, energy homeostasis, synaptogenesis and long-term potentiation (LTP). It also governs appetite regulation and systemic metabolic balance (\u003Ca href=\"#B26\">26\u003C/a>). Brain insulin resistance (BIR) is recognized as a key factor linking metabolic disorders like obesity and T2DM to cognitive decline. It disrupts normal insulin signaling pathways, leading to mitochondrial structural and functional abnormalities, which in turn result in &#x200b;&#x200b;impaired energy metabolism&#x200b;&#x200b; and &#x200b;&#x200b;increased oxidative stress&#x200b;&#x200b;. This dysfunction triggers &#x200b;&#x200b;neuronal damage&#x200b;&#x200b; and &#x200b;&#x200b;cognitive deterioration&#x200b;&#x200b;, ultimately contributing to &#x200b;&#x200b;cognitive impairment&#x200b;&#x200b; (\u003Ca href=\"#B27\">27\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">BIR reduces plasma levels of neurotrophic factors such as brain-derived neurotrophic factor (BDNF) (\u003Ca href=\"#B28\">28\u003C/a>), which plays a critical role in promoting structural and functional plasticity in the central nervous system (CNS) (\u003Ca href=\"#B29\">29\u003C/a>). Additionally, BIR downregulates the expression of neuronal glucose transporters (e.g., GLUT4), impairing cerebral glucose uptake (\u003Ca href=\"#B30\">30\u003C/a>). This energy deficit results in decreased brain glucose utilization, triggering neuronal metabolic dysfunction. Such metabolic disturbances not only compromise synaptic plasticity but may also threaten neuronal survival, contributing to memory deficits and executive dysfunction.\u003C/p>\u003Ch3>3.2 Chronic inflammatory response\u003C/h3>\u003Cp class=\"mb15\">Diabetes mellitus, a chronic metabolic disorder, significantly disrupts systemic and localized inflammatory responses, thereby compromising brain health. The systemic inflammation associated with diabetes promotes increased BBB permeability, neuroinflammation, and subsequent neurodegenerative alterations. These inflammatory processes are mechanistically linked to cognitive impairment and an elevated risk of neurodegenerative disorders, including Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease.\u003C/p>\u003Cp class=\"mb0\">Characterized by chronic low-grade inflammation, diabetes alters the expression of key inflammatory mediators such as monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6), and C-C motif chemokine receptor 2 (CCR2), which collectively modulate peripheral and central immune responses (\u003Ca href=\"#B31\">31\u003C/a>). Activation of inflammatory pathways, particularly those mediated by NF-&#x3ba;B, synergizes with oxidative stress and impaired autophagy to exacerbate neuronal damage and accelerate cognitive decline (\u003Ca href=\"#B32\">32\u003C/a>). Dysregulated inflammatory signaling in diabetic individuals amplifies ischemic brain injury.\u003C/p>\u003Ch3>3.3 Vascular injury and microangiopathy\u003C/h3>\u003Cp class=\"mb15\">Diabetes exerts profound detrimental effects on cerebrovascular health, precipitating vascular injury and microvascular pathologies closely associated with cognitive impairment. The relationship between diabetes and cerebrovascular pathology is multifaceted, encompassing both macrovascular and microvascular abnormalities that synergistically contribute to cognitive decline (\u003Ca href=\"#B33\">33\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">Accumulating evidence indicates that diabetes independently increases the incidence of cerebral infarctions and vascular brain injuries, both of which are critical determinants of cognitive deterioration (\u003Ca href=\"#B33\">33\u003C/a>). Diabetic-induced cerebrovascular damage manifests as endothelial dysfunction, increased arterial stiffness, and thickening of capillary basement membranes (\u003Ca href=\"#B34\">34\u003C/a>). These pathological alterations compromise cerebrovascular elasticity and integrity, leading to reduced cerebral blood flow and chronic cerebral hypoperfusion, thereby exacerbating cognitive deficits.\u003C/p>\u003Cp class=\"mb0\">As an established risk factor for cerebrovascular diseases, diabetes is characterized by a higher prevalence of cerebral infarctions, white matter hyperintensities (WMH), and cerebral small vessel disease (CSVD) (\u003Ca href=\"#B33\">33\u003C/a>). These pathologies exhibit greater severity in diabetic populations and correlate with an elevated risk of accelerated cognitive decline. Preclinical studies utilizing diabetic rodent models demonstrate that hyperglycemia exacerbates cerebrovascular dysfunction, which parallels observed cognitive impairments, highlighting diabetes-specific vulnerabilities in neurovascular coupling (\u003Ca href=\"#B35\">35\u003C/a>).\u003C/p>\u003Ch3>3.4 Oxidative stress and neuronal injury\u003C/h3>\u003Cp class=\"mb15\">Chronic hyperglycemia drives oxidative stress, a pivotal mechanism underlying neuronal injury in diabetes. Sustained elevation of blood glucose promotes excessive generation of ROS and reactive nitrogen species (RNS), overwhelming endogenous antioxidant defenses. This redox imbalance critically contributes multifaceted biochemical cascades and cellular dysfunction. Prolonged hyperglycemia activates four major oxidative stress-inducing pathways: the polyol pathway, advanced glycation end-product (AGE) accumulation, protein kinase C (PKC) activation, and dysregulation of the hexosamine pathway (\u003Ca href=\"#B36\">36\u003C/a>, \u003Ca href=\"#B37\">37\u003C/a>). These interconnected pathways work synergistically to amplify ROS production, which directly damages neuronal membranes, proteins, and DNA.\u003C/p>\u003Cp class=\"mb0\">Moreover, oxidative stress activates redox-sensitive transcription factors, such as NF-&#x3ba;B, leading to the upregulation of pro-inflammatory cytokines (e.g., TNF-&#x3b1;, IL-1&#x3b2;, IL-6) (\u003Ca href=\"#B37\">37\u003C/a>, \u003Ca href=\"#B38\">38\u003C/a>). These cytokines exacerbate neuroinflammation, creating a vicious cycle in which oxidative stress and inflammation synergistically drive neurodegeneration. Diabetic rodents exhibit elevated oxidative markers (8-OHdG, nitrotyrosine) and increased apoptosis in dorsal root ganglion (DRG) neurons, confirming oxidative damage as a driver of peripheral neuropathy (\u003Ca href=\"#B39\">39\u003C/a>).\u003C/p>\u003Ch3>3.5 The interplay between T2DM and Alzheimer&#x2019;s disease\u003C/h3>\u003Cp class=\"mb0\">Emerging evidence reveals significant pathophysiological intersections between diabetes mellitus, particularly T2DM, and neurodegenerative disorders, with Alzheimer&#x2019;s disease (AD) demonstrating particularly strong associations (\u003Ca href=\"#B40\">40\u003C/a>). T2DM has been established as an independent risk factor for accelerated cognitive decline and neurodegeneration, potentially increasing AD susceptibility through shared biological mechanisms. The disease continuum appears driven by overlapping pathways including chronic insulin resistance, systemic inflammation, and mitochondrial dysfunction, which collectively create a neurodegenerative milieu (\u003Ca href=\"#B41\">41\u003C/a>, \u003Ca href=\"#B42\">42\u003C/a>). Notably, hallmark AD pathologies &#x2013; &#x3b2;-amyloid (A&#x3b2;) plaque deposition and tau protein hyperphosphorylation &#x2013; are exacerbated by diabetic metabolic disturbances. Sustained hyperglycemia and impaired insulin signaling in T2DM patients potentiate amyloidogenic processing while compromising tau protein homeostasis, thereby accelerating the neuropathological cascade characteristic of AD progression (\u003Ca href=\"#B43\">43\u003C/a>).\u003C/p>\u003Ch3>3.6 T2DM-related cognitive impairment and gut-brain axis disruption\u003C/h3>\u003Cp class=\"mb15\">The gut-brain axis is a bidirectional communication system between the gastrointestinal tract and the central nervous system that influences cognitive function through various mechanisms (\u003Ca href=\"#B44\">44\u003C/a>). In T2DM, significant alterations occur in the composition of the gut microbiota, which affect cognitive abilities. Specific genera (e.g., \u003Ci>Parabacteroides\u003C/i> and \u003Ci>Lactobacillus\u003C/i>) have been shown to modulate metabolites, thereby improving cognitive behavior in diabetic models (\u003Ca href=\"#B45\">45\u003C/a>). Changes in the gut microbiome directly or indirectly impact brain function through vagal, endocrine, and immune pathways. Metabolites directly activate vagal afferent nerves, transmitting signals to the brain via vagal pathways. In the endocrine pathway, enteroendocrine L cells release gut hormones such as GLP1, peptide YY (PYY), and cholecystokinin (CCK), which subsequently influence learning, memory, and mood. Within the immune pathway, immune cells including helper T cell 1 (Th1), helper T cell 17 (Th17), regulatory T cells (Treg), neutrophils, and macrophages are stimulated (\u003Ca href=\"#B46\">46\u003C/a>). Fecal microbiota transplantation has demonstrated potential in alleviating diabetes-related cognitive decline by altering gut microbiota composition and enhancing brain insulin signaling pathways (\u003Ca href=\"#B45\">45\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">Although the gut-brain axis plays a significant role in T2DM-related cognitive impairment, it is essential to consider other contributing factors, such as genetic predisposition and lifestyle. The interactions between these factors and the gut-brain axis are complex and require further research to fully elucidate the underlying mechanisms.\u003C/p>\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>4 Sociodemographic moderators in T2DM-related cognitive impairment\u003C/h2>\u003Cp class=\"mb15\">In recent years, an increasing number of studies have explored the potential roles of gender, age, educational level, and social determinants in the link between T2DM and cognitive function from demographic and sociological perspectives, offering new pathways for identifying vulnerable populations and developing intervention strategies.\u003C/p>\u003Cp class=\"mb15\">Age is a key factor for cognitive impairment in T2DM patients. Older age has consistently been associated with a higher risk of cognitive impairment. Studies show that individuals aged 60 and above with T2DM are particularly susceptible to cognitive decline, with the risk increasing with advancing age (\u003Ca href=\"#B47\">47\u003C/a>, \u003Ca href=\"#B48\">48\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">Research shows that, independent of diabetes status, women generally perform better in certain cognitive domains (e.g., global cognition and verbal abilities) (\u003Ca href=\"#B49\">49\u003C/a>). However, other studies suggest that middle-aged men with T2D have a higher risk of mild cognitive impairment (MCI) compared to women (\u003Ca href=\"#B50\">50\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">Education is widely recognized as a core component of cognitive reserve and also plays a significant moderating role in the association between T2DM and cognitive function. Research by Reinke published in \u003Ci>BMC Public Health\u003C/i> indicates that higher education is not only associated with better glycemic control but can also slow diabetes-related cognitive decline (\u003Ca href=\"#B51\">51\u003C/a>). Pe&#xf1;a-Gonz&#xe1;lez further points out that education can mitigate the negative effects of the disease by building cognitive reserve, enhancing an individual&#x2019;s neuroplasticity and cognitive resilience in the face of hyperglycemia or metabolic dysregulation (\u003Ca href=\"#B52\">52\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">Social determinants such as socioeconomic status, race/ethnicity, and healthcare access also play crucial roles in T2DM-related cognitive impairment (\u003Ca href=\"#B53\">53\u003C/a>). Studies comparing elderly populations in the US and Mexico found that low socioeconomic status is significantly associated with cognitive decline, and the level of social support significantly influences the cognitive trajectory of diabetes (\u003Ca href=\"#B54\">54\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">In summary, gender, age, education, and social determinants all play complex and interacting roles in the link between T2DM and cognitive function. Research indicates that individuals with early-onset diabetes, those with lower educational attainment, and those of low socioeconomic status face a higher risk of cognitive impairment. Theories such as cognitive reserve, the accumulated stress model, and research on health inequalities provide multidimensional perspectives for understanding diabetes-induced cognitive impairment. Future research should deepen efforts in the following areas: First, strengthen stratified studies on different population subgroups to precisely identify high-risk groups. Second, integrate metabolic, physiological, psychological, and social dimensions to construct multi-level assessment models. Third, enhance educational interventions and social support within community health promotion to mitigate the cognitive risks stemming from structural health inequalities.\u003C/p>\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>5 T2DM management and cognitive impairment\u003C/h2>\u003Ch3>5.1 Glycemic control and cognitive function in T2DM\u003C/h3>\u003Cp class=\"mb0\">The relationship between glycemic control and cognitive performance represents a critical focus in diabetes research, particularly in the context of neurodegeneration. Accumulating evidence indicates that suboptimal glycemic management is strongly associated with accelerated cognitive impairment, whereas rigorous blood glucose regulation may attenuate neurodegenerative progression. In patients with T2DM, chronic hyperglycemia and elevated glycated hemoglobin (HbA1c) levels correlate with measurable declines in global cognitive function. Multiple studies have shown that improving blood sugar control can enhance cognitive function. For example, a systematic review found that antidiabetic treatment can significantly alleviate the decline in cognitive ability in diabetic patients (\u003Ca href=\"#B55\">55\u003C/a>).\u003C/p>\u003Ch3>5.2 Potential effects of common glucose-lowering drugs on cognitive function\u003C/h3>\u003Cp class=\"mb0\">The potential impact of glucose-lowering drugs on cognitive function is multifaceted, encompassing both adverse effects resulting from drug-induced hypoglycemia and possible cognitive benefits associated with specific drugs. These effects are systematically summarized in \u003Ca href=\"#T1\">Table 1\u003C/a>.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">Table&#xa0;1\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg\" name=\"table&#xa0;1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cb>Table&#xa0;1\u003C/b>. Potential effects of common glucose-lowering drugs on cognitive function.\u003C/p>\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cp class=\"mb0\">As a first-line oral hypoglycemic agent for T2DM, metformin demonstrates bidirectional regulatory effects on cognition. Accumulating evidence suggests its neuroprotective properties through mechanisms including AMPK signaling pathway activation and oxidative stress inhibition, with demonstrated improvements in specific cognitive domains such as verbal learning, working memory, and executive function in diabetic patients (\u003Ca href=\"#B56\">56\u003C/a>). Notably, prolonged metformin therapy may induce vitamin B12 deficiency, which has been established as a risk factor for cognitive decline (\u003Ca href=\"#B57\">57\u003C/a>, \u003Ca href=\"#B58\">58\u003C/a>). This dual mechanism indicates that while metformin may mitigate diabetes-related neurodegenerative processes, it could paradoxically impair cognitive health in susceptible individuals through nutritional metabolic disturbances. Clinical protocols should therefore incorporate regular serum vitamin B12 monitoring and timely nutritional supplementation to prevent associated complications (\u003Ca href=\"#B59\">59\u003C/a>).\u003C/p>\u003Ch4>5.2.1 GLP-1 receptor agonists\u003C/h4>\u003Cp class=\"mb0\">The neuroprotective effects of GLP-1RA are believed to be mediated through multiple mechanisms, including the reduction of neuroinflammation, enhancement of mitochondrial function, antioxidant stress, prevention of &#x3b2;-amyloid and tau protein aggregation, and improvement of synaptic function (\u003Ca href=\"#B60\">60\u003C/a>). A systematic review and meta-analysis found that GLP-1RA did not significantly affect overall cognitive function in patients with type 2 diabetes. However, subgroup analysis indicated potential benefits for patients under 65 years of age or those without a history of cardiovascular or cerebrovascular disease, suggesting that age and comorbidities may influence cognitive outcomes with GLP-1 therapy (\u003Ca href=\"#B61\">61\u003C/a>). Another study reported that the GLP-1RA liraglutide improved short-term memory and memory composite scores in obese patients with prediabetes or early-stage type 2 diabetes, independent of weight loss effects. This suggests that GLP-1RA provide direct cognitive benefits in early-stage diabetes (\u003Ca href=\"#B62\">62\u003C/a>). In animal models, GLP-1RA have shown promising results in improving cognitive function. For example, liraglutide improved memory retention and increased hippocampal neuron count in an Alzheimer&#x2019;s disease mouse model, indicating its potential neuroprotective effects (\u003Ca href=\"#B63\">63\u003C/a>).\u003C/p>\u003Ch4>5.2.2 Sodium-glucose cotransporter 2 inhibitors\u003C/h4>\u003Cp class=\"mb15\">(SGLT2is) exerts beneficial effects on cognitive impairment through multifaceted mechanisms involving metabolic regulation, anti-inflammatory actions, antioxidant properties, and modulation of neurotrophic factors (\u003Ca href=\"#B64\">64\u003C/a>). Preclinical studies demonstrate that dapagliflozin ameliorates cognitive deficits in diabetic murine models by restoring hippocampal mitochondrial dynamics - a critical process for synaptic plasticity and memory formation (\u003Ca href=\"#B65\">65\u003C/a>). Particularly in dual pathology models combining T2DM and AD, SGLT2is not only enhance insulin sensitivity but also significantly reduce &#x3b2;-amyloid deposition, addressing two fundamental pathological hallmarks of AD.\u003C/p>\u003Cp class=\"mb15\">Clinical investigations reveal substantial cognitive improvements associated with SGLT2i therapy, especially in populations with mild cognitive impairment or established dementia. A meta-analysis quantifying cognitive outcomes showed a standardized mean difference of 0.88 (95% CI: 0.32-1.44) in cognitive assessment scores, indicating clinically meaningful enhancement (\u003Ca href=\"#B66\">66\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">Notably, large-scale clinical data analysis demonstrates significant dementia risk reduction with SGLT2i use. In a population-based study of 331,908 T2DM patients, SGLT2i treatment was associated with 23% lower dementia incidence (HR: 0.77; 95% CI: 0.71-0.84) (\u003Ca href=\"#B67\">67\u003C/a>). The observed cerebroprotection may derive from synergistic effects including blood pressure optimization, sodium homeostasis regulation, and metabolic reprogramming, collectively preserving neuronal integrity in chronic metabolic disorders (\u003Ca href=\"#B68\">68\u003C/a>).\u003C/p>\u003Ch4>5.2.3 DPP-4 inhibitors\u003C/h4>\u003Cp class=\"mb15\">DPP-4is improve glucose tolerance and insulin sensitivity, which are critical for maintaining cognitive function in diabetic patients. Improvements in metabolic parameters such as reduced fasting blood glucose and HbA1c levels are consistently associated with better cognitive outcomes (\u003Ca href=\"#B69\">69\u003C/a>, \u003Ca href=\"#B70\">70\u003C/a>). Sitagliptin has been shown to reduce oxidative stress and promote hippocampal neurogenesis, both essential for cognitive health. These effects are further supported by the upregulation of genes involved in neuroprotection and synaptic plasticity (\u003Ca href=\"#B69\">69\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">At the molecular level, DPP-4is likely exert their benefits via the AMPK/mTOR pathway, enhancing neuronal autophagy and reducing tau protein phosphorylation&#x2014;mechanisms that are neuroprotective (\u003Ca href=\"#B71\">71\u003C/a>). A meta-analysis involving 5,583 participants demonstrated that DPP-4is significantly reduce the incidence of cognitive impairment in T2DM patients, with a standardized mean difference (SMD) of 0.99. Additionally, clinical studies revealed that these agents improve scores on the Mini-Mental State Examination (MMSE) and Instrumental Activities of Daily Living (IADL), indicating measurable cognitive benefits (\u003Ca href=\"#B70\">70\u003C/a>, \u003Ca href=\"#B72\">72\u003C/a>). Notably, in elderly patients with mild cognitive impairment, DPP-4is stabilize cognitive function by reducing glycemic variability (\u003Ca href=\"#B73\">73\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">Preclinical evidence further supports these findings: in insulin-resistant rat models, DPP-4is such as sitagliptin and vildagliptin improve cognitive behaviors and restore cerebral mitochondrial function, demonstrating protective effects against diet-induced cognitive decline (\u003Ca href=\"#B74\">74\u003C/a>).\u003C/p>\u003Ch4>5.2.4 Sulfonylureas\u003C/h4>\u003Cp class=\"mb15\">Sulfonylureas may exert dual effects on cognitive function in diabetic populations. Preclinical studies indicate potential neuroprotective properties: glimepiride ameliorated learning and memory deficits in diabetic rodent models, potentially through antioxidant mechanisms and upregulation of BDNF levels (\u003Ca href=\"#B75\">75\u003C/a>). Similarly, glyburide prevented chronic stress-induced cognitive impairment in murine models, possibly via modulation of the hypothalamic-pituitary-adrenal (HPA) axis and glucocorticoid receptor stabilization (\u003Ca href=\"#B76\">76\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">However, these potential benefits must be weighed against well-documented adverse effects. Sulfonylureas are associated with hypoglycemia episodes and progressive &#x3b2;-cell exhaustion, factors that may exacerbate cognitive decline, particularly in elderly patients with compromised cerebral autoregulation. Population-based studies reveal concerning epidemiological patterns. A retrospective cohort analysis (n = 45,632 T2DM patients) comparing sulfonylureas with DPP-4is demonstrated increased dementia risk with sulfonylurea use over 4.82 mean follow-up years (\u003Ca href=\"#B77\">77\u003C/a>). Network meta-analyses further position sulfonylureas as second-highest among antidiabetic agents for dementia risk escalation (surface under cumulative ranking [SUCRA] score: 73.4), surpassed only by insulin analogs (\u003Ca href=\"#B78\">78\u003C/a>).\u003C/p>\u003Ch3>5.3 Behavioral and lifestyle interventions: synergistic effects of diet, exercise, and cognitive training\u003C/h3>\u003Cp class=\"mb0\">Accumulating evidence supports behavioral and lifestyle interventions&#x2014;including dietary modification, physical exercise, and cognitive training&#x2014;as promising non-pharmacological strategies to mitigate diabetes-related cognitive decline. T2DM is a well-established independent risk factor for mild cognitive impairment and dementia progression. While current pharmacological interventions remain suboptimal, multimodal lifestyle approaches demonstrate clinically meaningful potential for preserving neurocognitive function in T2DM populations.\u003C/p>\u003Ch4>5.3.1 Exercise and cognitive function\u003C/h4>\u003Cp class=\"mb0\">Controlled trials reveal differential cognitive benefits of structured exercise regimens in T2DM patients. Both resistance training and aerobic exercise protocols show efficacy (\u003Ca href=\"#B79\">79\u003C/a>), with meta-analytic data indicating significant attenuation of cognitive decline through multicomponent programs (sessions &gt;40 minutes, &#x2265;4 times weekly over 6 months; pooled effect size: 0.61, 95% CI: 0.40&#x2013;0.82) (\u003Ca href=\"#B80\">80\u003C/a>). Notably, intervention heterogeneity exists, with some studies reporting only moderate effects or null findings in single-modality approaches, underscoring the need for optimized intensity-duration parameters (\u003Ca href=\"#B81\">81\u003C/a>, \u003Ca href=\"#B82\">82\u003C/a>).\u003C/p>\u003Ch4>5.3.2 Cognitive training interventions\u003C/h4>\u003Cp class=\"mb0\">Domain-specific cognitive interventions yield measurable neuropsychological improvements. Dual-task training and targeted cognitive remediation significantly enhance memory performance and executive function in T2DM cohorts. Although mechanistic links to glycemic control remain inconclusive, these interventions demonstrate synergistic benefits when combined with lifestyle education, enhancing both cognitive capacity and diabetes self-management skills (\u003Ca href=\"#B83\">83\u003C/a>).\u003C/p>\u003Ch4>5.3.3 Combined interventions\u003C/h4>\u003Cp class=\"mb15\">Integrating diet, exercise, and cognitive training&#x2014;seem to offer the most comprehensive benefits. Research indicates that multimodal interventions can improve cognitive function and overall health outcomes in patients with T2DM (\u003Ca href=\"#B80\">80\u003C/a>). The LIFE study, which included physical activity interventions, reported beneficial effects on global cognitive function and memory slowing in elderly individuals with T2DM, highlighting the potential of a combined approach (\u003Ca href=\"#B84\">84\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">Current evidence positions multimodal lifestyle interventions as clinically actionable strategies for addressing diabetes-associated cognitive impairment. The triad of dietary optimization, structured exercise, and cognitive engagement demonstrates synergistic neuroprotection, potentially delaying dementia onset while improving metabolic health. Future research should prioritize protocol standardization.\u003C/p>\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>6 Biomarkers of cognitive impairment in T2DM\u003C/h2>\u003Cp class=\"mb15\">Given the significantly increased risk of dementia and cognitive decline in patients with T2DM, research on predictive biomarkers and early detection technologies for cognitive impairment in this population has gained increasing attention in recent years, which is of great significance for achieving early diagnosis and timely intervention. Recent research advances have revealed several categories of biomarkers with potential clinical applications, including but not limited to Neuron-Derived Exosomes (NDEs) and metabolic signatures.\u003C/p>\u003Cp class=\"mb15\">NDEs are small extracellular vesicles that can cross the blood-brain barrier and are enriched with neuron-specific proteins, RNAs, and other biomolecules. These vesicles have emerged as promising tools for early diagnosis of neurodegenerative diseases (\u003Ca href=\"#B85\">85\u003C/a>). Chi et&#xa0;al. discovered that plasma NDEs from T2DM patients showed significantly reduced levels of mitochondrial complex I protein NDUFS3 and complex II protein SDHB. Lower SDHB levels were positively correlated with progression from MCI to AD (\u003Ca href=\"#B86\">86\u003C/a>). Specific miRNAs and proteins in NDEs, including but not limited to miR-185-5p, miR-132-3p, and miR-34a-5p (\u003Ca href=\"#B87\">87\u003C/a>&#x2013;\u003Ca href=\"#B89\">89\u003C/a>), have been linked to AD and cognitive impairment, highlighting their biomarker potential.\u003C/p>\u003Cp class=\"mb15\">Elevated myo-inositol (MI) concentrations coupled with reduced glutamate (Glu), Glx (glutamate + glutamine), and NAA/Cr (N-acetylaspartate/creatine) ratios within the hippocampus represent sensitive metabolic biomarkers for monitoring diabetic cognitive impairment progression (\u003Ca href=\"#B90\">90\u003C/a>). Additional metabolic biomarkers under consideration include C-reactive protein, tau protein, BDNF and AGEs (\u003Ca href=\"#B91\">91\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">The hippocampus, a brain region critically involved in learning and memory processes, may serve as an early &#x201c;warning indicator&#x201d; for diabetes-associated cognitive impairment through its volumetric changes (\u003Ca href=\"#B92\">92\u003C/a>). High-resolution MRI segmentation analyses have demonstrated significant volumetric reductions in memory-critical hippocampal subfields (CA1, dentate gyrus [DG], and subiculum) among middle-aged T2DM patients. These specific subregions are known to be fundamentally involved in memory encoding and consolidation processes. These structurally measured hippocampal subfield atrophies not only directly correlated with cognitive performance but may also reflect persistent neural damage caused by glucose metabolic dysregulation. Importantly, these findings provide neuroimaging evidence for early identification of high-risk populations (\u003Ca href=\"#B93\">93\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">In newly diagnosed T2DM patients, elevated venular tortuosity shows significant association with cognitive impairment. This correlation remained significant after adjustment for multiple demographic and health factors, suggesting retinal vascular tortuosity may serve as an early indicator of cognitive decline (\u003Ca href=\"#B94\">94\u003C/a>). Retinal vascular metrics (RVMs) can function as imaging biomarkers to predict cognitive impairment in T2DM, thereby enhancing risk stratification (\u003Ca href=\"#B95\">95\u003C/a>). Furthermore, patients with T2DM and mild cognitive impairment (MCI) exhibit significant thinning of the macular retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) (\u003Ca href=\"#B96\">96\u003C/a>). These structural changes can be effectively quantified through \u003Ci>in vivo\u003C/i> optical coherence tomography (OCT) imaging, highlighting the potential of retinal assessment for predicting diabetes-related cognitive dysfunction (\u003Ca href=\"#B97\">97\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">The complexity of T2DM-related cognitive dysfunction involves multiple pathways and contributing factors, necessitating a multi-faceted approach to biomarker discovery. Future research should prioritize validation of these biomarkers in larger longitudinal cohorts and explore their potential for guiding personalized therapeutic strategies.\u003C/p>\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>7 Conclusion\u003C/h2>\u003Cp class=\"mb15\">In summary, a complex pathophysiological relationship exists between T2DM and cognitive impairment. Mechanisms including insulin resistance, chronic inflammation, vascular injury, and oxidative stress collectively drive disease progression. Effective glycemic control not only mitigates metabolic dysregulation but also exerts protective effects on cognitive function. Concurrently, factors such as age, educational attainment, and socioeconomic determinants play pivotal roles in disease development, thereby providing new perspectives for multidimensional intervention strategies. Furthermore, the discovery of novel biomarkers and early detection technologies offers promising avenues for early screening and disease monitoring.\u003C/p>\u003Cp class=\"mb15\">These findings hold significant implications for both clinical practice and public health: On the one hand, they underscore the necessity for early cognitive assessment and integrated management in T2DM patients; On the other hand, they emphasize the importance of establishing social support systems to reduce cognitive risk in high-risk populations. However, current research still has limitations, such as small sample sizes in longitudinal cohort studies, incomplete understanding of mechanistic differences across diverse ethnic groups, and the need for further validation of newly identified biomarkers in clinical translation.\u003C/p>\u003Cp class=\"mb15\">Future research could focus on leveraging multi-omics technologies to explore novel pathogenic mechanisms, conducting long-term, multicenter, cross-cultural cohort studies to clarify the universality of risk factors, and developing early warning models based on emerging biomarkers. There is also an urgent need to explore personalized comprehensive treatment strategies that integrate metabolic regulation and social interventions, thereby providing a more robust theoretical and practical foundation for improving cognitive health in patients with T2DM.\u003C/p>\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Author contributions\u003C/h2>\u003Cp class=\"mb0\">WK: Writing &#x2013; original draft. MQ: Writing &#x2013; review &amp; editing. YW: Writing &#x2013; review &amp; editing. XZ: Writing &#x2013; review &amp; editing. LX: Writing &#x2013; review &amp; editing, Supervision.\u003C/p>\u003Ca id=\"h10\" name=\"h10\">\u003C/a>\u003Ch2>Funding\u003C/h2>\u003Cp class=\"mb0\">The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.\u003C/p>\u003Ca id=\"h11\" name=\"h11\">\u003C/a>\u003Ch2>Conflict of interest\u003C/h2>\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\u003Ca id=\"h12\" name=\"h12\">\u003C/a>\u003Ch2>Generative AI statement\u003C/h2>\u003Cp class=\"mb0\">The author(s) declare that Generative AI was used in the creation of this manuscript. We acknowledge the use of ChatGPT for language polishing and proofreading in the preparation of this manuscript. The authors take full responsibility for the content and interpretation of the study.\u003C/p>\u003Ca id=\"h13\" name=\"h13\">\u003C/a>\u003Ch2>Publisher&#x2019;s note\u003C/h2>\u003Cp class=\"mb15\">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C/p>\u003Ca id=\"h14\" name=\"h14\">\u003C/a>\u003Ch2>References\u003C/h2>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a> 1. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, AlKaabi J, et al. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. \u003Ci>J Epidemiol Global Health\u003C/i>. (2020) 10:107&#x2013;11. doi:&#xa0;10.2991/jegh.k.191028.001\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32175717/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2991/jegh.k.191028.001\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MAB+Khan&amp;author=MJ+Hashim&amp;author=JK+King&amp;author=RD+Govender&amp;author=H+Mustafa&amp;author=J+AlKaabi&amp;publication_year=2020&amp;title=Epidemiology%20of%20type%202%20diabetes%20-%20global%20burden%20of%20disease%20and%20forecasted%20trends&amp;journal=J+Epidemiol+Global+Health&amp;volume=10&amp;pages=107-11\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a> 2. M&#x142;ynarska E, Czarnik W, Dzie&#x17c;a N, J&#x119;draszak W, Majchrowicz G, Prusinowski F, et al. Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications. \u003Ci>Int J Mol Sci\u003C/i>. (2025) 26(3):1094. doi:&#xa0;10.3390/ijms26031094\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39940862/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/ijms26031094\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=E+M%C5%82ynarska&amp;author=W+Czarnik&amp;author=N+Dzie%C5%BCa&amp;author=W+J%C4%99draszak&amp;author=G+Majchrowicz&amp;author=F+Prusinowski&amp;publication_year=2025&amp;title=Type%202%20diabetes%20mellitus%3A%20new%20pathogenetic%20mechanisms%2C%20treatment%20and%20the%20most%20important%20complications&amp;journal=Int+J+Mol+Sci&amp;volume=26&amp;pages=1094\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a> 3. Chang HJ, Burke AE, and Glass RM. Older drivers and cognitive impairment. \u003Ci>JAMA\u003C/i>. (2010) 303:1660&#x2013;. doi:&#xa0;10.1001/jama.281.16.1560\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://doi.org/10.1001/jama.281.16.1560\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=HJ+Chang&amp;author=AE+Burke&amp;author=RM+Glass&amp;publication_year=2010&amp;title=Older%20drivers%20and%20cognitive%20impairment&amp;journal=JAMA&amp;volume=303&amp;pages=1660-\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a> 4. Shang H, Xu C, Lu H, and Zhang J. The early stage of abnormal aging: cognitive impairment. \u003Ci>Adv Exp Med Biol\u003C/i>. (2023) 1419:149&#x2013;55. doi:&#xa0;10.1007/978-981-99-1627-6_11\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37418212/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/978-981-99-1627-6_11\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H+Shang&amp;author=C+Xu&amp;author=H+Lu&amp;author=J+Zhang&amp;publication_year=2023&amp;title=The%20early%20stage%20of%20abnormal%20aging%3A%20cognitive%20impairment&amp;journal=Adv+Exp+Med+Biol&amp;volume=1419&amp;pages=149-55\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a> 5. Foreman MD and Grabowski R. Diagnostic dilemma: cognitive impairment in the elderly. \u003Ci>J gerontological Nurs\u003C/i>. (1992) 18:5&#x2013;12. doi:&#xa0;10.3928/0098-9134-19920901-04\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/1430903/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3928/0098-9134-19920901-04\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MD+Foreman&amp;author=R+Grabowski&amp;publication_year=1992&amp;title=Diagnostic%20dilemma%3A%20cognitive%20impairment%20in%20the%20elderly&amp;journal=J+gerontological+Nurs&amp;volume=18&amp;pages=5\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a> 6. Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. \u003Ci>Signal transduction targeted Ther\u003C/i>. (2024) 9:262. doi:&#xa0;10.1038/s41392-024-01951-9\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39353925/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41392-024-01951-9\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X+Lu&amp;author=Q+Xie&amp;author=X+Pan&amp;author=R+Zhang&amp;author=X+Zhang&amp;author=G+Peng&amp;publication_year=2024&amp;title=Type%202%20diabetes%20mellitus%20in%20adults%3A%20pathogenesis%2C%20prevention%20and%20therapy&amp;journal=Signal+transduction+targeted+Ther&amp;volume=9&amp;pages=262\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a> 7. DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. \u003Ci>Nat Rev Dis Primers\u003C/i>. (2015) 1:15019. doi:&#xa0;10.1038/nrdp.2015.19\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27189025/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nrdp.2015.19\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=RA+DeFronzo&amp;author=E+Ferrannini&amp;author=L+Groop&amp;author=RR+Henry&amp;author=WH+Herman&amp;author=JJ+Holst&amp;publication_year=2015&amp;title=Type%202%20diabetes%20mellitus&amp;journal=Nat+Rev+Dis+Primers&amp;volume=1&amp;pages=15019\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a> 8. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. \u003Ci>Int J Mol Sci\u003C/i>. (2020) 21(17):6275. doi:&#xa0;10.3390/ijms21176275\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32872570/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/ijms21176275\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=U+Galicia-Garcia&amp;author=A+Benito-Vicente&amp;author=S+Jebari&amp;author=A+Larrea-Sebal&amp;author=H+Siddiqi&amp;author=KB+Uribe&amp;publication_year=2020&amp;title=Pathophysiology%20of%20type%202%20diabetes%20mellitus&amp;journal=Int+J+Mol+Sci&amp;volume=21&amp;pages=6275\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a> 9. Lee SH, Park SY, and Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. \u003Ci>Diabetes Metab J\u003C/i>. (2022) 46:15&#x2013;37. doi:&#xa0;10.4093/dmj.2021.0280\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34965646/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.4093/dmj.2021.0280\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SH+Lee&amp;author=SY+Park&amp;author=CS+Choi&amp;publication_year=2022&amp;title=Insulin%20resistance%3A%20from%20mechanisms%20to%20therapeutic%20strategies&amp;journal=Diabetes+Metab+J&amp;volume=46&amp;pages=15\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a> 10. Alhusaini S, Karama S, Nguyen TV, Thiel A, Bernhardt BC, Cox SR, et al. Association between carotid atheroma and cerebral cortex structure at age 73 years. \u003Ci>Ann Neurol\u003C/i>. (2018) 84:576&#x2013;87. doi:&#xa0;10.1002/ana.25324\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30179274/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/ana.25324\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Alhusaini&amp;author=S+Karama&amp;author=TV+Nguyen&amp;author=A+Thiel&amp;author=BC+Bernhardt&amp;author=SR+Cox&amp;publication_year=2018&amp;title=Association%20between%20carotid%20atheroma%20and%20cerebral%20cortex%20structure%20at%20age%2073%20years&amp;journal=Ann+Neurol&amp;volume=84&amp;pages=576-87\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a> 11. Aparicio HJ, Petrea RE, Massaro JM, Manning WJ, Oyama-Manabe N, Beiser AS, et al. Association of descending thoracic aortic plaque with brain atrophy and white matter hyperintensities: The Framingham Heart Study. \u003Ci>Atherosclerosis\u003C/i>. (2017) 265:305&#x2013;11. doi:&#xa0;10.1016/j.atherosclerosis.2017.06.919\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28673480/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.atherosclerosis.2017.06.919\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=HJ+Aparicio&amp;author=RE+Petrea&amp;author=JM+Massaro&amp;author=WJ+Manning&amp;author=N+Oyama-Manabe&amp;author=AS+Beiser&amp;publication_year=2017&amp;title=Association%20of%20descending%20thoracic%20aortic%20plaque%20with%20brain%20atrophy%20and%20white%20matter%20hyperintensities%3A%20The%20Framingham%20Heart%20Study&amp;journal=Atherosclerosis&amp;volume=265&amp;pages=305-11\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a> 12. Ogoh S. Relationship between cognitive function and regulation of cerebral blood flow. \u003Ci>J Physiol sciences: JPS\u003C/i>. (2017) 67:345&#x2013;51. doi:&#xa0;10.1007/s12576-017-0525-0\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28155036/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s12576-017-0525-0\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Ogoh&amp;publication_year=2017&amp;title=Relationship%20between%20cognitive%20function%20and%20regulation%20of%20cerebral%20blood%20flow&amp;journal=J+Physiol+sciences:+JPS&amp;volume=67&amp;pages=345-51\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a> 13. Moroni F, Ammirati E, Magnoni M, D'Ascenzo F, Anselmino M, Anzalone N, et al. Carotid atherosclerosis, silent ischemic brain damage and brain atrophy: A systematic review and meta-analysis. \u003Ci>Int J Cardiol\u003C/i>. (2016) 223:681&#x2013;7. doi:&#xa0;10.1016/j.ijcard.2016.08.234\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27568989/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.ijcard.2016.08.234\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F+Moroni&amp;author=E+Ammirati&amp;author=M+Magnoni&amp;author=F+D%27Ascenzo&amp;author=M+Anselmino&amp;author=N+Anzalone&amp;publication_year=2016&amp;title=Carotid%20atherosclerosis%2C%20silent%20ischemic%20brain%20damage%20and%20brain%20atrophy%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Int+J+Cardiol&amp;volume=223&amp;pages=681-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a> 14. Chen H, Wang M, Xia L, Dong J, Xu G, Wang Z, et al. New evidence of central nervous system damage in diabetes: impairment of fine visual discrimination. \u003Ci>Diabetes\u003C/i>. (2022) 71:1772&#x2013;84. doi:&#xa0;10.2337/db21-0715\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35612428/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2337/db21-0715\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H+Chen&amp;author=M+Wang&amp;author=L+Xia&amp;author=J+Dong&amp;author=G+Xu&amp;author=Z+Wang&amp;publication_year=2022&amp;title=New%20evidence%20of%20central%20nervous%20system%20damage%20in%20diabetes%3A%20impairment%20of%20fine%20visual%20discrimination&amp;journal=Diabetes&amp;volume=71&amp;pages=1772-84\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a> 15. Heringa SM, Bouvy WH, VanDenBerg E, Moll AC, Kappelle LJ, Biessels GJ, et al. Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review. \u003Ci>J Cereb Blood Flow Metab\u003C/i>. (2013) 33:983&#x2013;95. doi:&#xa0;10.1038/jcbfm.2013.58\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23591648/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/jcbfm.2013.58\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SM+Heringa&amp;author=WH+Bouvy&amp;author=E+VanDenBerg&amp;author=AC+Moll&amp;author=LJ+Kappelle&amp;author=GJ+Biessels&amp;publication_year=2013&amp;title=Associations%20between%20retinal%20microvascular%20changes%20and%20dementia%2C%20cognitive%20functioning%2C%20and%20brain%20imaging%20abnormalities%3A%20a%20systematic%20review&amp;journal=J+Cereb+Blood+Flow+Metab&amp;volume=33&amp;pages=983-95\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a> 16. Shi X, Zhang Y, Niu H, Wang R, Shen J, Zhou S, et al. Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus. \u003Ci>Zhong nan da xue xue bao Yi xue ban = J Cent South Univ Med Sci\u003C/i>. (2016) 41:143&#x2013;50. doi:&#xa0;10.11817/j.issn.1672-7347.2016.02.005\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26932211/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.11817/j.issn.1672-7347.2016.02.005\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X+Shi&amp;author=Y+Zhang&amp;author=H+Niu&amp;author=R+Wang&amp;author=J+Shen&amp;author=S+Zhou&amp;publication_year=2016&amp;title=Correlation%20between%20cognitive%20impairment%20and%20diabetic%20nephropathy%20in%20patients%20with%20Type%202%20diabetes%20mellitus&amp;journal=Zhong+nan+da+xue+xue+bao+Yi+xue+ban+=+J+Cent+South+Univ+Med+Sci&amp;volume=41&amp;pages=143-50\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a> 17. Bossola M and Picconi B. Uremic toxins and the brain in chronic kidney disease. \u003Ci>J Nephrol\u003C/i>. (2024) 37:1391&#x2013;5. doi:&#xa0;10.1007/s40620-024-01929-4\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38625502/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s40620-024-01929-4\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M+Bossola&amp;author=B+Picconi&amp;publication_year=2024&amp;title=Uremic%20toxins%20and%20the%20brain%20in%20chronic%20kidney%20disease&amp;journal=J+Nephrol&amp;volume=37&amp;pages=1391-5\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a> 18. Xiao Y, Devakumar V, Xu L, Liu L, Mo H, Hong X, et al. Elevated serum creatinine levels and risk of cognitive impairment in older adults with diabetes: a NHANES study from 2011&#x2013;2014. \u003Ci>Front Endocrinol\u003C/i>. (2023) 14:1149084. doi:&#xa0;10.3389/fendo.2023.1149084\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37900140/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fendo.2023.1149084\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Xiao&amp;author=V+Devakumar&amp;author=L+Xu&amp;author=L+Liu&amp;author=H+Mo&amp;author=X+Hong&amp;publication_year=2023&amp;title=Elevated%20serum%20creatinine%20levels%20and%20risk%20of%20cognitive%20impairment%20in%20older%20adults%20with%20diabetes%3A%20a%20NHANES%20study%20from%202011%E2%80%932014&amp;journal=Front+Endocrinol&amp;volume=14&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a> 19. Palomo-Osuna J, DeSola H, Due&#xf1;as M, Moral-Munoz JA, and Failde I. Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis. \u003Ci>Expert Rev Neurother\u003C/i>. (2022) 22:269&#x2013;81. doi:&#xa0;10.1080/14737175.2022.2048649\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35232335/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1080/14737175.2022.2048649\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Palomo-Osuna&amp;author=H+DeSola&amp;author=M+Due%C3%B1as&amp;author=JA+Moral-Munoz&amp;author=I+Failde&amp;publication_year=2022&amp;title=Cognitive%20function%20in%20diabetic%20persons%20with%20peripheral%20neuropathy%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Expert+Rev+Neurother&amp;volume=22&amp;pages=269-81\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a> 20. Ding X, Fang C, Li X, Cao YJ, Zhang QL, Huang Y, et al. Type 1 diabetes-associated cognitive impairment and diabetic peripheral neuropathy in Chinese adults: results from a prospective cross-sectional study. \u003Ci>BMC endocrine Disord\u003C/i>. (2019) 19:34. doi:&#xa0;10.1186/s12902-019-0359-2\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30917808/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1186/s12902-019-0359-2\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X+Ding&amp;author=C+Fang&amp;author=X+Li&amp;author=YJ+Cao&amp;author=QL+Zhang&amp;author=Y+Huang&amp;publication_year=2019&amp;title=Type%201%20diabetes-associated%20cognitive%20impairment%20and%20diabetic%20peripheral%20neuropathy%20in%20Chinese%20adults%3A%20results%20from%20a%20prospective%20cross-sectional%20study&amp;journal=BMC+endocrine+Disord&amp;volume=19&amp;pages=34\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a> 21. Abo-Elfetoh NM, Farag AI, and Gabra RH. Impact of pain severity on functioning domains, sleep, and cognition in painful diabetic peripheral polyneuropathy patients. \u003Ci>Middle East Curr Psychiatry\u003C/i>. (2022) 29:83. doi:&#xa0;10.1186/s43045-022-00243-8\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://doi.org/10.1186/s43045-022-00243-8\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=NM+Abo-Elfetoh&amp;author=AI+Farag&amp;author=RH+Gabra&amp;publication_year=2022&amp;title=Impact%20of%20pain%20severity%20on%20functioning%20domains%2C%20sleep%2C%20and%20cognition%20in%20painful%20diabetic%20peripheral%20polyneuropathy%20patients&amp;journal=Middle+East+Curr+Psychiatry&amp;volume=29&amp;pages=83\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a> 22. Croosu SS, Gjela M, R&#xf8;ikjer J, Hansen TM, M&#xf8;rch CD, Fr&#xf8;kj&#xe6;r JB, et al. Cognitive function in individuals with and without painful and painless diabetic polyneuropathy-A cross-sectional study in type 1 diabetes. \u003Ci>Endocrinology Diabetes Metab\u003C/i>. (2023) 6:e420. doi:&#xa0;10.1002/edm2.420\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37073434/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/edm2.420\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SS+Croosu&amp;author=M+Gjela&amp;author=J+R%C3%B8ikjer&amp;author=TM+Hansen&amp;author=CD+M%C3%B8rch&amp;author=JB+Fr%C3%B8kj%C3%A6r&amp;publication_year=2023&amp;title=Cognitive%20function%20in%20individuals%20with%20and%20without%20painful%20and%20painless%20diabetic%20polyneuropathy-A%20cross-sectional%20study%20in%20type%201%20diabetes&amp;journal=Endocrinology+Diabetes+Metab&amp;volume=6&amp;pages=e420\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a> 23. Nguyen ML, Wong D, Barson E, Staunton E, and Fisher CA. Cognitive dysfunction in diabetes-related foot complications: A cohort study. \u003Ci>J Diabetes Metab Disord\u003C/i>. (2024) 23:1017&#x2013;38. doi:&#xa0;10.1007/s40200-023-01381-4\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38932904/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s40200-023-01381-4\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=ML+Nguyen&amp;author=D+Wong&amp;author=E+Barson&amp;author=E+Staunton&amp;author=CA+Fisher&amp;publication_year=2024&amp;title=Cognitive%20dysfunction%20in%20diabetes-related%20foot%20complications%3A%20A%20cohort%20study&amp;journal=J+Diabetes+Metab+Disord&amp;volume=23&amp;pages=1017-38\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a> 24. Yu X, He H, Wen J, Xu X, Ruan Z, Hu R, et al. Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments. \u003Ci>Open Med (Warsaw Poland)\u003C/i>. (2025) 20:20241091. doi:&#xa0;10.1515/med-2024-1091\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39822993/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1515/med-2024-1091\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X+Yu&amp;author=H+He&amp;author=J+Wen&amp;author=X+Xu&amp;author=Z+Ruan&amp;author=R+Hu&amp;publication_year=2025&amp;title=Diabetes-related%20cognitive%20impairment%3A%20Mechanisms%2C%20symptoms%2C%20and%20treatments&amp;journal=Open+Med+(Warsaw+Poland)&amp;volume=20&amp;pages=20241091\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a> 25. Milstein JL and Ferris HA. The brain as an insulin-sensitive metabolic organ. \u003Ci>Mol Metab\u003C/i>. (2021) 52:101234. doi:&#xa0;10.1016/j.molmet.2021.101234\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33845179/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.molmet.2021.101234\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=JL+Milstein&amp;author=HA+Ferris&amp;publication_year=2021&amp;title=The%20brain%20as%20an%20insulin-sensitive%20metabolic%20organ&amp;journal=Mol+Metab&amp;volume=52&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a> 26. Cetinkalp S, Simsir IY, and Ertek S. Insulin resistance in brain and possible therapeutic approaches. \u003Ci>Curr Vasc Pharmacol\u003C/i>. (2014) 12:553&#x2013;64. doi:&#xa0;10.2174/1570161112999140206130426\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23627981/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2174/1570161112999140206130426\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Cetinkalp&amp;author=IY+Simsir&amp;author=S+Ertek&amp;publication_year=2014&amp;title=Insulin%20resistance%20in%20brain%20and%20possible%20therapeutic%20approaches&amp;journal=Curr+Vasc+Pharmacol&amp;volume=12&amp;pages=553-64\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a> 27. Luo JS, Ning JQ, Chen ZY, Li WJ, Zhou RL, Yan RY, et al. The role of mitochondrial quality control in cognitive dysfunction in diabetes. \u003Ci>Neurochemical Res\u003C/i>. (2022) 47:2158&#x2013;72. doi:&#xa0;10.1007/s11064-022-03631-y\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35661963/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s11064-022-03631-y\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=JS+Luo&amp;author=JQ+Ning&amp;author=ZY+Chen&amp;author=WJ+Li&amp;author=RL+Zhou&amp;author=RY+Yan&amp;publication_year=2022&amp;title=The%20role%20of%20mitochondrial%20quality%20control%20in%20cognitive%20dysfunction%20in%20diabetes&amp;journal=Neurochemical+Res&amp;volume=47&amp;pages=2158-72\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a> 28. Grillo CA, Woodruff JL, Macht VA, and Reagan LP. Insulin resistance and hippocampal dysfunction: Disentangling peripheral and brain causes from consequences. \u003Ci>Exp Neurol\u003C/i>. (2019) 318:71&#x2013;7. doi:&#xa0;10.1016/j.expneurol.2019.04.012\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31028829/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.expneurol.2019.04.012\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=CA+Grillo&amp;author=JL+Woodruff&amp;author=VA+Macht&amp;author=LP+Reagan&amp;publication_year=2019&amp;title=Insulin%20resistance%20and%20hippocampal%20dysfunction%3A%20Disentangling%20peripheral%20and%20brain%20causes%20from%20consequences&amp;journal=Exp+Neurol&amp;volume=318&amp;pages=71-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a> 29. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. \u003Ci>Proc Natl Acad Sci U S A\u003C/i>. (2004) 101:10827&#x2013;32. doi:&#xa0;10.1073/pnas.0402141101\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15249684/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1073/pnas.0402141101\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=LM+Monteggia&amp;author=M+Barrot&amp;author=CM+Powell&amp;author=O+Berton&amp;author=V+Galanis&amp;author=T+Gemelli&amp;publication_year=2004&amp;title=Essential%20role%20of%20brain-derived%20neurotrophic%20factor%20in%20adult%20hippocampal%20function&amp;journal=Proc+Natl+Acad+Sci+U+S+A&amp;volume=101&amp;pages=10827-32\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a> 30. Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT, et al. Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease. \u003Ci>JAMA Neurol\u003C/i>. (2015) 72:1013&#x2013;20. doi:&#xa0;10.1001/jamaneurol.2015.0613\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26214150/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1001/jamaneurol.2015.0613\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=AA+Willette&amp;author=BB+Bendlin&amp;author=EJ+Starks&amp;author=AC+Birdsill&amp;author=SC+Johnson&amp;author=BT+Christian&amp;publication_year=2015&amp;title=Association%20of%20insulin%20resistance%20with%20cerebral%20glucose%20uptake%20in%20late%20middle-aged%20adults%20at%20risk%20for%20Alzheimer%20disease&amp;journal=JAMA+Neurol&amp;volume=72&amp;pages=1013-20\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a> 31. Kim E, Tolhurst AT, and Cho S. Deregulation of inflammatory response in the diabetic condition is associated with increased ischemic brain injury. \u003Ci>J Neuroinflamm\u003C/i>. (2014) 11:83. doi:&#xa0;10.1186/1742-2094-11-83\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24886035/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1186/1742-2094-11-83\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=E+Kim&amp;author=AT+Tolhurst&amp;author=S+Cho&amp;publication_year=2014&amp;title=Deregulation%20of%20inflammatory%20response%20in%20the%20diabetic%20condition%20is%20associated%20with%20increased%20ischemic%20brain%20injury&amp;journal=J+Neuroinflamm&amp;volume=11&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B32\" id=\"B32\">\u003C/a> 32. Muriach M, Flores-Bellver M, Romero FJ, and Barcia JM. Diabetes and the brain: oxidative stress, inflammation, and autophagy. \u003Ci>Oxid Med Cell Longevity\u003C/i>. (2014) 2014:102158. doi:&#xa0;10.1155/2014/102158\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25215171/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1155/2014/102158\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M+Muriach&amp;author=M+Flores-Bellver&amp;author=FJ+Romero&amp;author=JM+Barcia&amp;publication_year=2014&amp;title=Diabetes%20and%20the%20brain%3A%20oxidative%20stress%2C%20inflammation%2C%20and%20autophagy&amp;journal=Oxid+Med+Cell+Longevity&amp;volume=2014&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B33\" id=\"B33\">\u003C/a> 33. Gerstein HC, Smith EE, Ramasundarahettige C, Desai D, Awadalla P, Broet P, et al. Diabetes, brain infarcts, cognition, and small vessels in the Canadian alliance for healthy hearts and minds study. \u003Ci>J Clin Endocrinol Metab\u003C/i>. (2021) 106:e891&#x2013;e8. doi:&#xa0;10.1210/clinem/dgaa815\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33165530/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1210/clinem/dgaa815\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=HC+Gerstein&amp;author=EE+Smith&amp;author=C+Ramasundarahettige&amp;author=D+Desai&amp;author=P+Awadalla&amp;author=P+Broet&amp;publication_year=2021&amp;title=Diabetes%2C%20brain%20infarcts%2C%20cognition%2C%20and%20small%20vessels%20in%20the%20Canadian%20alliance%20for%20healthy%20hearts%20and%20minds%20study&amp;journal=J+Clin+Endocrinol+Metab&amp;volume=106&amp;pages=e891-e8\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B34\" id=\"B34\">\u003C/a> 34. Mechanisms of cognitive decline in newly diagnosed diabetics: A review of pathophysiological contributions and intervention strategies. \u003Ci>MEDS Basic Med\u003C/i>. (2024) 2(2). doi:&#xa0;10.23977/medbm.2024.020203\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://doi.org/10.23977/medbm.2024.020203\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?publication_year=2024&amp;title=Mechanisms%20of%20cognitive%20decline%20in%20newly%20diagnosed%20diabetics%3A%20A%20review%20of%20pathophysiological%20contributions%20and%20intervention%20strategies&amp;journal=MEDS+Basic+Med&amp;volume=2&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B35\" id=\"B35\">\u003C/a> 35. Chandran R, He L, Nie X, Voltin J, Jamil S, Doueiry C, et al. Magnetic resonance imaging reveals microemboli-mediated pathological changes in brain microstructure in diabetic rats: relevance to vascular cognitive impairment/dementia. \u003Ci>Clin Sci (London England: 1979)\u003C/i>. (2022) 136:1555&#x2013;70. doi:&#xa0;10.1042/cs20220465\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36314470/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1042/cs20220465\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R+Chandran&amp;author=L+He&amp;author=X+Nie&amp;author=J+Voltin&amp;author=S+Jamil&amp;author=C+Doueiry&amp;publication_year=2022&amp;title=Magnetic%20resonance%20imaging%20reveals%20microemboli-mediated%20pathological%20changes%20in%20brain%20microstructure%20in%20diabetic%20rats%3A%20relevance%20to%20vascular%20cognitive%20impairment%2Fdementia&amp;journal=Clin+Sci+(London+England:+1979)&amp;volume=136&amp;pages=1555-70\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B36\" id=\"B36\">\u003C/a> 36. Umegaki H. Neurodegeneration in diabetes mellitus. \u003Ci>Adv Exp Med Biol\u003C/i>. (2012) 724:258&#x2013;65. doi:&#xa0;10.1007/978-1-4614-0653-2_19\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22411248/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/978-1-4614-0653-2_19\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H+Umegaki&amp;publication_year=2012&amp;title=Neurodegeneration%20in%20diabetes%20mellitus&amp;journal=Adv+Exp+Med+Biol&amp;volume=724&amp;pages=258-65\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B37\" id=\"B37\">\u003C/a> 37. Sandireddy R, Yerra VG, Areti A, Komirishetty P, and Kumar A. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. \u003Ci>Int J Endocrinol\u003C/i>. (2014) 2014:674987. doi:&#xa0;10.1155/2014/674987\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24883061/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1155/2014/674987\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R+Sandireddy&amp;author=VG+Yerra&amp;author=A+Areti&amp;author=P+Komirishetty&amp;author=A+Kumar&amp;publication_year=2014&amp;title=Neuroinflammation%20and%20oxidative%20stress%20in%20diabetic%20neuropathy%3A%20futuristic%20strategies%20based%20on%20these%20targets&amp;journal=Int+J+Endocrinol&amp;volume=2014&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B38\" id=\"B38\">\u003C/a> 38. Kumar P, Raman T, Swain MM, Mishra R, and Pal A. Hyperglycemia-induced oxidative-nitrosative stress induces inflammation and neurodegeneration via augmented tuberous sclerosis complex-2 (TSC-2) activation in neuronal cells. \u003Ci>Mol Neurobiol\u003C/i>. (2017) 54:238&#x2013;54. doi:&#xa0;10.1007/s12035-015-9667-3\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26738854/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s12035-015-9667-3\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P+Kumar&amp;author=T+Raman&amp;author=MM+Swain&amp;author=R+Mishra&amp;author=A+Pal&amp;publication_year=2017&amp;title=Hyperglycemia-induced%20oxidative-nitrosative%20stress%20induces%20inflammation%20and%20neurodegeneration%20via%20augmented%20tuberous%20sclerosis%20complex-2%20%28TSC-2%29%20activation%20in%20neuronal%20cells&amp;journal=Mol+Neurobiol&amp;volume=54&amp;pages=238-54\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B39\" id=\"B39\">\u003C/a> 39. Schmeichel AM, Schmelzer JD, and Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. \u003Ci>Diabetes\u003C/i>. (2003) 52:165&#x2013;71. doi:&#xa0;10.2337/diabetes.52.1.165\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12502508/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2337/diabetes.52.1.165\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=AM+Schmeichel&amp;author=JD+Schmelzer&amp;author=PA+Low&amp;publication_year=2003&amp;title=Oxidative%20injury%20and%20apoptosis%20of%20dorsal%20root%20ganglion%20neurons%20in%20chronic%20experimental%20diabetic%20neuropathy&amp;journal=Diabetes&amp;volume=52&amp;pages=165-71\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B40\" id=\"B40\">\u003C/a> 40. Kale MB, Bhondge HM, Wankhede NL, Shende PV, Thanekaer RP, Aglawe MM, et al. Navigating the intersection: Diabetes and Alzheimer's intertwined relationship. \u003Ci>Ageing Res Rev\u003C/i>. (2024) 100:102415. doi:&#xa0;10.1016/j.arr.2024.102415\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39002642/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.arr.2024.102415\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MB+Kale&amp;author=HM+Bhondge&amp;author=NL+Wankhede&amp;author=PV+Shende&amp;author=RP+Thanekaer&amp;author=MM+Aglawe&amp;publication_year=2024&amp;title=Navigating%20the%20intersection%3A%20Diabetes%20and%20Alzheimer%27s%20intertwined%20relationship&amp;journal=Ageing+Res+Rev&amp;volume=100&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B41\" id=\"B41\">\u003C/a> 41. Nasrolahi A, Mahmoudi J, Noori-Zadeh A, Haghani K, Bakhtiyari S, Darabi S, et al. Shared pathological mechanisms between diabetes mellitus and neurodegenerative diseases. \u003Ci>Curr Pharmacol Rep\u003C/i>. (2019) 5:219&#x2013;31. doi:&#xa0;10.1007/s40495-019-00191-8\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://doi.org/10.1007/s40495-019-00191-8\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A+Nasrolahi&amp;author=J+Mahmoudi&amp;author=A+Noori-Zadeh&amp;author=K+Haghani&amp;author=S+Bakhtiyari&amp;author=S+Darabi&amp;publication_year=2019&amp;title=Shared%20pathological%20mechanisms%20between%20diabetes%20mellitus%20and%20neurodegenerative%20diseases&amp;journal=Curr+Pharmacol+Rep&amp;volume=5&amp;pages=219-31\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B42\" id=\"B42\">\u003C/a> 42. Szablewski L. Associations between diabetes mellitus and neurodegenerative diseases. \u003Ci>Int J Mol Sci\u003C/i>. (2025) 26(2):542. doi:&#xa0;10.3390/ijms26020542\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39859258/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/ijms26020542\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=L+Szablewski&amp;publication_year=2025&amp;title=Associations%20between%20diabetes%20mellitus%20and%20neurodegenerative%20diseases&amp;journal=Int+J+Mol+Sci&amp;volume=26&amp;pages=542\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B43\" id=\"B43\">\u003C/a> 43. Ahmad R, Chowdhury K, Kumar S, Irfan M, Reddy GS, Akter F, et al. Diabetes mellitus: A path to amnesia, personality, and behavior change. \u003Ci>Biology\u003C/i>. (2022) 11(3):382. doi:&#xa0;10.3390/biology11030382\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35336756/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/biology11030382\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R+Ahmad&amp;author=K+Chowdhury&amp;author=S+Kumar&amp;author=M+Irfan&amp;author=GS+Reddy&amp;author=F+Akter&amp;publication_year=2022&amp;title=Diabetes%20mellitus%3A%20A%20path%20to%20amnesia%2C%20personality%2C%20and%20behavior%20change&amp;journal=Biology&amp;volume=11&amp;pages=382\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B44\" id=\"B44\">\u003C/a> 44. H S, T T, and Vellapandian C. Gut-brain axis: unveiling the interplay between diabetes mellitus and Alzheimer's disease. \u003Ci>Cureus\u003C/i>. (2024) 16:e68083. doi:&#xa0;10.7759/cureus.68083\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39347125/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.7759/cureus.68083\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+H&amp;author=T+T&amp;author=C+Vellapandian&amp;publication_year=2024&amp;title=Gut-brain%20axis%3A%20unveiling%20the%20interplay%20between%20diabetes%20mellitus%20and%20Alzheimer%27s%20disease&amp;journal=Cureus&amp;volume=16&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B45\" id=\"B45\">\u003C/a> 45. Bi T, Zhang L, Zhan L, Feng R, Zhao T, Ren W, et al. Integrated analyses of microbiomics and metabolomics explore the effect of gut microbiota transplantation on diabetes-associated cognitive decline in Zucker diabetic fatty rats. \u003Ci>Front Aging Neurosci\u003C/i>. (2022) 14:913002. doi:&#xa0;10.3389/fnagi.2022.913002\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35721013/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnagi.2022.913002\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=T+Bi&amp;author=L+Zhang&amp;author=L+Zhan&amp;author=R+Feng&amp;author=T+Zhao&amp;author=W+Ren&amp;publication_year=2022&amp;title=Integrated%20analyses%20of%20microbiomics%20and%20metabolomics%20explore%20the%20effect%20of%20gut%20microbiota%20transplantation%20on%20diabetes-associated%20cognitive%20decline%20in%20Zucker%20diabetic%20fatty%20rats&amp;journal=Front+Aging+Neurosci&amp;volume=14&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B46\" id=\"B46\">\u003C/a> 46. Zhang Q, Jin K, Chen B, Liu R, Cheng S, Zhang Y, et al. Overnutrition induced cognitive impairment: insulin resistance, gut-brain axis, and neuroinflammation. \u003Ci>Front Neurosci\u003C/i>. (2022) 16:884579. doi:&#xa0;10.3389/fnins.2022.884579\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35873818/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnins.2022.884579\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Q+Zhang&amp;author=K+Jin&amp;author=B+Chen&amp;author=R+Liu&amp;author=S+Cheng&amp;author=Y+Zhang&amp;publication_year=2022&amp;title=Overnutrition%20induced%20cognitive%20impairment%3A%20insulin%20resistance%2C%20gut-brain%20axis%2C%20and%20neuroinflammation&amp;journal=Front+Neurosci&amp;volume=16&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B47\" id=\"B47\">\u003C/a> 47. Bozanic A, Toro P, Bello-Lepe S, Hurtado-Oliva J, Beyle C, Vald&#xe9;s C, et al. Cognitive impairment with Type 2 Diabetes Mellitus among community-dwelling older adults in Chile: Prevalence, risk factors and cognitive characteristics. \u003Ci>Front Hum Neurosci\u003C/i>. (2022) 16:1070611. doi:&#xa0;10.3389/fnhum.2022.1070611\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36741779/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnhum.2022.1070611\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A+Bozanic&amp;author=P+Toro&amp;author=S+Bello-Lepe&amp;author=J+Hurtado-Oliva&amp;author=C+Beyle&amp;author=C+Vald%C3%A9s&amp;publication_year=2022&amp;title=Cognitive%20impairment%20with%20Type%202%20Diabetes%20Mellitus%20among%20community-dwelling%20older%20adults%20in%20Chile%3A%20Prevalence%2C%20risk%20factors%20and%20cognitive%20characteristics&amp;journal=Front+Hum+Neurosci&amp;volume=16&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B48\" id=\"B48\">\u003C/a> 48. Wu X, Tang Y, He Y, Wang Q, Wang Y, Qin X, et al. Prevalence of cognitive impairment and its related factors among Chinese older adults: an analysis based on the 2018 CHARLS data. \u003Ci>Front Public Health\u003C/i>. (2024) 12:1500172. doi:&#xa0;10.3389/fpubh.2024.1500172\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39776486/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fpubh.2024.1500172\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X+Wu&amp;author=Y+Tang&amp;author=Y+He&amp;author=Q+Wang&amp;author=Y+Wang&amp;author=X+Qin&amp;publication_year=2024&amp;title=Prevalence%20of%20cognitive%20impairment%20and%20its%20related%20factors%20among%20Chinese%20older%20adults%3A%20an%20analysis%20based%20on%20the%202018%20CHARLS%20data&amp;journal=Front+Public+Health&amp;volume=12&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B49\" id=\"B49\">\u003C/a> 49. Moran C, Gilsanz P, Beeri MS, Whitmer RA, and Lacy ME. Sex, diabetes status and cognition: findings from the study of longevity in diabetes. \u003Ci>BMJ Open Diabetes Res Care\u003C/i>. (2021) 9:e001646. doi:&#xa0;10.1136/bmjdrc-2020-001646\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33509934/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1136/bmjdrc-2020-001646\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C+Moran&amp;author=P+Gilsanz&amp;author=MS+Beeri&amp;author=RA+Whitmer&amp;author=ME+Lacy&amp;publication_year=2021&amp;title=Sex%2C%20diabetes%20status%20and%20cognition%3A%20findings%20from%20the%20study%20of%20longevity%20in%20diabetes&amp;journal=BMJ+Open+Diabetes+Res+Care&amp;volume=9&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B50\" id=\"B50\">\u003C/a> 50. Jokisch M, Platzbecker AL, Gronewold J, J&#xf6;ckel KH, Moebus S, Erbel R, et al. Gender- and age-specific association of known type 2 diabetes mellitus on incident mild cognitive impairment five years later: Results from the population-based Heinz Nixdorf Recall Study. \u003Ci>Alzheimer's Dementia\u003C/i>. (2024) 20:e084652. doi:&#xa0;10.1002/alz.084652\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/40502925/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/alz.084652\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M+Jokisch&amp;author=AL+Platzbecker&amp;author=J+Gronewold&amp;author=KH+J%C3%B6ckel&amp;author=S+Moebus&amp;author=R+Erbel&amp;publication_year=2024&amp;title=Gender-%20and%20age-specific%20association%20of%20known%20type%202%20diabetes%20mellitus%20on%20incident%20mild%20cognitive%20impairment%20five%20years%20later%3A%20Results%20from%20the%20population-based%20Heinz%20Nixdorf%20Recall%20Study&amp;journal=Alzheimer's+Dementia&amp;volume=20&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B51\" id=\"B51\">\u003C/a> 51. Reinke C. The effect of diabetes in the multifaceted relationship between education and cognitive function. \u003Ci>BMC Public Health\u003C/i>. (2024) 24:2584. doi:&#xa0;10.1186/s12889-024-20156-x\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39334040/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1186/s12889-024-20156-x\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C+Reinke&amp;publication_year=2024&amp;title=The%20effect%20of%20diabetes%20in%20the%20multifaceted%20relationship%20between%20education%20and%20cognitive%20function&amp;journal=BMC+Public+Health&amp;volume=24&amp;pages=2584\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B52\" id=\"B52\">\u003C/a> 52. Pe&#xf1;a-Gonz&#xe1;lez P, Mondrag&#xf3;n-Maya A, Silva-Pereyra J, and Roa-Rojas P. Cognitive reserve and executive functions in adults with type 2 diabetes. \u003Ci>J Diabetes Res\u003C/i>. (2020) 2020:7941543. doi:&#xa0;10.1155/2020/7941543\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33083496/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1155/2020/7941543\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P+Pe%C3%B1a-Gonz%C3%A1lez&amp;author=A+Mondrag%C3%B3n-Maya&amp;author=J+Silva-Pereyra&amp;author=P+Roa-Rojas&amp;publication_year=2020&amp;title=Cognitive%20reserve%20and%20executive%20functions%20in%20adults%20with%20type%202%20diabetes&amp;journal=J+Diabetes+Res&amp;volume=2020&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B53\" id=\"B53\">\u003C/a> 53. Connors MH, Seeher K, Teixeira-Pinto A, Woodward M, Ames D, Brodaty H, et al. Dementia and caregiver burden: A three-year longitudinal study. \u003Ci>Int J geriatric Psychiatry\u003C/i>. (2020) 35:250&#x2013;8. doi:&#xa0;10.1002/gps.5244\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31821606/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/gps.5244\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MH+Connors&amp;author=K+Seeher&amp;author=A+Teixeira-Pinto&amp;author=M+Woodward&amp;author=D+Ames&amp;author=H+Brodaty&amp;publication_year=2020&amp;title=Dementia%20and%20caregiver%20burden%3A%20A%20three-year%20longitudinal%20study&amp;journal=Int+J+geriatric+Psychiatry&amp;volume=35&amp;pages=250-8\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B54\" id=\"B54\">\u003C/a> 54. Saldana SL and Guarnaccia CA. Comparing cognitive function in white Mexican &amp; non-Hispanic white Americans with/without diabetes. \u003Ci>J Diabetes Metab Disord\u003C/i>. (2022) 21:599&#x2013;605. doi:&#xa0;10.1007/s40200-022-01022-2\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35673415/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s40200-022-01022-2\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SL+Saldana&amp;author=CA+Guarnaccia&amp;publication_year=2022&amp;title=Comparing%20cognitive%20function%20in%20white%20Mexican%20%26%20non-Hispanic%20white%20Americans%20with%2Fwithout%20diabetes&amp;journal=J+Diabetes+Metab+Disord&amp;volume=21&amp;pages=599\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B55\" id=\"B55\">\u003C/a> 55. Lin Y, Gong Z, Ma C, Wang Z, and Wang K. Relationship between glycemic control and cognitive impairment: A systematic review and meta-analysis. \u003Ci>Front Aging Neurosci\u003C/i>. (2023) 15:1126183. doi:&#xa0;10.3389/fnagi.2023.1126183\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36776436/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnagi.2023.1126183\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Lin&amp;author=Z+Gong&amp;author=C+Ma&amp;author=Z+Wang&amp;author=K+Wang&amp;publication_year=2023&amp;title=Relationship%20between%20glycemic%20control%20and%20cognitive%20impairment%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Front+Aging+Neurosci&amp;volume=15&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B56\" id=\"B56\">\u003C/a> 56. Herath PM, Cherbuin N, Eramudugolla R, and Anstey KJ. The effect of diabetes medication on cognitive function: evidence from the PATH through life study. \u003Ci>BioMed Res Int\u003C/i>. (2016) 2016:7208429. doi:&#xa0;10.1155/2016/7208429\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27195294/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1155/2016/7208429\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=PM+Herath&amp;author=N+Cherbuin&amp;author=R+Eramudugolla&amp;author=KJ+Anstey&amp;publication_year=2016&amp;title=The%20effect%20of%20diabetes%20medication%20on%20cognitive%20function%3A%20evidence%20from%20the%20PATH%20through%20life%20study&amp;journal=BioMed+Res+Int&amp;volume=2016&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B57\" id=\"B57\">\u003C/a> 57. Chapman LE, Darling AL, and Brown JE. Association between metformin and vitamin B(12) deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. \u003Ci>Diabetes Metab\u003C/i>. (2016) 42:316&#x2013;27. doi:&#xa0;10.1016/j.diabet.2016.03.008\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27130885/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.diabet.2016.03.008\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=LE+Chapman&amp;author=AL+Darling&amp;author=JE+Brown&amp;publication_year=2016&amp;title=Association%20between%20metformin%20and%20vitamin%20B%2812%29%20deficiency%20in%20patients%20with%20type%202%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Diabetes+Metab&amp;volume=42&amp;pages=316-27\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B58\" id=\"B58\">\u003C/a> 58. Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D, et al. Cognitive impairment and vitamin B12: a review. \u003Ci>Int psychogeriatrics\u003C/i>. (2012) 24:541&#x2013;56. doi:&#xa0;10.1017/s1041610211002511\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22221769/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1017/s1041610211002511\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=E+Moore&amp;author=A+Mander&amp;author=D+Ames&amp;author=R+Carne&amp;author=K+Sanders&amp;author=D+Watters&amp;publication_year=2012&amp;title=Cognitive%20impairment%20and%20vitamin%20B12%3A%20a%20review&amp;journal=Int+psychogeriatrics&amp;volume=24&amp;pages=541-56\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B59\" id=\"B59\">\u003C/a> 59. Campbell JM, Stephenson MD, De Courten B, Chapman I, Bellman SM, Aromataris E, et al. Metformin use associated with reduced risk of dementia in patients with diabetes: A systematic review and meta-analysis. \u003Ci>J Alzheimer's disease: JAD\u003C/i>. (2018) 65:1225&#x2013;36. doi:&#xa0;10.3233/jad-180263\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30149446/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3233/jad-180263\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=JM+Campbell&amp;author=MD+Stephenson&amp;author=B+De%20Courten&amp;author=I+Chapman&amp;author=SM+Bellman&amp;author=E+Aromataris&amp;publication_year=2018&amp;title=Metformin%20use%20associated%20with%20reduced%20risk%20of%20dementia%20in%20patients%20with%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=J+Alzheimer's+disease:+JAD&amp;volume=65&amp;pages=1225-36\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B60\" id=\"B60\">\u003C/a> 60. Siddeeque N, Hussein MH, Abdelmaksoud A, Bishop J, Attia AS, Elshazli RM, et al. Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study. \u003Ci>Int Immunopharmacol\u003C/i>. (2024) 143:113537. doi:&#xa0;10.1016/j.intimp.2024.113537\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39486172/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.intimp.2024.113537\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=N+Siddeeque&amp;author=MH+Hussein&amp;author=A+Abdelmaksoud&amp;author=J+Bishop&amp;author=AS+Attia&amp;author=RM+Elshazli&amp;publication_year=2024&amp;title=Neuroprotective%20effects%20of%20GLP-1%20receptor%20agonists%20in%20neurodegenerative%20Disorders%3A%20A%20Large-Scale%20Propensity-Matched%20cohort%20study&amp;journal=Int+Immunopharmacol&amp;volume=143&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B61\" id=\"B61\">\u003C/a> 61. Luan S, Cheng W, Wang C, Gong J, and Zhou J. Impact of glucagon-like peptide 1 analogs on cognitive function among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. \u003Ci>Front Endocrinol\u003C/i>. (2022) 13:1047883. doi:&#xa0;10.3389/fendo.2022.1047883\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36387915/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fendo.2022.1047883\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Luan&amp;author=W+Cheng&amp;author=C+Wang&amp;author=J+Gong&amp;author=J+Zhou&amp;publication_year=2022&amp;title=Impact%20of%20glucagon-like%20peptide%201%20analogs%20on%20cognitive%20function%20among%20patients%20with%20type%202%20diabetes%20mellitus%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Front+Endocrinol&amp;volume=13&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B62\" id=\"B62\">\u003C/a> 62. Vadini F, Simeone PG, Boccatonda A, Guagnano MT, Liani R, Tripaldi R, et al. Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study. \u003Ci>Int J Obes (2005)\u003C/i>. (2020) 44:1254&#x2013;63. doi:&#xa0;10.1038/s41366-020-0535-5\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31965072/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41366-020-0535-5\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F+Vadini&amp;author=PG+Simeone&amp;author=A+Boccatonda&amp;author=MT+Guagnano&amp;author=R+Liani&amp;author=R+Tripaldi&amp;publication_year=2020&amp;title=Liraglutide%20improves%20memory%20in%20obese%20patients%20with%20prediabetes%20or%20early%20type%202%20diabetes%3A%20a%20randomized%2C%20controlled%20study&amp;journal=Int+J+Obes+(2005)&amp;volume=44&amp;pages=1254-63\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B63\" id=\"B63\">\u003C/a> 63. Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, et al. The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer's disease. \u003Ci>J Alzheimer's disease: JAD\u003C/i>. (2015) 46:877&#x2013;88. doi:&#xa0;10.3233/jad-143090\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25869785/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3233/jad-143090\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=HH+Hansen&amp;author=K+Fabricius&amp;author=P+Barkholt&amp;author=ML+Niehoff&amp;author=JE+Morley&amp;author=J+Jelsing&amp;publication_year=2015&amp;title=The%20GLP-1%20receptor%20agonist%20liraglutide%20improves%20memory%20function%20and%20increases%20hippocampal%20CA1%20neuronal%20numbers%20in%20a%20senescence-accelerated%20mouse%20model%20of%20Alzheimer%27s%20disease&amp;journal=J+Alzheimer's+disease:+JAD&amp;volume=46&amp;pages=877-88\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B64\" id=\"B64\">\u003C/a> 64. Zhang Y, Liao X, Xu J, Yin J, Li S, Li M, et al. The promising potency of sodium-glucose cotransporter 2 inhibitors in the prevention of and as treatment for cognitive impairment among type 2 diabetes patients. \u003Ci>Biomedicines\u003C/i>. (2024) 12(12):2783. doi:&#xa0;10.3390/biomedicines12122783\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39767690/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/biomedicines12122783\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Zhang&amp;author=X+Liao&amp;author=J+Xu&amp;author=J+Yin&amp;author=S+Li&amp;author=M+Li&amp;publication_year=2024&amp;title=The%20promising%20potency%20of%20sodium-glucose%20cotransporter%202%20inhibitors%20in%20the%20prevention%20of%20and%20as%20treatment%20for%20cognitive%20impairment%20among%20type%202%20diabetes%20patients&amp;journal=Biomedicines&amp;volume=12&amp;pages=2783\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B65\" id=\"B65\">\u003C/a> 65. Gui Z, Wang J, Zhang Y, et al. Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice. \u003Ci>BioFactors (Oxford England)\u003C/i>. (2024) 50:145&#x2013;60. doi:&#xa0;10.1002/biof.1998\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37596888/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/biof.1998\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Z+Gui&amp;author=J+Wang&amp;author=Y+Zhang&amp;publication_year=2024&amp;title=Dapagliflozin%20improves%20diabetic%20cognitive%20impairment%20via%20indirectly%20modulating%20the%20mitochondria%20homeostasis%20of%20hippocampus%20in%20diabetic%20mice&amp;journal=BioFactors+(Oxford+England)&amp;volume=50&amp;pages=145-60\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B66\" id=\"B66\">\u003C/a> 66. Youn YJ, Kim S, Jeong HJ, Ah YM, and Yu YM. Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis. \u003Ci>Front Neuroendocrinol\u003C/i>. (2024) 73:101131. doi:&#xa0;10.1016/j.yfrne.2024.101131\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38367940/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.yfrne.2024.101131\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=YJ+Youn&amp;author=S+Kim&amp;author=HJ+Jeong&amp;author=YM+Ah&amp;author=YM+Yu&amp;publication_year=2024&amp;title=Sodium-glucose%20cotransporter-2%20inhibitors%20and%20their%20potential%20role%20in%20dementia%20onset%20and%20cognitive%20function%20in%20patients%20with%20diabetes%20mellitus%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Front+Neuroendocrinol&amp;volume=73&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B67\" id=\"B67\">\u003C/a> 67. Pan J, Yang H, Lu J, Chen L, Wen T, Zhao S, et al. The impact of SGLT2 inhibitors on dementia onset in patients with type 2 diabetes: A meta-analysis of cohort studies. \u003Ci>Neuroendocrinology\u003C/i>. (2025) 115(3-4):351&#x2013;9. doi:&#xa0;10.1159/000543533\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39799939/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1159/000543533\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Pan&amp;author=H+Yang&amp;author=J+Lu&amp;author=L+Chen&amp;author=T+Wen&amp;author=S+Zhao&amp;publication_year=2025&amp;title=The%20impact%20of%20SGLT2%20inhibitors%20on%20dementia%20onset%20in%20patients%20with%20type%202%20diabetes%3A%20A%20meta-analysis%20of%20cohort%20studies&amp;journal=Neuroendocrinology&amp;volume=115&amp;pages=351-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B68\" id=\"B68\">\u003C/a> 68. Lardaro A, Quarta L, Pagnotta S, Sodero G, Mariani S, Del Ben M, et al. Impact of sodium glucose cotransporter 2 inhibitors (SGLT2i) therapy on dementia and cognitive decline. \u003Ci>Biomedicines\u003C/i>. (2024) 12(8):1750. doi:&#xa0;10.3390/biomedicines12081750\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39200215/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/biomedicines12081750\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A+Lardaro&amp;author=L+Quarta&amp;author=S+Pagnotta&amp;author=G+Sodero&amp;author=S+Mariani&amp;author=M+Del%20Ben&amp;publication_year=2024&amp;title=Impact%20of%20sodium%20glucose%20cotransporter%202%20inhibitors%20%28SGLT2i%29%20therapy%20on%20dementia%20and%20cognitive%20decline&amp;journal=Biomedicines&amp;volume=12&amp;pages=1750\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B69\" id=\"B69\">\u003C/a> 69. Gault VA, Lennox R, and Flatt PR. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline. \u003Ci>Diabetes Obes Metab\u003C/i>. (2015) 17:403&#x2013;13. doi:&#xa0;10.1111/dom.12432\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25580570/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/dom.12432\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=VA+Gault&amp;author=R+Lennox&amp;author=PR+Flatt&amp;publication_year=2015&amp;title=Sitagliptin%2C%20a%20dipeptidyl%20peptidase-4%20inhibitor%2C%20improves%20recognition%20memory%2C%20oxidative%20stress%20and%20hippocampal%20neurogenesis%20and%20upregulates%20key%20genes%20involved%20in%20cognitive%20decline&amp;journal=Diabetes+Obes+Metab&amp;volume=17&amp;pages=403-13\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B70\" id=\"B70\">\u003C/a> 70. Yuan Y, Zhang Y, Lei M, Guo X, Yang X, Ouyang C, et al. Effects of DPP4 inhibitors as neuroprotective drug on cognitive impairment in patients with type 2 diabetes mellitus: A meta-analysis and systematic review. \u003Ci>Int J Endocrinol\u003C/i>. (2024) 2024:9294113. doi:&#xa0;10.1155/2024/9294113\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38379936/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1155/2024/9294113\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Yuan&amp;author=Y+Zhang&amp;author=M+Lei&amp;author=X+Guo&amp;author=X+Yang&amp;author=C+Ouyang&amp;publication_year=2024&amp;title=Effects%20of%20DPP4%20inhibitors%20as%20neuroprotective%20drug%20on%20cognitive%20impairment%20in%20patients%20with%20type%202%20diabetes%20mellitus%3A%20A%20meta-analysis%20and%20systematic%20review&amp;journal=Int+J+Endocrinol&amp;volume=2024&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B71\" id=\"B71\">\u003C/a> 71. Hu Y, Xu J, Wang J, Zhu L, Wang J, Zhang Q, et al. DPP-4 inhibitors suppress tau phosphorylation and promote neuron autophagy through the AMPK/mTOR pathway to ameliorate cognitive dysfunction in diabetic mellitus. \u003Ci>ACS Chem Neurosci\u003C/i>. (2023) 14:3335&#x2013;46. doi:&#xa0;10.1021/acschemneuro.2c00733\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37655714/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1021/acschemneuro.2c00733\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Hu&amp;author=J+Xu&amp;author=J+Wang&amp;author=L+Zhu&amp;author=J+Wang&amp;author=Q+Zhang&amp;publication_year=2023&amp;title=DPP-4%20inhibitors%20suppress%20tau%20phosphorylation%20and%20promote%20neuron%20autophagy%20through%20the%20AMPK%2FmTOR%20pathway%20to%20ameliorate%20cognitive%20dysfunction%20in%20diabetic%20mellitus&amp;journal=ACS+Chem+Neurosci&amp;volume=14&amp;pages=3335-46\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B72\" id=\"B72\">\u003C/a> 72. Meng J, Yan R, Zhang C, Bai X, Yang X, Yang Y, et al. Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus. \u003Ci>Lipids Health Dis\u003C/i>. (2023) 22:219. doi:&#xa0;10.1186/s12944-023-01985-y\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38082288/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1186/s12944-023-01985-y\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Meng&amp;author=R+Yan&amp;author=C+Zhang&amp;author=X+Bai&amp;author=X+Yang&amp;author=Y+Yang&amp;publication_year=2023&amp;title=Dipeptidyl%20peptidase-4%20inhibitors%20alleviate%20cognitive%20dysfunction%20in%20type%202%20diabetes%20mellitus&amp;journal=Lipids+Health+Dis&amp;volume=22&amp;pages=219\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B73\" id=\"B73\">\u003C/a> 73. Rizzo MR, Barbieri M, Boccardi V, Angellotti E, Marfella R, Paolisso G, et al. Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment. \u003Ci>journals gerontology Ser A Biol Sci Med Sci\u003C/i>. (2014) 69:1122&#x2013;31. doi:&#xa0;10.1093/gerona/glu032\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24671867/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/gerona/glu032\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MR+Rizzo&amp;author=M+Barbieri&amp;author=V+Boccardi&amp;author=E+Angellotti&amp;author=R+Marfella&amp;author=G+Paolisso&amp;publication_year=2014&amp;title=Dipeptidyl%20peptidase-4%20inhibitors%20have%20protective%20effect%20on%20cognitive%20impairment%20in%20aged%20diabetic%20patients%20with%20mild%20cognitive%20impairment&amp;journal=journals+gerontology+Ser+A+Biol+Sci+Med+Sci&amp;volume=69&amp;pages=1122-31\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B74\" id=\"B74\">\u003C/a> 74. Pintana H, Apaijai N, Chattipakorn N, and Chattipakorn SC. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. \u003Ci>J Endocrinol\u003C/i>. (2013) 218:1&#x2013;11. doi:&#xa0;10.1530/joe-12-0521\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23591914/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1530/joe-12-0521\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H+Pintana&amp;author=N+Apaijai&amp;author=N+Chattipakorn&amp;author=SC+Chattipakorn&amp;publication_year=2013&amp;title=DPP-4%20inhibitors%20improve%20cognition%20and%20brain%20mitochondrial%20function%20of%20insulin-resistant%20rats&amp;journal=J+Endocrinol&amp;volume=218&amp;pages=1\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B75\" id=\"B75\">\u003C/a> 75. Anirudhan A, Ahmad SF, Emran TB, Angulo-Bejarano PI, Sharma A, Ahmed S, et al. Comparative efficacy of metformin and glimepiride in modulating pharmacological network to increase BDNF levels and benefit type 2 diabetes-related cognitive impairment. \u003Ci>Biomedicines\u003C/i>. (2023) 11(11):2939. doi:&#xa0;10.3390/biomedicines11112939\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38001940/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/biomedicines11112939\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A+Anirudhan&amp;author=SF+Ahmad&amp;author=TB+Emran&amp;author=PI+Angulo-Bejarano&amp;author=A+Sharma&amp;author=S+Ahmed&amp;publication_year=2023&amp;title=Comparative%20efficacy%20of%20metformin%20and%20glimepiride%20in%20modulating%20pharmacological%20network%20to%20increase%20BDNF%20levels%20and%20benefit%20type%202%20diabetes-related%20cognitive%20impairment&amp;journal=Biomedicines&amp;volume=11&amp;pages=2939\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B76\" id=\"B76\">\u003C/a> 76. Rosado AF, Rosa PB, Platt N, Pierone BC, Neis VB, Severo Rodrigues AL, et al. Glibenclamide treatment prevents depressive-like behavior and memory impairment induced by chronic unpredictable stress in female mice. \u003Ci>Behav Pharmacol\u003C/i>. (2021) 32:170&#x2013;81. doi:&#xa0;10.1097/fbp.0000000000000599\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33079735/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1097/fbp.0000000000000599\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=AF+Rosado&amp;author=PB+Rosa&amp;author=N+Platt&amp;author=BC+Pierone&amp;author=VB+Neis&amp;author=AL+Severo%20Rodrigues&amp;publication_year=2021&amp;title=Glibenclamide%20treatment%20prevents%20depressive-like%20behavior%20and%20memory%20impairment%20induced%20by%20chronic%20unpredictable%20stress%20in%20female%20mice&amp;journal=Behav+Pharmacol&amp;volume=32&amp;pages=170-81\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B77\" id=\"B77\">\u003C/a> 77. Wu CY, Iskander C, Wang C, Xiong LY, Shah BR, Edwards JD, et al. Association of sulfonylureas with the risk of dementia: A population-based cohort study. \u003Ci>J Am Geriatrics Soc\u003C/i>. (2023) 71:3059&#x2013;70. doi:&#xa0;10.1111/jgs.18397\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37218376/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/jgs.18397\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=CY+Wu&amp;author=C+Iskander&amp;author=C+Wang&amp;author=LY+Xiong&amp;author=BR+Shah&amp;author=JD+Edwards&amp;publication_year=2023&amp;title=Association%20of%20sulfonylureas%20with%20the%20risk%20of%20dementia%3A%20A%20population-based%20cohort%20study&amp;journal=J+Am+Geriatrics+Soc&amp;volume=71&amp;pages=3059-70\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B78\" id=\"B78\">\u003C/a> 78. Tian S, Jiang J, Wang J, Zhang Z, Miao Y, Ji X, et al. Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis. \u003Ci>Diabetes/metabolism Res Rev\u003C/i>. (2023) 39:e3673. doi:&#xa0;10.1002/dmrr.3673\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37302139/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/dmrr.3673\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Tian&amp;author=J+Jiang&amp;author=J+Wang&amp;author=Z+Zhang&amp;author=Y+Miao&amp;author=X+Ji&amp;publication_year=2023&amp;title=Comparison%20on%20cognitive%20outcomes%20of%20antidiabetic%20agents%20for%20type%202%20diabetes%3A%20A%20systematic%20review%20and%20network%20meta-analysis&amp;journal=Diabetes/metabolism+Res+Rev&amp;volume=39&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B79\" id=\"B79\">\u003C/a> 79. Vandersmissen J, Dewachter I, Cuypers K, and Hansen D. The impact of exercise training on the brain and cognition in T2DM, and its physiological mediators: a systematic review. \u003Ci>medRxiv\u003C/i>. (2024) 11:42. doi:&#xa0;10.1101/2024.09.19.24313875\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/40274715/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1101/2024.09.19.24313875\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Vandersmissen&amp;author=I+Dewachter&amp;author=K+Cuypers&amp;author=D+Hansen&amp;publication_year=2024&amp;title=The%20impact%20of%20exercise%20training%20on%20the%20brain%20and%20cognition%20in%20T2DM%2C%20and%20its%20physiological%20mediators%3A%20a%20systematic%20review&amp;journal=medRxiv&amp;volume=11&amp;pages=42\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B80\" id=\"B80\">\u003C/a> 80. Sun Z, Liu H, Yan M, Zeng H, Hu Y, Tian X, et al. The effect of multi-component exercise on cognition function in patients with diabetes: A systematic review and meta-analysis. \u003Ci>PLoS One\u003C/i>. (2024) 19:e0304795. doi:&#xa0;10.1371/journal.pone.0304795\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38900771/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0304795\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Z+Sun&amp;author=H+Liu&amp;author=M+Yan&amp;author=H+Zeng&amp;author=Y+Hu&amp;author=X+Tian&amp;publication_year=2024&amp;title=The%20effect%20of%20multi-component%20exercise%20on%20cognition%20function%20in%20patients%20with%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=PLoS+One&amp;volume=19&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B81\" id=\"B81\">\u003C/a> 81. Cooke S, Pennington K, Jones A, Bridle C, Smith MF, Curtis F, et al. Effects of exercise, cognitive, and dual-task interventions on cognition in type 2 diabetes mellitus: A systematic review and meta-analysis. \u003Ci>PLoS One\u003C/i>. (2020) 15:e0232958. doi:&#xa0;10.1371/journal.pone.0232958\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32407347/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0232958\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Cooke&amp;author=K+Pennington&amp;author=A+Jones&amp;author=C+Bridle&amp;author=MF+Smith&amp;author=F+Curtis&amp;publication_year=2020&amp;title=Effects%20of%20exercise%2C%20cognitive%2C%20and%20dual-task%20interventions%20on%20cognition%20in%20type%202%20diabetes%20mellitus%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=PLoS+One&amp;volume=15&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B82\" id=\"B82\">\u003C/a> 82. Wang R, Yan W, Du M, Tao L, and Liu J. The effect of physical activity interventions on cognition function in patients with diabetes: A systematic review and meta-analysis. \u003Ci>Diabetes/metabolism Res Rev\u003C/i>. (2021) 37:e3443. doi:&#xa0;10.1002/dmrr.3443\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33616310/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/dmrr.3443\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R+Wang&amp;author=W+Yan&amp;author=M+Du&amp;author=L+Tao&amp;author=J+Liu&amp;publication_year=2021&amp;title=The%20effect%20of%20physical%20activity%20interventions%20on%20cognition%20function%20in%20patients%20with%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Diabetes/metabolism+Res+Rev&amp;volume=37&amp;pages=e3443\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B83\" id=\"B83\">\u003C/a> 83. Cuevas HE, Stuifbergen AK, Brown SA, and Ward C. A. A nurse-led cognitive training intervention for individuals with type 2 diabetes. \u003Ci>Res gerontological Nurs\u003C/i>. (2019) 12:203&#x2013;12. doi:&#xa0;10.3928/19404921-20190612-01\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31335962/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3928/19404921-20190612-01\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=HE+Cuevas&amp;author=AK+Stuifbergen&amp;author=SA+Brown&amp;author=C.%20A+Ward&amp;publication_year=2019&amp;title=A%20nurse-led%20cognitive%20training%20intervention%20for%20individuals%20with%20type%202%20diabetes&amp;journal=Res+gerontological+Nurs&amp;volume=12&amp;pages=203-12\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B84\" id=\"B84\">\u003C/a> 84. Dyer AH, Briggs R, Mockler D, Gibney J, and Kennelly SP. Non-pharmacological interventions for cognition in patients with Type 2 diabetes mellitus: a systematic review. \u003Ci>QJM: monthly J Assoc Physicians\u003C/i>. (2020) 113:155&#x2013;61. doi:&#xa0;10.1093/qjmed/hcz053\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30825309/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/qjmed/hcz053\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=AH+Dyer&amp;author=R+Briggs&amp;author=D+Mockler&amp;author=J+Gibney&amp;author=SP+Kennelly&amp;publication_year=2020&amp;title=Non-pharmacological%20interventions%20for%20cognition%20in%20patients%20with%20Type%202%20diabetes%20mellitus%3A%20a%20systematic%20review&amp;journal=QJM:+monthly+J+Assoc+Physicians&amp;volume=113&amp;pages=155-61\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B85\" id=\"B85\">\u003C/a> 85. Goetzl EJ, Mustapic M, Kapogiannis D, Eitan E, Lobach IV, Goetzl L, et al. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease. \u003Ci>FASEB J\u003C/i>. (2016) 30:3853&#x2013;9. doi:&#xa0;10.1096/fj.201600756R\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27511944/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1096/fj.201600756R\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=EJ+Goetzl&amp;author=M+Mustapic&amp;author=D+Kapogiannis&amp;author=E+Eitan&amp;author=IV+Lobach&amp;author=L+Goetzl&amp;publication_year=2016&amp;title=Cargo%20proteins%20of%20plasma%20astrocyte-derived%20exosomes%20in%20Alzheimer%27s%20disease&amp;journal=FASEB+J&amp;volume=30&amp;pages=3853-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B86\" id=\"B86\">\u003C/a> 86. Chi H, Yao R, Sun C, Leng B, Shen T, Wang T, et al. Blood neuroexosomal mitochondrial proteins predict Alzheimer disease in diabetes. \u003Ci>Diabetes\u003C/i>. (2022) 71:1313&#x2013;23. doi:&#xa0;10.2337/db21-0969\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35287177/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2337/db21-0969\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H+Chi&amp;author=R+Yao&amp;author=C+Sun&amp;author=B+Leng&amp;author=T+Shen&amp;author=T+Wang&amp;publication_year=2022&amp;title=Blood%20neuroexosomal%20mitochondrial%20proteins%20predict%20Alzheimer%20disease%20in%20diabetes&amp;journal=Diabetes&amp;volume=71&amp;pages=1313-23\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B87\" id=\"B87\">\u003C/a> 87. Kumar A, Cleary JA, Su Y, Singh S, Howard M, Hayden KM, et al. Multi-omics analysis of neuron-derived small extracellular vesicles to identify novel peripheral biomarker of cognitive impairment in individuals with type 2 diabetes. \u003Ci>Alzheimer's Dementia\u003C/i>. (2024) 20:e091878. doi:&#xa0;10.1002/alz.091878\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://doi.org/10.1002/alz.091878\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A+Kumar&amp;author=JA+Cleary&amp;author=Y+Su&amp;author=S+Singh&amp;author=M+Howard&amp;author=KM+Hayden&amp;publication_year=2024&amp;title=Multi-omics%20analysis%20of%20neuron-derived%20small%20extracellular%20vesicles%20to%20identify%20novel%20peripheral%20biomarker%20of%20cognitive%20impairment%20in%20individuals%20with%20type%202%20diabetes&amp;journal=Alzheimer's+Dementia&amp;volume=20&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B88\" id=\"B88\">\u003C/a> 88. Van Den Berg MMJ, Krauskopf J, Ramaekers JG, Kleinjans JCS, Prickaerts J, Briede JJ, et al. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. \u003Ci>Prog Neurobiol\u003C/i>. (2020) 185:101732. doi:&#xa0;10.1016/j.pneurobio.2019.101732\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31816349/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.pneurobio.2019.101732\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MMJ+Van%20Den%20Berg&amp;author=J+Krauskopf&amp;author=JG+Ramaekers&amp;author=JCS+Kleinjans&amp;author=J+Prickaerts&amp;author=JJ+Briede&amp;publication_year=2020&amp;title=Circulating%20microRNAs%20as%20potential%20biomarkers%20for%20psychiatric%20and%20neurodegenerative%20disorders&amp;journal=Prog+Neurobiol&amp;volume=185&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B89\" id=\"B89\">\u003C/a> 89. Liu X, Zhao Z, Chen D, Zhang Z, Lin X, Shen Z, et al. SIRT1 and miR-34a-5p expression in PBMCs as potential biomarkers for patients with type 2 diabetes with cognitive impairments. \u003Ci>J Clin Endocrinol Metab\u003C/i>. (2024) 109:815&#x2013;26. doi:&#xa0;10.1210/clinem/dgad562\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37758217/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1210/clinem/dgad562\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X+Liu&amp;author=Z+Zhao&amp;author=D+Chen&amp;author=Z+Zhang&amp;author=X+Lin&amp;author=Z+Shen&amp;publication_year=2024&amp;title=SIRT1%20and%20miR-34a-5p%20expression%20in%20PBMCs%20as%20potential%20biomarkers%20for%20patients%20with%20type%202%20diabetes%20with%20cognitive%20impairments&amp;journal=J+Clin+Endocrinol+Metab&amp;volume=109&amp;pages=815-26\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B90\" id=\"B90\">\u003C/a> 90. Chen MD, Deng CF, Chen PF, Li A, Wu HZ, Ouyang F, et al. Non-invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta-analysis. \u003Ci>Diabetes Obes Metab\u003C/i>. (2024) 26:5519&#x2013;36. doi:&#xa0;10.1111/dom.15916\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39233493/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/dom.15916\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MD+Chen&amp;author=CF+Deng&amp;author=PF+Chen&amp;author=A+Li&amp;author=HZ+Wu&amp;author=F+Ouyang&amp;publication_year=2024&amp;title=Non-invasive%20metabolic%20biomarkers%20in%20initial%20cognitive%20impairment%20in%20patients%20with%20diabetes%3A%20A%20systematic%20review%20and%20meta-analysis&amp;journal=Diabetes+Obes+Metab&amp;volume=26&amp;pages=5519-36\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B91\" id=\"B91\">\u003C/a> 91. Ehtewish H, Arredouani A, and El-Agnaf O. Diagnostic, prognostic, and mechanistic biomarkers of diabetes mellitus-associated cognitive decline. \u003Ci>Int J Mol Sci\u003C/i>. (2022) 23(11):6144. doi:&#xa0;10.3390/ijms23116144\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35682821/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/ijms23116144\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H+Ehtewish&amp;author=A+Arredouani&amp;author=O+El-Agnaf&amp;publication_year=2022&amp;title=Diagnostic%2C%20prognostic%2C%20and%20mechanistic%20biomarkers%20of%20diabetes%20mellitus-associated%20cognitive%20decline&amp;journal=Int+J+Mol+Sci&amp;volume=23&amp;pages=6144\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B92\" id=\"B92\">\u003C/a> 92. Zhang T, Shaw M, and Cherbuin N. Association between type 2 diabetes mellitus and brain atrophy: A meta-analysis. \u003Ci>Diabetes Metab J\u003C/i>. (2022) 46:781&#x2013;802. doi:&#xa0;10.4093/dmj.2021.0189\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35255549/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.4093/dmj.2021.0189\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=T+Zhang&amp;author=M+Shaw&amp;author=N+Cherbuin&amp;publication_year=2022&amp;title=Association%20between%20type%202%20diabetes%20mellitus%20and%20brain%20atrophy%3A%20A%20meta-analysis&amp;journal=Diabetes+Metab+J&amp;volume=46&amp;pages=781\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B93\" id=\"B93\">\u003C/a> 93. Zhang W, Gao C, Qing Z, Zhang Z, Bi Y, Zeng W, et al. Hippocampal subfields atrophy contribute more to cognitive impairment in middle-aged patients with type 2 diabetes rather than microvascular lesions. \u003Ci>Acta Diabetologica\u003C/i>. (2021) 58:1023&#x2013;33. doi:&#xa0;10.1007/s00592-020-01670-x\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33751221/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00592-020-01670-x\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W+Zhang&amp;author=C+Gao&amp;author=Z+Qing&amp;author=Z+Zhang&amp;author=Y+Bi&amp;author=W+Zeng&amp;publication_year=2021&amp;title=Hippocampal%20subfields%20atrophy%20contribute%20more%20to%20cognitive%20impairment%20in%20middle-aged%20patients%20with%20type%202%20diabetes%20rather%20than%20microvascular%20lesions&amp;journal=Acta+Diabetologica&amp;volume=58&amp;pages=1023-33\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B94\" id=\"B94\">\u003C/a> 94. Naidu VV, Ismail K, Amiel S, Kohli R, Crosby-Nwaobi R, Sivaprasad S, et al. Associations between retinal markers of microvascular disease and cognitive impairment in newly diagnosed type 2 diabetes mellitus: A case control study. \u003Ci>PLoS One\u003C/i>. (2016) 11:e0147160. doi:&#xa0;10.1371/journal.pone.0147160\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26771382/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0147160\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=VV+Naidu&amp;author=K+Ismail&amp;author=S+Amiel&amp;author=R+Kohli&amp;author=R+Crosby-Nwaobi&amp;author=S+Sivaprasad&amp;publication_year=2016&amp;title=Associations%20between%20retinal%20markers%20of%20microvascular%20disease%20and%20cognitive%20impairment%20in%20newly%20diagnosed%20type%202%20diabetes%20mellitus%3A%20A%20case%20control%20study&amp;journal=PLoS+One&amp;volume=11&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B95\" id=\"B95\">\u003C/a> 95. Doney ASF, Nar A, Huang Y, Trucco E, MacGillivray T, Connelly P, et al. Retinal vascular measures from diabetes retinal screening photographs and risk of incident dementia in type 2 diabetes: A GoDARTS study. \u003Ci>Front digital Health\u003C/i>. (2022) 4:945276. doi:&#xa0;10.3389/fdgth.2022.945276\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36120710/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fdgth.2022.945276\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=ASF+Doney&amp;author=A+Nar&amp;author=Y+Huang&amp;author=E+Trucco&amp;author=T+MacGillivray&amp;author=P+Connelly&amp;publication_year=2022&amp;title=Retinal%20vascular%20measures%20from%20diabetes%20retinal%20screening%20photographs%20and%20risk%20of%20incident%20dementia%20in%20type%202%20diabetes%3A%20A%20GoDARTS%20study&amp;journal=Front+digital+Health&amp;volume=4&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B96\" id=\"B96\">\u003C/a> 96. Pedersen FN, Stokholm L, Lois N, Yang D, Cheung CY, Biessels GJ, et al. Structural and metabolic retinal changes associated with mild cognitive impairment in type 2 diabetes. \u003Ci>Diabetes\u003C/i>. (2023) 72:1853&#x2013;63. doi:&#xa0;10.2337/db23-0025\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37725903/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2337/db23-0025\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=FN+Pedersen&amp;author=L+Stokholm&amp;author=N+Lois&amp;author=D+Yang&amp;author=CY+Cheung&amp;author=GJ+Biessels&amp;publication_year=2023&amp;title=Structural%20and%20metabolic%20retinal%20changes%20associated%20with%20mild%20cognitive%20impairment%20in%20type%202%20diabetes&amp;journal=Diabetes&amp;volume=72&amp;pages=1853-63\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:0em;\">\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0em; text-indent:0em;\">\u003Ca name=\"B97\" id=\"B97\">\u003C/a> 97. Majimbi M, McLenachan S, Nesbit M, Chen FK, Lam V, Mamo J, et al. \u003Ci>In vivo\u003C/i> retinal imaging is associated with cognitive decline, blood-brain barrier disruption and neuroinflammation in type 2 diabetic mice. \u003Ci>Front Endocrinol\u003C/i>. (2023) 14:2023.1224418. doi:&#xa0;10.3389/fendo.2023.1224418\u003C/p>\u003Cp class=\"ReferencesCopy2\" style=\"margin-left:0em;\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37850093/\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fendo.2023.1224418\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M+Majimbi&amp;author=S+McLenachan&amp;author=M+Nesbit&amp;author=FK+Chen&amp;author=V+Lam&amp;author=J+Mamo&amp;publication_year=2023&amp;title=In%20vivo%20retinal%20imaging%20is%20associated%20with%20cognitive%20decline%2C%20blood-brain%20barrier%20disruption%20and%20neuroinflammation%20in%20type%202%20diabetic%20mice&amp;journal=Front+Endocrinol&amp;volume=14&amp;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003C/div>\u003Cdiv class=\"thinLineM20\">\u003C/div>\u003Cdiv class=\"AbstractSummary\">\u003Cp>\u003Cspan>Keywords:\u003C/span> type 2 diabetes mellitus, cognitive impairment, insulin resistance, oxidative stress, mitochondrial dysfunction\u003C/p>\u003Cp>\u003Cspan>Citation:\u003C/span> Kan W, Qu M, Wang Y, Zhang X and Xu L (2025) A review of type 2 diabetes mellitus and cognitive impairment. \u003Ci>Front. Endocrinol.\u003C/i> 16:1624472. doi: 10.3389/fendo.2025.1624472\u003C/p>\u003Cp id=\"timestamps\">\u003Cspan>Received:\u003C/span> 07 May 2025; \u003Cspan>Accepted:\u003C/span> 16 July 2025;\u003Cbr>\u003Cspan>Published:\u003C/span> 04 August 2025.\u003C/p>\u003Cdiv>\u003Cp>Edited by:\u003C/p>\u003Ca href=\"https://loop.frontiersin.org/people/651910\">Xiaodong Sun\u003C/a>, Affiliated Hospital Of Shandong Second Medical University, China\u003C/div>\u003Cdiv>\u003Cp>Reviewed by:\u003C/p>\u003Ca href=\"https://loop.frontiersin.org/people/2225980\">Xiao-Jing Shi\u003C/a>, Massachusetts Institute of Technology, United States\u003Cbr>\u003Ca href=\"https://loop.frontiersin.org/people/2251029\">Maarja Randv&#xe4;li\u003C/a>, Tallinn University, Estonia\u003C/div>\u003Cp>\u003Cspan>Copyright\u003C/span> &#xa9; 2025 Kan, Qu, Wang, Zhang and Xu. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY)\u003C/a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\u003Cp>\u003Cspan>*Correspondence:\u003C/span> Lili Xu, \u003Ca id=\"encmail\">eHVsaWxpMjAxMzE0QDEyNi5jb20=\u003C/a>\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>","\u003Cul class=\"flyoutJournal\">\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h2\">1 Introduction\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h3\">2 Pathophysiology of T2DM and its impact on cognitive function\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h4\">3 Mechanistic insights into T2DM and cognitive impairment\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h5\">4 Sociodemographic moderators in T2DM-related cognitive impairment\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h6\">5 T2DM management and cognitive impairment\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h7\">6 Biomarkers of cognitive impairment in T2DM\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h8\">7 Conclusion\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h9\">Author contributions\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h10\">Funding\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h11\">Conflict of interest\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h12\">Generative AI statement\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h13\">Publisher&#x2019;s note\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h14\">References\u003C/a>\u003C/li>\u003C/ul>",[634,640,646],{"name":635,"fileServerPackageEntryId":19,"fileServerId":636,"fileServerVersionNumber":384,"type":637},"EPUB.epub","1624472/epub",{"code":638,"name":639},"EPUB","epub",{"name":641,"fileServerPackageEntryId":19,"fileServerId":642,"fileServerVersionNumber":384,"type":643},"Publishers-Proof.pdf","1624472/publishers-proof",{"code":644,"name":645},"PDF","pdf",{"name":647,"fileServerPackageEntryId":647,"fileServerId":648,"fileServerVersionNumber":384,"type":649},"fendo-16-1624472.xml","1624472/xml",{"code":650,"name":651},"NLM_XML","xml","fendo-16-1624472-HTML","v3",{"title":655,"link":656,"meta":660,"script":764},"Frontiers | A review of type 2 diabetes mellitus and cognitive impairment",[657],{"rel":658,"href":659},"canonical","https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/full",[661,664,667,669,672,676,679,683,686,689,692,694,696,698,700,702,705,708,710,713,715,717,720,723,726,729,732,736,740,743,746,749,751,754,756,759,761],{"hid":662,"property":662,"name":662,"content":663},"description","The association between type 2 diabetes mellitus (T2DM) and cognitive impairment represents a critical public health concern, particularly against the backdr...",{"hid":665,"property":665,"name":666,"content":655},"og:title","title",{"hid":668,"property":668,"name":662,"content":663},"og:description",{"hid":670,"name":670,"content":671},"keywords","type 2 diabetes mellitus,insulin resistance,oxidative stress,cognitive impairment,mitochondrial dysfunction",{"hid":673,"property":673,"name":674,"content":675},"og:site_name","site_name","Frontiers",{"hid":677,"property":677,"name":377,"content":678},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1624472/fendo-16-1624472-HTML/image_m/fendo-16-1624472-t001.jpg",{"hid":680,"property":680,"name":681,"content":682},"og:type","type","article",{"hid":684,"property":684,"name":685,"content":659},"og:url","url",{"hid":687,"name":687,"content":688},"twitter:card","summary_large_image",{"hid":690,"name":690,"content":691},"citation_volume","16",{"hid":693,"name":693,"content":116},"citation_journal_title",{"hid":695,"name":695,"content":675},"citation_publisher",{"hid":697,"name":697,"content":615},"citation_journal_abbrev",{"hid":699,"name":699,"content":616},"citation_issn",{"hid":701,"name":701,"content":528},"citation_doi",{"hid":703,"name":703,"content":704},"citation_firstpage","1624472",{"hid":706,"name":706,"content":707},"citation_language","English",{"hid":709,"name":709,"content":529},"citation_title",{"hid":711,"name":711,"content":712},"citation_keywords","type 2 diabetes mellitus; insulin resistance; oxidative stress; cognitive impairment; mitochondrial dysfunction",{"hid":714,"name":714,"content":534},"citation_abstract",{"hid":716,"name":716,"content":543},"citation_article_type",{"hid":718,"name":718,"content":719},"citation_pdf_url","https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/pdf",{"hid":721,"name":721,"content":722},"citation_xml_url","https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624472/xml",{"hid":724,"name":724,"content":725},"citation_fulltext_world_readable","yes",{"hid":727,"name":727,"content":728},"citation_online_date","2025/07/16",{"hid":730,"name":730,"content":731},"citation_publication_date","2025/08/04",{"hid":733,"name":734,"content":735},"citation_author_0","citation_author","Kan, Wen ",{"hid":737,"name":738,"content":739},"citation_author_institution_0","citation_author_institution","Department of Endocrinology and Metabolic Diseases, Affiliated Hospital of Qingdao University, China",{"hid":741,"name":734,"content":742},"citation_author_1","Qu, Meijie ",{"hid":744,"name":738,"content":745},"citation_author_institution_1","Department of Neurology, Affiliated Hospital of Qingdao University, China",{"hid":747,"name":734,"content":748},"citation_author_2","Wang, Yunyang ",{"hid":750,"name":738,"content":739},"citation_author_institution_2",{"hid":752,"name":734,"content":753},"citation_author_3","Zhang, Xianjun ",{"hid":755,"name":738,"content":745},"citation_author_institution_3",{"hid":757,"name":734,"content":758},"citation_author_4","Xu, Lili ",{"hid":760,"name":738,"content":739},"citation_author_institution_4",{"hid":762,"name":762,"content":763},"dc.identifier","doi:10.3389/fendo.2025.1624472",[765,768,770,772,774],{"src":766,"body":13,"type":767,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":769,"body":13,"type":767,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":771,"body":13,"type":767,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":773,"body":13,"type":767,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fendo.2025.1624472?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":775,"body":13,"type":767,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":777,"articleHubArticlesList":778,"canJournalHasArticleHub":355,"articleDoiList":779},{},[],[],{"title":19,"image":-1,"breadcrumbs":781,"linksCollection":782,"metricsCollection":784},[],{"total":381,"items":783},[],{"total":381,"items":785},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false,\"useXmlImages\":true}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"b9b23680-846c-4155-9f00-37c6bae31c9f",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fendo.2025.1624472?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>